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During development and after birth neural stem cells in the subventricular zone (SVZ) generate 
neuroblasts that migrate along the rostral migratory stream (RMS) to populate the olfactory bulb 
(OB) with neurons. Multiple factors promote neuroblast migration, but the contribution that many 
of these make to guidance within the intact RMS is not known. In the first part of this present 
study we have characterised in detail how endocannabinoid (eCB), fibroblast growth factor 
receptor (FGFR) and brain-derived neurotrophic factor (BDNF) signalling regulate motility and 
guidance, and also determined whether any of these receptors operate in a regionally restricted 
manner. We used in vivo electroporation in postnatal mice to fluorescently label neuroblasts, 
followed by live cell imaging to detail their migratory properties. Cannabinoid receptor antagonists 
rendered neuroblasts less mobile, and when they did move guidance was lost. Similar results 
were obtained when eCB synthesis was blocked with diacylglycerol lipase (DAGL, enzymes that 
are responsible for the synthesis of the eCB receptor ligand 2-AG) inhibitor. Importantly eCB 
function is required for directed migration at both ends of the RMS. Likewise, inhibition of BDNF 
signalling disrupted motility and guidance in a similar manner along the entire RMS. In contrast, 
altering FGFR signalling inhibits motility and perturbs guidance, but only at the beginning of the 
stream. Inhibition of FGFR signalling in vivo also reduces the length of the leading process on 
migratory neuroblasts in a graded manner along the RMS.  
In the second part of this study we focus on the intracellular trafficking of DAGLs. Apart from their 
function in neuroblast migration as shown above, DAGLs are also involved in axonal growth, 
guidance and synaptic signalling. We developed a new construct which allows the surface 
labelling of DAGLα. By expressing this construct in neurons, we found DAGLα co-localizes with 
Homer, a postsynaptic marker. An antibody feeding assay revealed that DAGLα undergoes 
constitutive endocytosis in cultured hippocampal neurons and COS-7 cells. Detailed studies 
showed that DAGLα co-localizes with early endosome markers and undergoes recycling in COS-
7 cells. This constitutive endocytosis and recycling of the enzyme is likely to be responsible for 
the distinct localization pattern of DAGLα in neurons.  
In summary, these results describe the important role of eCB, FGFR and BDNF signalling in 
neuroblast migration in the postnatal brain. Also it is the first time it has been shown that DAGLα 
undergoes constitutive endocytosis and recycling inside of the cell.  
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Chapter 1 Introduction 
‘The brain is a wonderful organ’ as written by American poet Robert Frost, ‘It starts working the 
moment we get up in the morning, and doesn’t stop until we get to the office’. From the scientific 
point of view, the human brain is wonderful not only because it enables the poet to write poetry 
and make jokes. It is wonderful because it is the most complex organ that we are trying to 
understand, using the brain itself. The complexity of the human brain can be presented by few 
facts: it is composed of approximately 86 billion neurons (Herculano-Houzel, 2009), with each of 
them has on average 7000 synaptic connections to other neurons. A typical adult human brain is 
estimated to have over 100 trillion synapses (Drachman, 2005). Apart from the numbers, it is 
amazing how these individual neurons and synapses connect to each other and make a 
functional brain. A functional human brain requires appropriate development that includes the 
development of the birth of neurons, their migration to appropriate locations, development of 
axons and formation of appropriate connections. The system then has to function and it does so 
largely via synaptic transmission. However, complex learning and memory are the features that 
set us apart from other animals and the basic features here include synaptic plasticity and cellular 
plasticity in the form of neurogenesis. In this thesis I will introduce the endocannabinoid (eCB) 
signalling and highlight the important contribution it plays in many aspects of the developing and 
functioning brain. 
1.1 The eCB system; a historical perspective 
1.1.1 Discovery of the eCB system 
The medicinal use of Cannabis sativa was first discovered by Shen Nong, a legendary emperor 
and father of Chinese medicine who tasted about 365 herbs and died of a toxic overdose over 
4000 years ago. The medicinal properties of cannabis were first recorded in ‘Shen Nong’s Herbal 
Classic’, a book attributed to him. While the exact dates of the life of Shen Nong and the 
completion of the book are not known, the earliest therapeutic applications of cannabis can be 
found in literature dated over 2700 years ago (Russo et al, 2008). However, the structure of Δ9–
tetrahydrocannabinol (THC), the major psychoactive ingredient of cannabis was only solved 50 
years ago (Mechoulam & Gaoni, 1965) and it triggered a cascade of crucial discoveries leading to 
the characterisation of the eCB signalling system.  
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The identification of the specific binding site of THC in the brain was followed by the cloning of the 
first CB receptor, cannabinoid receptor 1 (CB1) from a rat brain cDNA library (Matsuda et al, 
1990). Another CB receptor, cannabinoid receptor 2 (CB2) which shares 48% sequence similarity 
with CB1 was cloned from a leukemic cell line shortly afterwards (Munro et al, 1993). The CB 
receptors are seven trans-membrane G-protein coupled receptors (GPCRs). The CB1 receptor is 
the most abundant GPCR in the CNS. High levels of expression of the CB1 receptor were found 
in the olfactory system, the hippocampal formation, the basal ganglia, the cerebellum and the 
neocortex in rat brain (Egertova & Elphick, 2000). It mainly localized in nerve fibre systems and 
axon terminals but not in neuronal somata (Egertova & Elphick, 2000). However, it can also be 
found in peripheral organs such as liver and skeletal muscle (Matias & Di Marzo, 2007). The CB2 
receptor is instead mainly expressed in immune system cells such as B cells, monocytes, 
neutrophils and T cells (Howlett, 2002). However, lower levels are believed to be present in some 
restricted areas of the CNS (Duff et al, 2013; Howlett, 2002). A more recent study supports 
broader CNS roles for the CB2 receptor, with the CB2 receptor immunoreactivity detected in 
various neuronal and glial cell types in a number of brain regions in the adult rat brain, suggesting 
the possible roles of this receptor may play in the brain (Gong et al, 2006).  
Identification of the CB receptors and further studies on their roles lead to the discoveries of their 
endogenous ligands (endocannabinoids; eCBs). 2-arachidonoylglycerol (2-AG), the most 
abundant eCB in the brain, was identified as an eCB in 1995 (Mechoulam et al, 1995; Sugiura et 
al, 1995). This was followed by the cloning of monoacylglycerol lipase (MAGL), the enzyme 
required for 2-AG degradation (Saario & Laitinen, 2007), and of two sn-1-selective diacylglycerol 
lipases (DAGLα and DAGLβ), the enzymes responsible for 2-AG synthesis (Bisogno et al, 2003). 
These discoveries greatly contributed to the development of new therapeutic strategies targeting 
components of the eCB system. Besides 2-AG, several other endogenous lipids have been 
proposed to function as eCBs. These include derivatives of arachidonic acid conjugated with 
ethanolamine or glycerol such as N-arachidonoylethanolamide (AEA), also known as anandamide 
which was the first eCB to be identified (Devane et al, 1992). Noladin ether (CB1 agonist), and 
virhodamine (CB1 antagonist/CB2 agonist) are also putative eCBs (Bisogno et al, 2005; Hanus et 
al, 2001). 2-AG and AEA, the two main eCBs found in the brain, are so far the best-characterised 
eCBs. By acting on the two Gi/o protein-coupled CB receptors (CB1 and CB2), they trigger 
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downstream signalling cascades regulating crucial events in brain development like axonal growth 
and guidance, neurogenesis, and retrograde signalling at synapses (Oudin et al, 2011b).  
In this thesis, the eCB system is used to collectively describe the CB receptors (CB1 and CB2), 
their two well-studied endogenous ligands (2-AG and AEA), and the enzymes involved in their 
synthesis and degradation (e.g. DAGLs and MAGL) which will be discussed in detail below. 
1.1.2 Synthesis and degradation of the eCBs 
2-AG is an ester containing an arachidonic acid (AA) chain at the sn-2 position of the glycerol 
backbone. It was originally studied as an intermediate product in the AA synthesis and in 1995, 
two studies revealed that 2-AG could bind to the CB receptors in canine intestines and rat brain, 
suggesting its important role as an eCB and raised interest of the field to further understand its 
synthesis and degradation (Mechoulam et al, 1995; Sugiura et al, 1995). Several studies reported 
the abundance of 2-AG in the CNS shortly afterwards (Bisogno et al, 1999b; Kondo et al, 1998; 
Stella et al, 1997). For example, Stella et al. reported that 2-AG is present in the rat brain in 
amounts 170 times higher than AEA, another main eCB in the brain (Stella et al, 1997). Bisogno 
et al. who measured 2-AG and AEA levels in 9 different brain regions also found 2-AG to be more 
abundant than AEA (Bisogno et al, 1999a).  
Synthesis of 2-AG can be mediated by DAGL from AA-containing diacylglycerol (DAG) and the 
first evidence was found in human platelets in 1979 (Bell et al, 1979). Several other groups also 
attempted to characterize the DAGL in the context of AA synthesis pathway and found that the 
enzyme has an optimal pH of 7.0 and its action at the sn-1 position can lead to the release of AA 
(Chau & Tai, 1981; Okazaki et al, 1981; Prescott & Majerus, 1983; Sutherland & Amin, 1982). 
However, DAGL remained to be an elusive enzyme until in 2003 our lab reported the cloning of 
two sn-1-selective DAGLs (DAGLα and β) (Bisogno et al, 2003). Both enzymes are highly specific 
sn-1 DAGLs and can release 2-AG in response to calcium influx. They can be inhibited by 
RHC80267 and tetrahydrolipstatin (THL), drugs known as DAGL inhibitors (Bisogno et al, 2003). 
Interestingly, DAGLs are expressed in the axonal tracts during development, but the expression 
shifted to dendrites in the adults, suggesting the important development-dependent switch in the 
role of the DAGLs (Bisogno et al, 2003). Knock-out mice studies further support the role of the 
enzymes in regulating the steady state levels of 2-AG throughout the body, with DAGLα and 
DAGLβmaking different contributions in different tissues (Gao et al, 2010). The role of DAGLα in 
retrograde eCB signalling in the CNS was also revealed by two independent knock-out mice 
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studies (Gao et al, 2010; Tanimura et al, 2010). Depolarization-induced suppression of inhibition 
(DSI) and depolarization-induced suppression of excitation (DSE), two related forms of short-term 
synaptic plasticity, were lost in hippocampus, cerebellum and striatum in DAGLα-/- but not in 
DAGLβ-/- mice (Gao et al, 2010; Tanimura et al, 2010). All these studies together support the 
important roles of DAGLs, especially DAGLα, as a component of the eCB signalling system in the 
CNS.  
DAGLs have been identified as the major enzymes for 2-AG synthesis. Other putative pathways 
involved in 2-AG synthesis have also been reported, for example, 2-AG can also be produced by 
sequential hydrolyses of phosphatidylinositol (PI) via Lyso PI and 2-arachidonoyl lysophosphatidic 
acid (LPA) can also be converted to 2-AG via a phosphatase (Figure 1-1A). However, the relative 
importance of these pathways is less clear and they may depend on the stimuli and type of cells 
(Ueda et al, 2011). 
MAGL is the principal enzyme for 2-AG degradation. MAGL is a serine hydrolase and it cleaves 2-
AG into AA and glycerol and this pathway is considered to be responsible for ~85% of the 2-AG 
hydrolysing activity in the brain (Ueda et al, 2011). Inhibiting MAGL activity by MAGL inhibitors in 
vivo can lead to a significant increase of endogenous 2-AG (Blankman et al, 2007; Ueda et al, 
2011). Apart from MAGL,  and -hydrolase domain-containing protein-6 (ABHD6) and ABHD12 
and fatty acid amide hydrolase (FAAH) can also hydrolyze 2-AG in the brain (Figure 1-1B). FAAH 
can hydrolyze both 2-AG and AEA, however, its role in 2-AG degradation is minor in the brain 
(Blankman et al, 2007; Ueda et al, 2011).  
Anandamide or AEA is another well studied eCB which was first identified as an eCB in a screen 
for endogenous ligands for the CB receptor in 1992 (Devane et al, 1992). It inhibited the specific 
binding of a radiolabelled cannabinoid probe to synaptosomal membranes in a manner typical of 
competitive ligands, suggesting it may function as a natural ligand for the CB receptor (Devane et 
al, 1992). AEA belongs to the N-acylethanolamine (NAE) family, a group of bioactive lipids. 
Despite the similarity of structures of 2-AG and AEA, they are synthesized by distinct pathways. 
AEA can be synthesized from N-arachidonoyl phosphatidylethanolamine (NAPE) by multiple 
pathways, some of which still need to be better understood (Wang & Ueda, 2009). The 
degradation of AEA is mainly carried out by FAAH, which converts AEA into ethanolamine and AA. 
Inhibition of FAAH activity by pharmacological tools or genetically knock-out of FAAH both lead to 
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elevated AEA levels in the brain (Hwang et al, 2010). Like MAGL, which is the main enzyme 
responsible for 2-AG degradation, FAAH is also pursued as a therapeutic target for 
neuroprotection (Gaetani et al, 2009; Hwang et al, 2010). Inhibiting FAAH has been shown to be 
able to improve the learning and memory performances in fmr1 knock-out mice, a model for 
Fragile X syndrome, indicating that the eCB system is a promising target for Fragile X syndrome 
treatment (Qin et al, 2015).  
Overall, 2-AG and AEA are the two main eCBs in the brain. Due to the abundance of 2-AG over 
AEA in the brain and the fact that 2-AG acts as a full agonist of both the CB1 and CB2 receptors, 
it is argued that 2-AG is indeed the ‘true’ eCB (Sugiura et al, 1999). Better understanding of the 
synthesis and degradation of 2-AG and AEA will lead to development of new pharmacological 









Figure 1-1 The main synthetic and degradative pathways of 2-AG 
The main pathways for 2-AG synthesis and degradation are shown above. (A) In the CNS, PLC 
synthesizes DAG from PI and DAGL then generates 2-AG from DAG (pathway shown in red). 2-
AG can also be produced from phosphatidic acid (PA) and phosphatidylcholine (PC) by the action 
of DAGL or by sequential hydrolyses of PI via Lyso PI, 2-arachidonoyl LPA can also be converted 
to 2-AG via a phosphatase, but the relative importance of these pathways is less clear. (B) 2-AG 
is mainly hydrolysed to AA and glycerol by MAGL and this pathway is considered to be 
responsible for ~85% of the 2-AG hydrolysing activity in the brain (pathway shown in red).  and 
-hydrolase domain-containing protein-6 (ABHD6) and ABHD12 and fatty acid amide hydrolase 
(FAAH) can also hydrolyze 2-AG in the brain. Adapted from Ueda et al (Ueda et al, 2011). 
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1.2 Functions of the eCB system in the developing CNS 
1.2.1 Axonal growth and guidance 
Axonal growth and guidance is the process by which neurons send out their axons to reach their 
correct targets. In the developing CNS, axons often manage to find their accurate paths and the 
underlying mechanisms are not fully understood (Bouquet & Nothias, 2007). The eCB signalling 
has been reported to be implicated in axonal growth and guidance in several studies (Berghuis et 
al, 2007; Keimpema et al, 2011; Watson et al, 2008; Williams et al, 2003; Wu et al, 2010). For 
example, consumption of cannabis during pregnancy and adolescence can cause damage to 
brain development and cognition (Spano et al, 2007). Prenatal THC exposure leads to over-
activation of the CB1 receptor, affecting the proper positioning of cortical neurons in the 
developing cortex. Indeed, expression of the CB1 receptor has been detected in the human foetal 
brain and prenatal cannabis exposure can complicate in utero development of the nervous 
system and lead to neurobehavioral and cognitive defects (Berghuis et al, 2007; Keimpema et al, 
2011; Wang et al, 2003). These findings together suggest that the eCB system might be involved 
in the forming of correct neuronal circuits during CNS development.  
The distribution pattern of the CB1 and CB2 receptors in the developing brain is highly correlated 
with the expression of the DAGLα/β enzymes, the enzymes responsible for 2-AG synthesis 
(Berghuis et al, 2007; Bisogno et al, 2003; Mulder et al, 2008; Oudin et al, 2011b), suggesting that 
locally synthesised 2-AG is able to trigger signalling via closely located CB receptors. For 
example, 2-AG synthesised by DAGL activates the CB1 receptor in the same presynaptic growth 
cone of developing axons to promote axonal growth from cultured neurons (Williams et al, 2003). 
The CB1 receptor is reported to be enriched in axonal growth cones of gamma-aminobutyric acid-
containing (GABAergic) interneurons during rodent cortex development, when the CB1 receptor is 
specifically deleted from these neurons, the target selection is impaired (Berghuis et al, 2007). In 
another study, both genetic and pharmacological ablation of the CB1 receptor leads to axon 
fasciculation deficits of pyramidal neurons in embryonic and early postnatal mice (Mulder et al, 
2008). DAGLs are expressed by pyramidal cells and targeted to the axon with DAGLα exhibiting a 
proximal localization to the CB1 receptor in elongating axon shafts and growth cones, while 
MAGL was limited to axonal shafts, suggesting an intrinsic eCB tone within the growth cone is 
required to initiate axonal elongation and polarization during development (Mulder et al, 2008). 
Moreover, DAGL-dependent eCB signalling has been shown to be an important modulator for 
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corticothalamic and thalamocortical axon fasciculation (Wu et al, 2010). All these data together 
support the role of the eCB signalling in axonal growth and guidance during brain development. 
Changes in the eCBs signalling can significantly affect brain development and impair cognitive 
performance by affecting correct axonal targeting and fasciculation. The key question is how does 
the eCB signalling couple to other signalling cues to regulate axonal growth and guidance?  
Axonal outgrowth and guidance is controlled by specific extracellular cues which are diffusible or 
bound to extracellular matrix or cell membranes (Bouquet & Nothias, 2007). Previous work in our 
lab has shown that cell adhesion molecules (CAMs) such as neural CAM (NCAM), N-cadherin 
and L1 play important roles in promoting axonal growth (Cavallaro & Dejana, 2011; Doherty et al, 
1990; Walsh & Doherty, 1997; Walsh et al, 1997; Williams et al, 2003). They can act as surrogate 
ligands for the FGFR (fibroblast growth factor receptor) to trigger subsequent signal cascades that 
allows calcium influx into the growth cones to promote axonal growth and guidance (Williams et al, 
2003). FGFR activated by CAMs can stimulate a phospholipase C-PLC-dependent 
synthesises of DAG, the substrate of the DAGLs (Hall et al, 1996b). DAGL couples the FGFR-
PLC pathway to an axonal response by stimulating calcium influx into the growth cone through 
N- and L-type calcium channels (Doherty et al, 2000; Williams et al, 1994a; Williams et al, 1994b). 
Inhibition of DAGL can abolish neurite outgrowth stimulated by CAMs. Also the CB1 receptor is 
shown to function downstream from the FGFR activation, but upstream from calcium influx into 
cells (Williams et al, 2003). Inhibiting DAGL significantly reduces axonal outgrowth stimulated by 
N-cadherin or FGF-2 in developing Xenopus retinal ganglion cells (RGCs) (Lom et al, 1998). 
Together these data support the hypothesis that activation of FGFR signalling can lead to 
activation of PLC to synthesize DAG, DAGL then uses this substrate to generate 2-AG to 
activate the CB1 receptors in an autocrine fashion, which in turn leads to calcium influx via L- and 
N-type calcium channels to promote axonal growth (Williams et al, 2003) (A model of this pathway 






Figure 1-2 DAGL-dependent eCB signalling in axonal growth 
A simplified model showing DAGL-dependent eCB signalling in axonal growth. This model 
suggests that molecules like CAMs or FGFs can activate FGFRs, which in turn activate PLC to 
synthesize DAG. DAGL would then generate the eCB 2-AG from DAG, which would be released 
to activate the CB receptors. Activation of CB receptors would lead to Ca2+ influx via N- and L-
type voltage gated Ca2+ channels into the cell, which would induce axonal growth. Adapted from 
(Williams et al, 2003; Zhou et al, 2014). 
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1.2.2 Signalling pathways cross talk to the eCB system: FGFR and BDNF signalling 
Besides the important roles in axonal growth and guidance, eCB signalling is also involved in 
many other physiological processes such as neurogenesis, synaptogenesis and the migration of 
neurons and neural progenitors of the developing and postnatal brain (Gao et al, 2010; Goncalves 
et al, 2008; Oudin et al, 2011a; Oudin et al, 2011b; Zhou et al, 2015). The wide variety of roles of 
the eCB system in the CNS is due to its ability to trigger or couple to downstream/upstream 
signalling pathways. CB receptors are GPCRs which are able to trigger a large number of 
downstream events, including regulation of the PI3K and MAPK pathways, cAMP and intracellular 
calcium levels, small GTPase-dependent cytoskeletal rearrangement upon stimulation (Zhou et al, 
2014). However, these signalling pathways, together with the pathways upstream of the eCB 
signalling are mainly uncharacterized. Studies in our lab and some other studies suggest that the 
FGFR and BDNF signalling are two possible candidates that drive the eCB signalling during 
development to promote axonal growth (Aso et al, 2008; Berghuis et al, 2005; Doherty et al, 2000; 
Hall et al, 1996a; Williams et al, 2003).  
As mentioned above, studies in axonal growth and guidance suggest that FGFRsignalling can 
cross talk to the eCB signalling by activating PLC and subsequently make 2-AG by DAGL to 
activate CB receptors (Williams et al, 2003). Like the eCB signalling, FGFR signalling also plays 
important roles in the CNS such as neurogenesis and neuronal migration. For example, cells 
within the subventricular zone (SVZ) express FGFR and its ligand FGF-2, FGF-2 knock-out in 
mice can reduce the SVZ proliferation levels and the number of cells migrating to the olfactory 
bulb (OB) by ~50% (Zheng et al, 2004). Likewise, pharmacological inhibition of DAGL or genetic 
deletion of DAGLα in mice leads to ~50% reduction in SVZ neurogenesis (Gao et al, 2010; 
Goncalves et al, 2008). Both FGF-2 and CB receptor agonist can promote neuroblast migration 
out of the explant derived from the rostral migratory stream (RMS) (Garcia-Gonzalez et al, 2010; 
Oudin et al, 2011a) (details on SVZ neurogenesis and neuroblast migration in the RMS will be 
discussed in the next section). Taken together, FGFR signalling can couple to the eCB system 
during axonal growth and guidance; it might also cross talk to the eCB signalling on SVZ 
neurogenesis and neuroblast migration.  
BDNF and its receptor TrkB have been shown to be able to cross talk to the eCB signalling in 
several studies (Aso et al, 2008; Berghuis et al, 2005; Blazquez et al, 2015; Lemtiri-Chlieh & 
Levine, 2010; Maison et al, 2009). For example, local administration of BDNF in the hippocampus 
28 
was able to reverse the anxiety-like phenotype seen in the CB1 receptor knock-out mice (Aso et 
al, 2008). BDNF can increase the expression of the CB1 receptor by increasing gene transcription 
and thereby increase neuronal sensitivity to 2-AG in cultured cerebellar granule neurons (CGNs) 
(Maison et al, 2009). BDNF also mediates the CB1 receptor function in mouse striatum. A single 
intracerebroventricular injection of BDNF in vivo was able to alter the activity of a subset of the 
CB1 receptor controlling GABA synapses in the striatum (De Chiara et al, 2010). The BDNF-TrkB 
signalling pathway has also been shown to be able to trigger eCB release at inhibitory synapses 
in the neocortex (Lemtiri-Chlieh & Levine, 2010). There is also evidence that the eCBs can use 
TrkB receptor-dependent signalling pathways to regulate interneuron migration (Berghuis et al, 
2005) (details of the BDNF and eCB on cell migration will be discussed in the next section). More 
recently, a study reported the interaction of BDNF with eCBs accounts for the regulation of 
cocaine-induced synaptic plasticity in mouse dopaminergic neurons (Zhong et al, 2015). Another 
recent study reported that injection of a viral vector expressing the CB1 receptor into the 
dorsolateral striatum of R6/2 mice, a well-established model of Huntington’s disease (HD), 
rescued the expression of BDNF as well as the HD-like molecular-pathology markers in these 
animals, suggesting an important role of the CB1/BDNF axis in disease (Blazquez et al, 2015).  
Together, both FGFR and BDNF are able to cross-talk with eCB signalling during brain 
development. FGFR couples to the eCB system to regulate axonal growth and guidance, while a 
wide range of mechanisms can account for the eCB/BDNF cross-talk. Other signalling pathway 
such as epidermal growth factor receptor (EGFR) may also be able to drive the eCB signalling in 
the CNS (Cipriano et al, 2014; Sutterlin et al, 2013). However, further studies will be required to 
identify other signalling pathways and understand the underlying mechanisms of the eCB 
signalling network in the CNS.  
1.3 Neurogenesis and neuronal migration 
1.3.1 Neurogenic niches in the CNS-studies implicating eCBs 
Neurogenesis is a process of generating functional neurons from neural stem cells and neural 
progenitors (Ming & Song, 2011). Neurogenesis is most active during prenatal CNS development 
to populate the growing brain with neurons. However, this process is restricted after birth in the 
mammalian brain, including humans (Ming & Song, 2011; Sanai et al, 2011). It is now widely 
accepted that in almost all mammals, active adult neurogenesis occurs throughout life in mainly 
two brain regions, the SVZ of the lateral ventricles and the subgranular zone (SGZ) in the dentate 
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gyrus of the hippocampus (Kazanis, 2013; Ming & Song, 2011). Altman, whose pioneering studies 
conducted in the 1960s discovered postnatal rat hippocampus neurogenesis, first suggested that 
new neurons are critical for learning and memory (Altman & Das, 1965; Altman & Das, 1967). In 
the past few years, considerable evidence has been obtained that supports a critical role of adult 
neurogenesis in hippocampal and olfactory bulb memory functions (Deng et al, 2010; Lazarini & 
Lledo, 2011; Ming & Song, 2011). Importantly, adult neurogenesis also holds therapeutic potential 
because of its relationship with degenerative neurological disorders, and the ability of neuroblasts 
to migrate to the site of brain injury and possibly replace dying neurons (Arvidsson et al, 2002; 
Curtis et al, 2009; Emsley & Hagg, 2003; Sundholm-Peters et al, 2005). 
The SVZ is one of the crucial neurogenic niches in the brain where thousands of neural 
precursors are created every day in the SVZ of postnatal and adult mammalian brains. SVZ-
derived neuroblasts then migrate in chains to the OB via the RMS, making it one of the longest 
migration process in the postnatal and adult brain (Figure 1-3B) (Doetsch & Alvarez-Buylla, 1996; 
Ming & Song, 2005; Ming & Song, 2011). Studies on postnatal and adult neurogenesis in the SVZ 
and migration along the RMS in the recent years have become a useful system in revealing the 
potential molecular mechanisms involved in neurogenesis and neuronal migration (Figure 1-3B) 
(Ming & Song, 2005; Ming & Song, 2011). Many proteins and signalling pathways, such as 
adhesion molecules (PSA-NCAM, integrin), extracellular cues (NRGs, Slits), Notch receptors, 
Ephrins and neurotrophins have been found to contribute to neurogenesis and migration in the 
SVZ and RMS. Some of these pathways are also conserved in embryonic development, but the 
whole system is far from been fully understood (Ming & Song, 2011). Additionally, some studies 
have suggested that the progenitor cells produced by the SVZ can migrate out of the RMS to the 
site of brain injury (Arvidsson et al, 2002; Curtis et al, 2009; Emsley & Hagg, 2003; Goings et al, 
2004; Gotts & Chesselet, 2005b; Romanko et al, 2004; Sundholm-Peters et al, 2005). It is 
therefore fundamental to fully understand how migration is regulated in the RMS for potential 
therapeutic applications.  
The eCB system has been shown to play a role in regulating proliferation of neural progenitors in 
both the adult hippocampus and SVZ and regulating neuroblast migration in the RMS (Gao et al, 
2010; Goncalves et al, 2008; Oudin et al, 2011a). DAGL-dependent eCB signalling regulates 
adult SVZ neurogenesis in an age-dependent manner (Goncalves et al, 2008). Both hippocampal 
and SVZ neurogenesis were compromised in DAGL knock-out mice and there was ~50% 
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reduction of SVZ neurogenesis in DAGLα knock-out mice (Gao et al, 2010), suggesting the 
important role of the eCB signalling in maintaining the function of neurogenic niches. Also RMS 
neuroblasts express several components of the eCB system including DAGLα, MAGL and the 
CB1 receptor, supporting their ability to synthesise 2-AG and at the same time respond to the CB 
receptor signalling (Oudin et al, 2011b). Studies on cultured neuroblasts have clearly shown that 
activation of the CB receptors promotes neuroblast migration, facilitating the cycling between 
leading process extension and forward nuclear movement (Oudin et al, 2011b). Inhibition of eCB 
signalling instead causes shortening and branching of the leading process in vitro and in vivo, and 
this is associated with reduced migration from SVZ explants (Oudin et al, 2011b). Taken together, 
the evidence gathered from these studies identifies a fundamental role for eCB signalling in 
neurogenesis and neuronal migration in the mammalian brain; however the studies on migration 










Figure 1-3 Neurogenic niches and SVZ neurogenesis in the postnatal and adult rodent 
brain  
A sagittal section view of a postnatal adult rodent brain highlighting the two restricted regions that 
exhibit active adult neurogenesis: dentate gyrus (DG) in the hippocampal formation (HP), and the 
subventricular zone (SVZ) of the lateral ventricle (LV) (A). (B) Summary of four developmental 
stages during adult SVZ neurogenesis: Stage 1. Proliferation: stem cells (blue) in the SVZ of the 
lateral ventricles give rise to transient amplifying cells (light blue). Stage 2. Fate specification: 
transient amplifying cells differentiate into immature neurons (green). Adjacent ependymal cells 
(gray) of the lateral ventricle are essential for neuronal fate specification by providing inhibitors of 
gliogenesis. Stage 3. Migration: Immature neurons (green) migrate with each other in chains 
through the RMS to the OB. The migrating neurons are ensheathed by astrocytes. Once reaching 
the bulb, new neurons then migrate radially to the outer cell layers. Stage 4. Synaptic integration: 
Immature neurons differentiate into either granule neurons (orange) or periglomerular neurons 
(red). Potential molecular mechanisms of each stage are summarized at the bottom, mainly on 
the basis of studies on adult mice. Adapted from Ming and Song (2005). 
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1.3.2 What regulates neuroblast migration in the RMS? 
The migration of neural progenitors and newborn neurons represents a fundamental process for 
brain development. Remarkably, the migration of niche-derived neural progenitors persists after 
birth, and is essential for proper maturation and integration of newborn neurons into the pre-
existing synaptic circuits (Belvindrah et al, 2011). Two classical types of migration have been 
identified in the CNS: radial and tangential migration (perpendicular and parallel to the pial 
surface, respectively) (Metin et al, 2008). These two types of migration are generally regarded to 
be operated by distinct cellular mechanisms; however, neuroblasts may alternate from radial to 
tangential movement and vice versa during their course of migration, suggesting that both types 
of migrations share common principles (Marin et al, 2010; Shinohara et al, 2012). For example, in 
postnatal rodent brain, SVZ-derived neuroblasts first migrate tangentially in chains from the SVZ 
to OB along the RMS, after reaching the OB, they switch to radial migration from the OB core 
towards different OB layers where they differentiate into interneurons (Doetsch & Alvarez-Buylla, 
1996; Ming & Song, 2011).  
Migratory neuroblasts in the RMS usually have a characteristic elongated cell body and a single 
leading process oriented toward the OB (Nam et al, 2007). They move towards the bulb in a 
unique form of collective migration by sliding over each other therefore this form of migration is 
not guided by radial glial or axonal fibres (Lois et al, 1996). As mentioned above, SVZ-derived 
neuroblasts migrating along the RMS to the OB is one of the longest migration routes in the CNS 
after birth. Also the RMS is a tortuous route which dips and curves. Therefore it’s very unlikely 
that the migration of the neuroblasts is controlled by a single factor or molecular pathway. Indeed, 
research carried out in the last decade has identified many factors and signalling pathways that 
contribute to the migration process in the RMS. These include architectural guides, growth factors 
(FGF, BDNF, GDNF), adhesion molecules (PSA-NCAM, integrin) and extracellular cues (NRGs, 
Slits) (Anton et al, 2004; Bolteus & Bordey, 2004; Cavallaro & Christofori, 2004; Chazal et al, 
2000; Chiaramello et al, 2007; Mobley & McCarty, 2011; Nguyen-Ba-Charvet et al, 2004; 
Sawamoto et al, 2006). However, the whole system is far from being fully understood (Ming & 
Song, 2011). Here we give a comprehensive but not exhaustive list of key guidance cues that 
have been implicated in the regulation of neuroblast migration in the postnatal RMS. 
1.3.2.1 Architectural guides 
The flow of cerebrospinal fluid (CSF) 
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The CSF is a colourless body fluid produced in the choroid plexuses of the ventricles of the brain 
which acts as a basic mechanical and immunological protection to the brain. Coordinated, 
whiplike motion of ependymal cilia is required for normal CSF flow (Sawamoto et al, 2006). In 
Tg737orpk mutant mice which have fewer, shorter and irregular cilia that are usually not motile, 
lack of normal CSF flow was observed (Sawamoto et al, 2006). PSA-NCAM staining showed that 
the migratory chains are disoriented in the SVZ in these mutant mice, and significantly less cells 
reach the OB compared to the wild type (WT) animals (Sawamoto et al, 2006). Using cell 
transplantation to graft mutant SVZ cells into WT mice, the authors found that the cells can 
migrate to the OB as normal, therefore it is not the mutant cells themselves that disrupt the 
migration. When grafting WT cells into mutant mice, the cells cannot migrate properly. Also the 
gradient of Slit2, which acts as a chemorepulsive factor for neuroblast migration (Hu, 1999), is 
absent in the mutant mice, suggesting that normal CSF flow is essential for the formation of a 
chemorepulsive factor gradient that guides directed neuroblast migration at the beginning of the 
RMS (Sawamoto et al, 2006). However, the neuroblasts migrated normally to the bulb once they 
managed to enter the stream despite the loss of the chemorepulsive gradient (Sawamoto et al, 
2006), indicating the existence of other guidance cues in the SVZ and RMS.  
Astrocytes  
Neuroblasts migrating in chains in the RMS are ensheathed by astrocytes which form glial tubes 
to support migration (Lois et al, 1996). This type of tangential migration within a glial tube is 20% 
faster than migration as individual cells, suggesting that the astrocytes might be one of the 
guidance cues for migration in the RMS (Bovetti et al, 2007). Indeed, knock-out mice studies have 
shown that beta1 class integrins are required for the maintenance of the glial tubes and, defects 
in the glial tubes lead to the ectopic migration of neuroblasts into the surrounding tissue 
(Belvindrah et al, 2007). Therefore, the astrocytes within the RMS seem to create a path to 
facilitate neuroblast migration and serve as a physical barrier. However, astrocytes are not 
required for the chain migration of neuroblasts in vitro such as neuroblast migration out of the 
RMS-derived explant cultures (Cayre et al, 2009; Wichterle et al, 1997), indicating the importance 
of other guidance cues for migration.  
Electric currents 
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A recent study reported that naturally occurring electric currents flow from the SVZ to the OB and 
these endogenous electric currents serve as a guidance cue for neuroblast migration (Cao et al, 
2013a). By using the vibrating probe system, the authors detected an inward electric current of 
1.6±0.4 μA/cm2 and an outward electric current of 1.5±0.6 μA/cm2 at the LV wall and the surface 
of OB, respectively (Cao et al, 2013a). Na+/K+ -ATPases distributed at the basal side of the LV 
wall and the apical side of epithelial layer of OB are likely to be responsible to generate this 3-5 
mV/mm voltage along the RMS pathway from the SVZ to the OB (Cao et al, 2013a). Moreover, 
applied electric fields of similar strength direct migration of neuroblasts from the SVZ in culture 
and in brain slices (Cao et al, 2013a). The authors also showed that the purinergic receptor P2Y1 
that are expressed transiently in the SVZ neuroblasts seem to mediate this electric field guided 
migration (Cao et al, 2013a). Therefore these data suggest that the naturally occurring electric 
potential gradients are a long-distance directional signal for neuroblast rostral migration (Cao et al, 
2013a).  
1.3.2.2 Growth factors 
FGF-2 
FGF-2 and the FGFRs play important roles in cell proliferation and neurogenesis in the SVZ 
(Frinchi et al, 2008; Mudo et al, 2007). FGF-2 is expressed in GFAP positive cells and may act on 
the FGFR1 expressed in nestin positive neural stem cells in the SVZ (Belluardo et al, 2008; Mudo 
et al, 2007). The role of FGF-2 on neuroblast migration has also been reported (Garcia-Gonzalez 
et al, 2010). Treatment of SVZ derived explant cultures with FGF-2 significantly increased 
migration out of the explants, and this effect was inhibited by the selective FGFR1 blocker, 
SU5402, suggesting an important role of FGF-2 and FGFR1 on neuroblast migration (Garcia-
Gonzalez et al, 2010). Moreover, an immunostaining study revealed a transient caudal-rostral 
expression gradient of FGF-2 along the RMS in postnatal rodent brain slices, with stronger 
labelling in the SVZ region than the OB (Garcia-Gonzalez et al, 2010). This caudal-rostral 
gradient of FGF-2 in the neuroblast migration route in the RMS might serve as a guidance cue to 
drive neuroblast migration in the RMS (Garcia-Gonzalez et al, 2010).  
BDNF 
BDNF signalling through the TrkB receptor plays an important role in controlling tangential 
interneuron migration in the developing cerebral cortex (Polleux et al, 2002). BDNF is also 
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involved in SVZ neurogenesis in the mammalian brain (Bath et al, 2012). Both BDNF and TrkB 
have been shown to be expressed throughout the SVZ-RMS-OB route in vivo, and TrkB is 
expressed by the migrating neuroblasts in the RMS (Bath et al, 2008; Chiaramello et al, 2007; 
Snapyan et al, 2009), suggesting a role for BDNF signalling in regulating the neuroblast migration 
in the RMS. By using in vitro explant cultures, BDNF has been demonstrated to promote SVZ 
derived neuroblast migration, acting both as inducer and attractant through TrkB activation 
(Chiaramello et al, 2007). Blocking BDNF function by an antibody has been reported to increase 
the speed of neuroblast migration without disrupting its guidance in the RMS (Bagley & Belluscio, 
2010). However, another study reported that inhibiting BDNF signalling with a TrkB-Fc impairs 
neuroblast migration as well as directionality within the RMS in acute brain slices (Snapyan et al, 
2009), also pharmacological blockade of BDNF-dependent pathways on SVZ explants in vitro 
impairs neuronal migration (Chiaramello et al, 2007). In addition, endothelial cells of blood vessels 
which outline the neuroblast migratory route in the RMS synthesize BDNF that fosters neuroblast 
migration via p75NTR expressed on neuroblasts (Snapyan et al, 2009). Together, these studies 
strongly suggest that BDNF signalling plays an important role in regulating neuroblast migration in 
the RMS by acting on multiple pathways.  
Other growth factors 
Apart from FGF-2 and BDNF, other growth factors such as GDNF (Paratcha et al, 2006), HGF 
(Garzotto et al, 2008) and VEGF (Wittko et al, 2009) have been reported to be involved in 
regulating neuroblast migration in the RMS.  
1.3.2.3 Adhesion molecules 
Since neuroblasts migrate in chains by sliding over each other in the RMS, it is not surprising to 
find that adhesion molecules such as the polysialylated form of NCAM (PSA-NCAM) and integrins 
which are located on the cell surface play important roles in regulating neuroblast migration. Both 
PSA-NCAM and integrins are expressed by the neuroblasts in the RMS (Belvindrah et al, 2007; 
Moraes et al, 2009). Enzymatic removal of polysialic acid (PSA) from the neuroblasts not only 
disrupts the tangential migration and cellular organization of the RMS, but also causes a massive 
dispersion of neuroblasts into the surrounding brain regions including the cortex and striatum 
(Battista & Rutishauser, 2010). Studies on genetically modified mice demonstrated that beta 1 
integrins promote the formation of cell chains and are required for the maintenance of the glial 
tubes in the RMS (Belvindrah et al, 2007). These studies support the important roles of adhesion 
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molecules in RMS neurolast migration by suggesting that PSA-NCAM may create a permissive 
environment for neuroblast migration, while integrins are responsible for the formation of 
migration chains in the RMS.  
1.3.2.4 The eCB signalling  
The eCB signalling system has been shown to be involved in neuronal migration in several 
studies. During brain development, active eCB signalling in the ventricular zone controls neural 
progenitor proliferation and radial migration of immature pyramidal cells to their appropriate 
location in the cortical layers (Mulder et al, 2008). Moreover, the eCB signalling regulates the 
radial migration of cortical neuron precursors derived from ganglionic eminences in the 
developing brain. This process ensures the targeting of neural precursors to their final location in 
the neocortex and hippocampus, where they differentiate into GABAergic interneurons (Berghuis 
et al, 2005). The CB1 receptor is highly expressed in a subpopulation of cholecystokinin (CCK)-
containing inhibitory interneurons, which follow a complex radial and tangential migratory pattern 
across the telencephalon, ultimately reaching the hippocampus (Morozov et al, 2009). Recent 
studies in our lab have shown that an endogenous cannabinoid tone controls the polarized 
morphology and migration of postnatal RMS neuroblasts in vitro and in vivo (Oudin et al, 2011a). 
Direct activation of the CB receptors increases RMS neuroblast migration from explant cultures. 
Likewise, preventing 2-AG breakdown by a MAGL inhibitor also has similar effect, suggesting an 
important role for DAGL-dependent eCB signalling in the RMS (Oudin et al, 2011a). Activation of 
the CB1 receptor also promotes the interaction between protein kinase C (PKC) and fascin, an 
actin-bundling protein highly expressed in migratory neuroblasts, and regulating the balance 
between actin remodelling and cell adhesion, an essential aspect of efficient neuroblast migration 
(Sonego et al, 2013a). Thus the eCB signalling is important for maintaining the polarized 
morphology of the neuroblasts, possibly by affecting a range of cytoskeletal regulators, to 
facilitate efficient cell migration in the RMS.  
1.3.2.5 Other guidance cues  
Other signalling pathways such as Slit proteins, which serve as chemorepulsive factors, also 
contribute to regulating neuroblast migration in the RMS (Hu, 1999; Wu et al, 1999). In summary, 
the correct migration process of the neuroblasts from the SVZ to the OB requires the migrating 
cells be able to read or respond to multiple guidance cues and integrate these signals in a co-
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ordinated manner. Further studies will be required to understand this integration and to perhaps 
draw a complete map on the regulation of the migration in the RMS.  
1.4 Synaptic plasticity in the adult brain 
1.4.1 Synaptic plasticity-roles of the eCB signalling  
The role of the synapses in the adult brain is not only to transfer information from one neuron to 
another; they also have the capacity to change their strength through their activity over time. 
These changes may involve the strengthening or weakening of existing synapses as well as 
synapse formation and elimination. It is widely accepted that these activity-dependent changes in 
synaptic efficacy are necessary and sufficient for information storage in the brain. Therefore 
synaptic plasticity is thought to be the basis for learning and memory in the adult brain (Holtmaat 
& Svoboda, 2009; Martin et al, 2000; Neves et al, 2008).  
One of the most important roles of the eCB signalling in the CNS is to act as a retrograde 
signalling system to regulate synaptic function (Castillo et al, 2012; Kano et al, 2009). Studies 
have shown that AEA and 2-AG can be released from postsynaptic neurons to act as retrograde 
messengers to target presynaptic CB receptors to suppress neurotransmitter release in either a 
transient or long-lasting manner, at both excitatory and inhibitory synapses in the adult brain 
(Alger, 2002; Alger, 2009; Castillo et al, 2012; Kano, 2014). Studies on knock-out animals also 
show that DAGLα, an enzyme required for calcium-dependent 2-AG production, is involved in 
both long-and short-term eCB-dependent synaptic plasticity (Gao et al, 2010; Tanimura et al, 
2010; Yoshino et al, 2011). Therefore, the eCB signalling can regulate a wide variety of neural 
functions in the brain such as learning, cognition and feeding behaviors by modulating synaptic 
plasticity and serves as an emerging therapeutic target (Castillo et al, 2012). Moreover, the 
abundance of the eCB components in the brain also suggest that the eCB signalling is 
fundamental modulator in synaptic function (Castillo et al, 2012).  
In general, synaptic plasticity can be divided into two forms: short-term synaptic plasticity which 
lasts from milliseconds to at most a few minutes, while long-term synaptic plasticity can last from 
minutes to hours, days, even life time (Citri & Malenka, 2008). There are many forms of short-
term and long-term synaptic plasticity that have been discovered so far (Citri & Malenka, 2008). 
Here we are going to review two forms of long-term synaptic plasticity (long-term potentiation 
(LTP) and long-term depression (LTD)) and two forms of short-term synaptic plasticity (DSI and 
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DSE) respectively. Among these, LTP is the most extensively studied form of synaptic plasticity 
with no evidence for eCB signalling playing a major role; however eCB signalling has been 
reported to contribute to, or mediate LTD, DSE and DSI (Castillo et al, 2012; Chevaleyre et al, 
2006; Kano, 2014; Wilson & Nicoll, 2001; Wilson & Nicoll, 2002).  
LTP 
LTP is a persistent strengthening of synapses based on recent patterns of activity, it was first 
observed by Terje Lømo who found long-lasting increases in efficiency of transmission at 
synapses on dentate granule cells induced by repetitive trains of stimuli to the perforant path in 
anaesthetized rabbits in 1966 (Lomo, 2003). This observation was further characterized in 1970s 
(Bliss & Lomo, 1973) and remains a popular research subject to this day. LTP has been most 
studied in the mammalian hippocampus, an area of the brain that is believed to be important for 
memory formation (Lynch, 2004). Here the axons of pyramidal neurons in the CA3 region of 
hippocampus form synapses in the CA1 region pyramidal neurons, these axons are called 
Schaffer collaterals. Electrical stimulation of Schaffer collaterals can generate excitatory 
postsynaptic potentials (EPSPs) in the postsynaptic CA1 neurons. If the stimulation is only two or 
three times per minute, the size of the evoked EPSP in the postsynaptic CA1 neurons remains 
relatively constant. However, strong tetanic stimulation (a brief, high-frequency sequence of 
individual stimulations) to the same axons causes a long-lasting increase in the postsynaptic 
EPSP amplitude, and this is LTP (Cooke & Bliss, 2005; Lomo, 2003; Lynch, 2004). LTP has been 
found to be input-specific, only activated synapses on a given cell are potentiated. It also has 
property of associativity. If two pathways converge upon the same postsynaptic neuron and one 
pathway has only modest compact on the postsynaptic neuron, this weak stimulation will not by 
itself trigger LTP. However, if this weak pathway is activated concurrently with the other strong 
pathway, then both pathways can be strengthened. These two properties of LTP are believed to 
serve as cellular basis for learning and memory such as associative learning and memory 
formation (Cooke & Bliss, 2005; Lynch, 2004).  
LTD 
LTD is another form of long-term synaptic plasticity. It is different from LTP, which occurs when 
the Schaffer collaterals (or other axons) are stimulated by high-frequency stimulation, in that LTD 
is stimulated by low rate stimuli (~1Hz) for long periods (10-15 min) and causes a long-lasting 
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reduction in the efficacy of synapses. However, like LTP, LTD is also activity-dependent and can 
last for a long period of time (Bol'shakov, 2001; Collingridge et al, 2010). These common features 
and complementarity of LTP and LTD suggest they reversibly affect synaptic efficacy to regulate 
synaptic plasticity in the CNS. LTD can selectively decrease synaptic strength and erase the 
increase in EPSP amplitude cause by LTP (Collingridge et al, 2010; Malleret et al, 2010). This 
function might be important for new information acquisition by clearing old memory traces, 
thereby preventing those traces from interfering with newly formed information (Malleret et al, 
2010).  
The molecular mechanisms of LTD are not entirely clear. Studies suggest that N-methyl-D-
aspartate receptors (NMDARs) and metabotropic glutamate receptors (mGluRs) are important in 
mediating LTD function (Collingridge et al, 2010; Hu et al, 2014; Yashiro & Philpot, 2008). Neural 
activity from the presynaptic neurons usually triggers the activation of these postsynaptic 
receptors and calcium-dependent second messenger systems. These second messenger 
systems can then alter the activity of protein kinases or phosphatases to mediate the early stages 
of long-term synaptic plasticity. As we mentioned above, DAGL-dependent eCB signalling is able 
to release 2-AG in response to calcium influx (Bisogno et al, 2003). Also, eCB signalling has been 
shown to mediate presynaptic forms of LTD at both excitatory and inhibitory synapses in several 
brain regions (Castillo et al, 2012; Kano et al, 2009). Postsynaptic Group I mGluRs, PLC, and 
DAGLα are usually required for eCB-mediated LTD, 2-AG synthesized by DAGLα can then act on 
the CB1 receptor localized to excitatory or inhibitory synaptic terminals to suppress 
neurotransmitter release (Figure 1-4A). However, there is not a full consensus on eCB-mediated 
LTD as different results have been reported from different brain regions (Chevaleyre & Castillo, 
2003; Kano et al, 2009). Therefore further studies will be required to fully understand the 











Figure 1-4 eCB-mediated long- and short-term synaptic plasticity 
In the adult brain, DAGL expression is restricted to dendritic postsynaptic compartments to 
release newly synthesised eCBs acting as retrograde messengers on the presynaptic CB1 
receptor, suppressing further transmitter release in excitatory and inhibitory synapses. (A) eCB-
mediated excitatory and inhibitory LTD. Patterned stimulation releases neurotransmitter glutamate 
(Glu) at presynaptic sites, Glu activates postsynaptic mGluRs which couple to PLCβ and DAGLα. 
2-AG synthesised by DAGLα then targets the CB1 receptor localized to excitatory or inhibitory 
synaptic terminals where Gi/o protein coupled to the CB1 receptor can reduce adenylyl cyclase 
(AC) and protein kinase A (PKA) activity to suppress neurotransmitter release. (B) eCB-mediated 
short-term depression. Postsynaptic activity triggers calcium influx via voltage-gated calcium 
channels (VGCCs) and leads to DAGLα-mediated eCB mobilization. Presynaptic activity can also 
promote 2-AG production through DAGLα by activating mGluRs. 2-AG then acts as a retrograde 
messenger to target the presynaptic CB1 receptors to reduce neurotransmitter release. Adapted 




DSI and DSE are two closely related forms of short-term synaptic plasticity induced by 
depolarization of the post-synaptic site resulting in suppression of the pre-synaptic release of 
inhibitory or excitatory neurotransmitters mediated by the release of a retrograde messenger 
(Diana & Marty, 2004). DSI was first described in the early 1990s and many observations led to 
the conclusion that the phenomenon must involve retrograde signalling (Diana & Marty, 2004; 
Llano et al, 1991). However, the identity of the retrograde messenger mediating DSI and DSE 
remained unknown until 2001 when two groups reported that eCB signalling is responsible for 
mediating DSI in cultured hippocampal neurons and hippocampal slices (Ohno-Shosaku et al, 
2001; Wilson & Nicoll, 2001). Shortly afterwards, the counterpart of DSI, eCB-mediated DSE for 
excitatory synaptic transmission in cerebellar Purkinje cells was also reported (Kreitzer & Regehr, 
2001a; Kreitzer & Regehr, 2001b). As a matter of fact, these are the first discoveries of the eCBs 
acting as retrograde signalling molecules in the brain (Castillo et al, 2012; Kreitzer & Regehr, 
2001a; Kreitzer & Regehr, 2001b; Ohno-Shosaku et al, 2001; Wilson & Nicoll, 2001). To date 
numerous studies have reported that a post-synaptically released eCB induces DSI and DSE in 
many different brain regions (Kano et al, 2009; Ohno-Shosaku et al, 2001; Pitler & Alger, 1992). 
Both DSI and DSE are calcium dependent and can be blocked by the CB1 antagonist AM251 
(Kano et al, 2009). DSI can be induced only at cannabinoid-sensitive synapses, supporting the 
important role of eCB signalling in these two forms of synaptic plasticity (Kano et al, 2009; Ohno-
Shosaku et al, 2001). Inhibition of MAGL, the enzyme responsible for 2-AG degradation, but not 
AEA hydrolyzing enzyme FAAH can generally prolong DSI and DSE (Hashimotodani et al, 2007). 
Moreover, two independent knock-out studies have shown that DSI and/or DSE are totally absent 
in the hippocampus, cerebellum and striatum in DAGLα (but not DAGLβ) knock-out mice (Gao et 
al, 2010; Tanimura et al, 2010), suggesting the important roles of DAGLα and 2-AG in mediating 
these two forms of synaptic plasticity. A model of eCB-mediated short-term synaptic plasticity is 
shown in (Figure 1-4B). The induction of DSI is triggered by elevation of postsynaptic calcium 
concentration. Calcium influx through voltage-gated calcium channels (VGCCs) or postsynaptic 
receptors like NMDA receptors may contribute to this process. This elevated calcium level leads 
to 2-AG production by DAGLα, 2-AG can then travel through the synaptic cleft by an unknown 
mechanism to activate the presynaptic CB1 receptors to reduce neurotransmitter release (Castillo 
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et al, 2012). The molecular mechanism of DSE on the other hand is less well understood (Diana 
& Marty, 2004).  
It is worth noting that other types of eCB-mediated synaptic plasticity have also been reported. 
For example, calcium influx through NMDA receptor can directly induce eCB release, this process 
was abolished by blocking NMDA receptors, CB1 receptors and DAGL, but not by inhibiting 
VGCCs (Ohno-Shosaku et al, 2007). Presynaptic activity can also promote 2-AG production 
through DAGLα by activating mGluRs. It has been reported that activation of group I mGluRs is 
sufficient to mobilize eCBs to trigger both short- and long-term synaptic plasticity (Figure 1-4) 
(Castillo et al, 2012; Chevaleyre et al, 2006). The mechanisms of this receptor-driven eCB 
release are not entirely clear (Kano, 2014). However, data in this section point to the important 
role of postsynaptic DAGLα in the eCB-mediated synaptic plasticity. As we will discuss in detail in 
the next section, DAGLα may dynamically interact with postsynaptic receptors or other 
postsynaptic components to regulate synaptic plasticity in the brain.  
1.4.2 Receptor endocytosis at the postsynaptic sites as a plasticity mechanism 
Neurotransmitter receptors located at the postsynaptic sites are directly responsible for receiving 
the information released by presynaptic neurons, therefore the type, number and density of these 
receptors at a particular spine will affect the synaptic strength (Arancibia-Carcamo et al, 2006; 
Collingridge et al, 2004). Receptor endocytosis, an energy-using cellular process used by cells to 
internalize receptors and sort them inside of the cell through distinct endocytic pathways either for 
degradation or recycling, can powerfully control the number and density or even type of the 
receptors that appear on the cell membrane of the postsynaptic site (Arancibia-Carcamo et al, 
2006; Collingridge et al, 2004). It has long been established that some of the most important 
postsynaptic receptors like AMPA, NMDA, GABA and mGluRs all undergo endocytosis and are 
dynamically cycled inside of the postsynaptic cells to regulate synaptic plasticity (Carroll et al, 
1999; Dhami & Ferguson, 2006; Hardt et al, 2014; Kittler et al, 2005; Kittler et al, 2000; Scott et al, 
2004; Yashiro & Philpot, 2008). Here we are going to review the endocytosis of those 
postsynaptic receptors to gain insights of this process in regulation of synaptic plasticity in the 
adult brain.  
AMPA and NMDA receptors 
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AMPA and NMDA receptors are both ionotropic glutamate receptors that often co-exist at the 
same synapse. They are tetrameric complexes each consisting of four subunits (Karakas et al, 
2015). When activated by glutamate, AMPA receptors react immediately to allow positively 
charged sodium ions to flow through the cell membrane thus mediate fast synaptic transmission 
(Gomes et al, 2003). NMDA receptors, on the other hand, mediate slow transmission because the 
pore of the receptor channel is blocked by a magnesium ion. This blockage is only broken when a 
certain level of depolarization is reached and AMPA receptors have allowed enough sodium to 
enter the cell membrane, thus this collection of positive charge will repel the magnesium ion out of 
the NMDA channels. When the NMDA receptors are open, they can actively respond to glutamate 
and allow not only sodium, but also calcium to enter the postsynaptic cell. The influx of calcium 
can then act as a second messenger to activate intracellular signalling cascades (Collingridge, 
1987; MacDonald et al, 2006). For example, when a significant depolarization occurs at a 
postsynaptic site which induces rapid elevation of postsynaptic calcium, this intracellular calcium 
can interact with protein kinases such as PKC to phosphorylate target proteins which are able to 
regulate the trafficking of AMPA receptors. As a result, more AMPA receptors are inserted back to 
the postsynaptic membrane to make the terminal more responsive to glutamate. Thus this 
particular synapse is strengthened and this is believed to be the molecular mechanisms for LTP 
(Carroll et al, 2001; Gomes et al, 2003). In contrast, a low frequency stimulation which induces a 
modest increase of postsynaptic calcium can instead lead to activation of protein phosphatases 
which lead to dephosphorylation of target proteins and the internalization of AMPA receptors 
(Casimiro et al, 2011). Therefore less AMPA receptors are available at the postsynaptic site and 
the synapse is weakened. These processes serve as the molecular basis for another long-term 
synaptic plasticity, LTD (Gomes et al, 2003; Malenka, 2003).  
Beyond the well-established role as triggers for LTP and LTD described above, NMDA receptors 
themselves are also dynamically regulated (Hunt & Castillo, 2012; Rebola et al, 2010). Increased 
α-synuclein expression, which is associated with neurodegenerative disorders such as 
Parkinson's disease (PD) and Alzheimer's disease (AD), has been shown to induce NMDA 
receptor internalization in cultured hippocampal neurons, as a result, the inward current and 
calcium influx upon NMDA receptor stimulation are reduced (Chen et al, 2015). In summary, the 
voltage-dependent property of the NMDA receptors and endocytosis of AMPA and NMDA 
receptors regulate the strength of the synapse and serve as molecular basis for learning and 
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memory and have been shown to be involved in many diseases such as epileptic seizures and 
depression (Casillas-Espinosa et al, 2012; Freudenberg et al, 2015).  
mGluRs 
Metabotropic glutamate receptors or mGluRs are 7-TM GPCRs. They can be classified into 3 
groups based on receptor structure and physiological activity (Dhami & Ferguson, 2006). Different 
types of mGluRs are distributed differently in cells, group II and group III mGluRs are 
predominantly localized to presynaptic elements, while group I mGluRs are localized to 
postsynaptic sites (Shigemoto et al, 1997). Therefore, we are going to focus on group I mGluRs in 
this thesis. Group I mGluRs (mGluR1 and mGluR5) are GPCRs coupled to the heterotrimeric G 
protein alpha-q/11 and can act as modulators of other receptors (Dhami & Ferguson, 2006). For 
example, mGluR5 have been shown to be clustered to NMDA receptor-associated PDS-95 
complex by Homer and Shank proteins, therefore they can be anchored close enough to NMDA 
receptors to modulate their activities (Tu et al, 1999). Indeed, activation of mGluRs and NMDA 
receptors has been shown to be able to trigger internalization of distinct populations of AMPA 
receptors in CA1 hippocampal neurons (Casimiro et al, 2011). Group I mGluRs can also regulate 
synaptic plasticity independent of NMDA receptors. A study reported that specific group I mGluR 
agonist (S)-3,5-dihydroxyphenylglycine (DHPG) can induce depotentiation (the reversal of LTP) 
and trigger a protein synthesis-dependent internalization of synaptic AMPA receptors at Schaffer 
collateral–CA1 synapses of rat hippocampal slices (Zho et al, 2002). 
Apart from modulating NMDA and other receptors, group I mGluRs also undergo endocytosis at 
postsynaptic sites themselves. For example, cycling of mGluR1 has been shown in both neuronal 
and non-neuronal cells (Pandey et al, 2014). In this study, the authors found that the majority of 
the mGluR1 receptors localized at the recycling compartment and can be recycled back to the cell 
membrane after been internalized. No significant presence of the receptor was noticed in the 
lysosome and the recycling of mGluR1 is protein phosphatase 2A dependent (Pandey et al, 2014). 
Studies on the molecular mechanisms of group I mGluRs have revealed that the endocytosis of 
these receptors can be both agonist-dependent and -independent (Dale et al, 2002). The 
regulation of group I mGluRs internalization appears to be mediated by similar molecular 
intermediates as have been described for more typical GPCR such as the beta(2)-adrenergic 
receptor (Dhami & Ferguson, 2006). Agonist-dependent mGluR internalization is mediated by 
clathrin and dynamin-dependent endocytic pathways (Dale et al, 2002). Upon activation, group I 
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mGluRs lead to the activation of PLCβ thereby stimulating IP3 and calcium release from 
intracellular stores and lead to further signal transduction (Dale et al, 2002). Referring to the 
DAGL signalling we mentioned above (Figure 1-1) and (Figure 1-4), we can see group 1 mGluRs 
and DAGLα converge at the postsynaptic sites. Indeed, uncoupling of mGluRs and DAGLα-
dependent eCB signalling at the synapse has been implicated in abnormal LTD at excitatory 
synapses and the pathogenesis of Fragile X syndrome, a type of autism and most commonly 
inherited form of mental retardation in human (Dolen et al, 2007; Jung et al, 2012; Maccarrone et 
al, 2010). Studies from Fragile X syndrome animal models lead the authors to propose that 
mGluR5 receptors and DAGLα are linked together in a postsynaptic signalling complex to 
maintain normal state retrograde transmission at the synapse (Jung et al, 2012). Therefore 
DAGLα may be subject to endocytosis and recycling in a similar manner as group I mGluRs and 
thus may perhaps be considered as a new element of synaptic plasticity, albeit one that might 
simply be a mechanistic component of the well-established eCB pathway. This new idea will be 
explored in the second half of this thesis. 
GABA receptors  
The GABA receptors are a class of receptors that respond to GABA, the principal inhibitory 
neurotransmitter in the adult mammalian brain. There are two types of GABA receptors: ionotropic 
GABA(A) receptors which are ion channels and metabotropic GABA(B) receptors which are 
GPCRs. The GABA(A) receptors are the major site of fast synaptic inhibition in the CNS while the 
GABA(B) receptors mediate slow and prolonged inhibitory signals in the CNS (Kittler et al, 2000; 
Terunuma et al, 2010). Both GABA(A) and GABA(B) receptors have been shown to undergo 
clathrin-dependent constitutive endocytosis to regulate synaptic plasticity (Kittler et al, 2000; 
Terunuma et al, 2010). For example, inhibition of GABA(A) receptor internalization can enhance 
the amplitude of miniature inhibitory synaptic current and whole cell GABA(A) receptor current, 
indicating that the endocytosis of GABA(A) receptors regulate the efficacy of synaptic inhibition in 
hippocampal neurons (Kittler et al, 2005; Kittler et al, 2000). The GABA receptors can also couple 
to other signalling pathways such as endocytosis of AMPA receptors to regulate synaptic 
plasticity. For instance, a patterned high-frequency stimulation can trigger GABA(A) receptor-
dependent LTD in rat hippocampus which is independent of NMDA receptors and requires the 
endocytosis of AMPA receptors (Zhu et al, 2013). Another study has reported the modulator effect 
of the GABA(B) receptors for mGluR1 in cerebellar Purkinje cells (Tabata & Kano, 2010). In these 
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cells, GABA(B) receptors co-localize with mGluR1 receptors around the postsynaptic membrane 
of the excitatory synapses to facilitate mGluR1-mediated synaptic plasticity like cerebellar LTP, 
which is crucial for cerebellar motor learning (Tabata & Kano, 2010).  
In summary, receptor endocytosis at postsynaptic sites is crucial for the regulation of synaptic 
plasticity such as LTP, LTD and retrograde signalling, thus is important for learning and memory 
of the mature brain. Postsynaptic receptor endocytosis also has therapeutic importance as it is 
involved in diseases like PD, AD and Fragile X syndrome. Studies on receptor cycling have 
contributed to better understanding of underlying mechanisms of synaptic plasticity, however, it is 
still an ongoing process and further studies will be required. In the next section we will discuss 
some of the available tools for the studying of receptor endocytosis.  
1.4.3 Tools for studying receptor endocytosis in neurons and non-neuronal cells 
Endocytosis is a cellular process used by cells to internalize membrane proteins, lipids, 
extracellular ligands and soluble molecules (Arancibia-Carcamo et al, 2006). It is a basic cellular 
process that controls the protein and lipid composition of the plasma membrane therefore 
regulating how cells interact with and respond to their environment (Doherty & McMahon, 2009). 
The postsynaptic membrane is subjected to dynamic stimulation and is a site of highly regulated 
endocytosis in the CNS (Collingridge et al, 2004). A variety of endocytic pathways have been 
discovered and studied so far, however, these pathways are generally divided into two groups: 
clathrin-mediated endocytosis or clathrin-independent endocytosis. Clathrin-mediated endocytosis 
is the most extensively studied and best understood endocytic pathway. Clathrin is a protein that 
forms a triskelion shape by its heavy and light chain complex; this triskelion can assemble into an 
apolygonal lattice that helps to deform the plasm membrane into a clathrin-coated pit and 
subsequently into clathrin coated vesicles. AP-2 is required for the recruitment of clathrin to the 
plasma membrane and it provides a link between clathrin and the molecules that will be 
internalised via the clathrin coated pit (Farsad et al, 2003; Heilker et al, 1996; Traub, 2003; Traub, 
2009). Dynamin is also essential for clathrin-coated vesicle formation as it is critical for the 
pinching and release of a completed vesicle from the plasma membrane (Doherty & McMahon, 
2009). Once the clathrin built small vesicles detach from the plasma membrane, they are then 
transported within the cells. On the other hand, clathrin-independent pathways such as Caveolin 
and lipid raft-dependent pathways are less well understood (Doherty & McMahon, 2009; Mayor et 
al, 2014; Miaczynska & Stenmark, 2008). However, these clathrin-independent pathways have 
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been suggested to be important (or only functional) in special situations such as cell migration or 
in specific cell types like hippocampal neurons (Bitsikas et al, 2014; Doherty & McMahon, 2009; 
Howes et al, 2010; Mayor et al, 2014; Sandvig et al, 2011).  
For both clathrin-dependent and -independent endocytosis pathways, once the receptors have 
been internalized, they enter the endocytic pathway which consists of distinct membrane 
compartments like endosomes or lysosomes (Arancibia-Carcamo et al, 2006). Studies on these 
intracellular compartments have revealed some important mechanisms in receptor intracellular 
trafficking and many important markers such as endosomal markers have also been identified 
(Arancibia-Carcamo et al, 2006; Barbieri et al, 1994; Bucci et al, 1992; Collingridge et al, 2004; 
Jovic et al, 2010; Mu et al, 1995). All of these findings have contributed to the development of 
new tools for receptor trafficking study. Here we are going to review some widely used tools that 
have been applied to both neurons and non-neuronal cells for receptor endocytosis study, some 
of these tools are used in this thesis for DAGL trafficking.  
Antibody feeding  
Antibody feeding is one of the key method that has been developed and widely used to study 
neurotransmitter receptor endocytosis and trafficking (Arancibia-Carcamo et al, 2006). It is an 
immunofluorescence labelling approach that involves using antibodies that recognize epitopes in 
the extracellular domains of the receptors being studied thus allowing the receptors to be 
visualized down to the endosomal pathway (Arancibia-Carcamo et al, 2006). Due to the 
increasing availability of fluorescent antibodies and the development in advanced microscopy and 
imaging techniques, this method has become really powerful in tracking the intracellular 
movement of the internalized receptors in either fixed or live cells.  
The schematic steps of a typical antibody feeding assay are shown in Figure 1-5. Generally, the 
first step is antibody binding to the live cell: the receptor of interest can be labelled using an 
antibody against the extracellular epitope tag in live cells. This step is usually carried out at room 
temperature or at 4°C to limit receptor endocytosis during this first labelling step. After antibody 
binding, the cells are washing in PBS to remove unbound antibodies from the media leaving 
behind only the cell surface labelled receptors. Then the second step of the assay is 
internalization: cells are returned back to 37°C for the desired period of time in conditioned 
medium to allow receptor (and bound antibody) internalization. Cells are then placed on ice to 
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stop further endocytosis and are fixed without permeabilization. The third step is to label any 
antibody bound receptor that has remained at the cell surface with a fluorescent secondary 
antibody. Cells are permeabilized after this step, the fourth step is to label the internalized pool of 
the antibody/receptor complexes with another secondary antibody which is conjugated with a 
different type of fluorophore (Carrodus et al, 2014). Thus the surface pool and the internalized 
pool of the receptor are differentiated by different types of fluorophores, the rate of receptor 
internalization can then be quantified by comparing the signal ratio of these two fluorophores.  
Modifications of the above steps are possible and variations of antibody feeding methods have 
been reported (Arancibia-Carcamo et al, 2006; Carrodus et al, 2014; Kennedy et al, 2010). For 
example, an antibody stripping method has been reported to be able to strip any remaining 
surface-bound primary antibody and leave intracellular antibody-receptor complexes intact by 
washing the cells at low pH prior to fixation (Arancibia-Carcamo et al, 2006; Hanley et al, 2002). 
This is extremely useful in studying postsynaptic receptor trafficking as extensive receptor 
expression at the cell surface could mask the signal for internalized receptors (Arancibia-Carcamo 
et al, 2006). Another study reported that an overnight blocking step can also be applied to 
distinguish surface and internalized receptors (Carrodus et al, 2014). In Figure 1-5C, it may 
happen that not all the surface receptors are labelled by the initial secondary antibody, these 
unlabelled receptors could be labelled by the subsequent secondary antibody at the later step 
thus make it difficult to differential the internalized receptors form the surface pool. For some 
experiments such as studies in cells lines this is not an issue as the rate of internalization can be 
calculated from the ratio of the fluorescence intensities normalized to untreated controls. However, 
for studies that requires higher resolution such as studies focusing on synapses and neuronal 
dendrites, this problem can be solved by applying an overnight blocking step with high-
concentration of unlabelled secondary antibody between step C and D in Figure 1-5 (Carrodus et 
al, 2014). The antibody feeding technique can also be used in conjugation with time-lapse 
imaging to track the receptor endocytosis in a dynamic manner (Bien-Ly et al, 2014; Wirz et al, 
2005). Overall, antibody feeding has been shown to be useful in obtaining information about the 
subcellular localization of a putative receptor in various cell types (Arancibia-Carcamo et al, 2006; 






Figure 1-5 Schematic steps of antibody feeding assay 
Cartoon showing an example of “antibody feeding” assay: In brief, live cultured cells were labelled 
for 20 min at room temperature (or 4°C) with an antibody directed against the extracellular tag 
(e.g. GFP) of the receptor (A). After washing in PBS to remove unbound antibodies from the cell 
surface, cells were incubated at 37°C in cell culture medium or medium containing 
pharmacological agents to allow for endocytosis (B). Cells were then fixed for 5 min at room 
temperature in 4% paraformaldehyde (PFA) without permeabilization, and stained with Alexa 
Fluor 488-conjugated secondary antibodies for 1 h at room temperature, to visualize surface 
receptors (C). Cells were then permeabilized for 10 min in 0.2% Triton X-100 in PBS containing 
2% BSA and stained with Alexa Fluor 594-conjugated secondary antibodies for 1 h at room 
temperature in the same solution, to visualize internalized receptors (D). Fluorescence images 
can then be acquired using confocal microscopy. Units of internalization can be measured as red 
(indicative of internalization) / green fluorescence intensities normalized to untreated controls. 
Adapted from Carrodus et al. (Carrodus et al, 2014). 
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Cell surface biotinylation 
Cell surface biotinylation is another widely used technique in studying receptor endocytosis. It is a 
biochemical method based on the covalent modification of surface receptors with biotin which 
enables all the cell surface proteins that have accessible lysine residues and sufficient 
extracellular exposure to be labelled at a particular time point. Treated cells can then be 
harvested and the subsequent fate of labelled surface proteins can be determined through affinity 
purification followed by SDS-PAGE and Western blotting (Arancibia-Carcamo et al, 2006). Cell 
surface biotinylation is becoming a popular technique due to the development of biotin related 
reagents and experimental kits. Although cell surface biotinylation does not allow visualization of 
the subcellular localization of the internalized receptors, it still has some advantages compared to 
the antibody feeding approach. First, the biotin molecule is much smaller than an antibody, 
therefore it is less likely to affect the properties of the labelled receptors. Second, cell surface 
biotinylation can label the total amount of receptor at the cell surface and millions of cells are 
assayed at the same time, therefore it is more sensitive in identifying small differences in receptor 
endocytosis between treatment groups (Arancibia-Carcamo et al, 2006). Cell surface biotinylation 
has also been shown to be extremely useful in studying receptor endocytosis kinetics and 
turnover rate (Arancibia-Carcamo et al, 2006).  
Other tools for studying receptor endocytosis  
As we mentioned above, many effector molecules and distinct endocytic pathways are involved in 
receptor endocytosis and trafficking. Therefore genetic or pharmacological tools that inhibit or 
block specific steps in the endocytic pathways have been developed. Dominant negative dynamin 
mutant constructs and dynamin inhibitors are such tools that inhibit the ‘pinch off’ process of the 
coated vesicles from the membrane, thus inhibiting receptor endocytosis (Arancibia-Carcamo et 
al, 2006). Endosomal markers such as EEA1 have been used in differentiating various types of 
endosomes (Mu et al, 1995). Rab proteins such as Rab5 and Rab11 are also widely used as 
markers to identify specific sub-compartments of the endocytic pathway (Arancibia-Carcamo et al, 
2006). Overall, these genetic or pharmacological tools are often used together with the antibody 
feeding or cell surface biotinylation methods to gain a better understanding of the mechanisms of 
receptor endocytosis (Arancibia-Carcamo et al, 2006).  
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1.5 Aims and objectives 
As discussed, the eCB signalling has been postulated to play an important role in regulating 
neuroblast migration in the RMS in the postnatal brain; however, much of the supporting work 
was obtained using isolated neuroblasts or explant cultures. Furthermore, the relative importance 
of eCB signalling as compared with, for example, BDNF and FGFR signalling is not known. The 
aims of the first half of this thesis were to:- 
 Use time-lapse live cell imaging of migratory neuroblasts to determine if DAGL-dependent 
eCB signalling regulates neuroblast motility and guidance in a regionally restricted manner 
within the relatively intact RMS. 
 To compare the effects of inhibiting eCB, BDNF and FGFR signalling on neuroblast motility 
and guidance to gain insights into the relative importance of each pathway and to explore the 
possibility of direct-cross talk between them. 
 
The regulated trafficking of neurotransmitter receptors in postsynaptic spines underpins short and 
long-term forms of synaptic plasticity. Some of these receptors (e.g. mGluR5) work “hand in 
glove” with DAGLα to regulate DSI and DSE. The aim of the second part of the thesis was to 
determine if DAGLα is similarly trafficked as this might serve as a mechanism contributing to eCB 
dependent synaptic plasticity.  In this context the specific aims were to:- 
 Develop assays to monitor DAGLα trafficking in a simple model cell type and determine 
which pathways regulating this. 
 To determine if there are cell surface and intracellular pools of DAGLα in dendritic spines and 
if they are interchangeable. 
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Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Animals 
P2-P3 mouse pups were bred from CD1 mice obtained from Charles River; all mouse pups in this 
thesis are from CD1 mice unless otherwise indicated. Fgfr1/2 flox/flox and Fgfr1/2 flox/+ mice were 
bred and genotyped by Dr Kieran M. Jones (Dr M. Albert Basson group, Department of 
Craniofacial Development and Stem Cell Biology, King’s College London). Embryonic day 18 
Sprague Dawley rats (Harlan) were used for hippocampal neuron cultures. All procedures were 
performed in accordance with U.K. Home Office regulations (Animals Scientific Procedures Act, 
1986).  
2.1.2 General solutions 
Phosphate Buffered Saline (PBS) 
One PBS tablet (Oxoid) dissolved in a 100 ml of water and autoclaved: KCl (0.20 g/l), 
KH2PO4 (0.2 g/l), NaCl (8 g/l) and Na2HPO4 (1.15 g/l). 
Dissection media 
Hank’s Buffered Salt Solution (HBSS; Invitrogen) containing 5 mM HEPES (Sigma), 
100 units/ml penicillin G and 100 μg/ml streptomycin (Invitrogen). 
Brain slice collection media 
Gey's Balanced Salt Solution (Invitrogen) supplemented with 0.45% glucose (Invitrogen). 
Brain slice imaging media 
Phenol red-free Dulbecco's Modified Eagle Medium (DMEM) supplemented with 
0.5% glucose, B27 supplement, 4 mM L-glutamine, 10 mM HEPES (pH 7.4), 100 units/ml 
penicillin G and 100 μg/ml streptomycin (Invitrogen) and 5% foetal calf serum (FCS). 
Neuron seeding media 
DMEM/F12 medium containing GlutaMax and 10% Horse serum (Gibco).  
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Neurobasal complete media 
Neurobasal A medium (Life Technology) containing B27 supplement and GlutaMAX (Life 
Technology). 
2.1.3 Constructs 
pCX-EGFP     
A kind gift from Dr. Masaru Okabe (Osaka University, Japan) 
pCAG-Cre-IRES2-EGFP      
From Addgene, plasmid 26646 (Woodhead et al, 2006) 
HA-DAGLα     
A HA peptide sequence (YPYDVPDYA) flanked by a glycine-serine-glycine-serine linker on either 
side was inserted into the first extracellular loop of Human DAGLα between H and E (performed 
by GenScript) in pcDNA™6.2-DEST/V5 construct cloned by gateway cloning by Dr Praveen K 
Singh. This construct was used to generate other DAGLα mutations.  
HA-DAGLβ     
A HA tag sequence (YPYDVPDYA) with GSGS as flanking on both side was inserted into the first 
extracellular loop of Human DAGLβ between D and C (performed by GenScript) in pcDNA™6.2-
DEST/V5 construct cloned by gateway cloning by Dr Praveen K Singh. This construct was used 
to generate other DAGLβ mutations.  
SEP-hCB1      
A gift from Dr. Andrew J. Irving, University of Dundee (McDonald et al, 2007b) 
Caveolin 1-GFP and GPI-GFP    
Gifts from Dr. Oleg O. Glebov, King’s College London (Glebov et al, 2006; Glebov & Nichols, 
2004) 
2.1.4 Drugs and factors 
List of drugs used 
56 
Drug  Description Concentration 
Range 
Source 
ACEA  CB1 receptor agonist 1 μM Sigma 
AM251  CB1 receptor antagonist 1 μM Sigma 
WIN 55, 212-2 CB1 receptor agonist 1 μM Tocris Bioscience 
JWH-133 CB2 receptor agonist  1 μM  Tocris Bioscience 




DAGL inhibitor  1 μM Kind gift from Dr. Di 
Marzo  
PD173074 FGFR inhibitor 1 μM  
1 mg/kg in vivo 
Calbiochem 
AZD4547 FGFR inhibitor 1 μM  
1-12.5 mg/kg in vivo 
Selleckchem 
FGFR1-Fc Recombinant Human FGF 
R1α (IIIc) Fc Chimera 
 
1 μg/ml R&D 
TrkA-Fc Recombinant human TrkA 
Fc Chimera 
 
1 µg/ml R&D 
TrkB-Fc Recombinant human TrkB 
Fc Chimera 
 




4% paraformaldehyde (PFA) in PBS, pH 7.4 
Blocking/Permeabilising solution for cell lines 
5% bovine serum albumin (BSA), 0.2% Triton-X 100 in 1 X PBS. 
Blocking/Permeabilising solution for neurons 
5% horse serum, 0.2% Triton-X 100 in 1 X PBS. 
Primary/Secondary antibody solution for cell lines 
5% bovine serum albumin (BSA), 0.2% Triton-X 100 in 1 X PBS. 
Primary/Secondary antibody solution for neurons 
5% horse serum, 0.2% Triton-X 100 in 1 X PBS. 
Antibodies for immunocytochemistry and other fluorescent reagents 
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Antibody/Dye Source  
 
Species/ Conjugate Dilution 
βlll Tubulin 
 
Abcam  Mouse monoclonal 1:1000 
DCX  
 
Abcam Rabbit polyclonal 1:100 
GFAP  
 
Dako  Rabbit polyclonal  1:200 
GFP  Invitrogen  
 
Rabbit polyclonal  1:1000 





Abcam  ab81984 Goat  1:100 
CB1 receptor 
 




BD Mouse 1:200 
Cholera Toxin B subunit 
 
Sigma C1655 N/A 1:500 
Anti-HA Roche 11867423001 
 
Rat 1:100-1:200 
Anti-V5 Abcam Rabbit  1:1000 
 
Rab 5 Cell signalling 3547 N/A 
 
1:200 




Abcam ab9179 Mouse monoclonal  1:1000 






Synaptic Systems Rabbit 1:400 
Bassoon 
 








Sigma (B-2883)  N/A  1:10,000 
Phalloidin A 488 Invitrogen N/A  1:400 
 




Goat Anti-Rat  Invitrogen  Alexa Fluor 594  
 
1:1000 
Goat Anti-Rat  Abcam  DyLight 650   
 
1:500 




Goat Anti-Mouse  Invitrogen  Texas red  1:1000 
 
Goat Anti-Mouse  Abcam DyLight 650  1:500 
 
Goat Anti-Rabbit  Invitrogen  Alexa Fluor 488  1:1000 
 
Goat Anti-Rabbit  Invitrogen  Texas red  
 
1:1000 






Fluorescent mounting media (Dako).  
2.2 Methods 
2.2.1 Cell culture 
Cell lines 
COS-7, HEK293, and Hela cells were cultured at 37°C and 5% CO2 in DMEM media containing 
10% FCS (Life Technology).  
Primary RMS neuroblasts/explants 
CD1 mice pups, postnatal day 5-7 (P5-P7), were sacrificed by cervical dislocation and then 
decapitated. Brains were collected in dissection medium. The most caudal third of the brain was 
removed and discarded. The remaining section of the brain was cut into 1.4 mm coronal slices 
using a Mcllwain Tissue Chopper. Slices were separated and the RMS was isolated from the 
tissue with the aid of a dissecting microscope. RMS explants were cut into fragments 
approximately 200-300 μm in diameter. 
Dissociated RMS neuroblasts 
To obtain dissociated neuroblasts, RMS fragments were triturated with 2 ml of HBSS containing 
0.25% trypsin (Gibco) and 40 μl of DNAse l (1 mg/ml; Worthington), and left at 37°C for 2 minutes. 
The trypsin was inactivated with 5 ml of DMEM (Gibco) containing 10% FCS and the solution was 
centrifuged at 1,500 rpm for 5 minutes. After another two washes with DMEM + 10% FCS to 
remove any traces of trypsin, the pellet was re-suspended in pre-equilibrated (37°C/5% CO2) 
Neurobasal complete medium (Gibco) containing B27 supplement, 2mM Lglutamine (Invitrogen), 
and 0.6% glucose (Sigma). Cells were plated onto 6 well plates (1,000,000 cells/well) or glass 
coverslips (30,000-50,000 cells/coverslip) coated with polyornithine (0.5 mg/ml; Sigma) and 
laminin (10 μg/ml; Sigma). Cells were maintained in Neurobasal complete medium at 37°C/5% 
CO2 for 48-72 hours. 
Hippocampal cultures  
Dissociated hippocampal cultures were prepared from embryonic day 18 Sprague Dawley rats. 
Neurons were dissociated using 0.05% trypsin-EDTA (5 ml for 15 min at 37°C), followed by 
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washing and trituration and then plated onto 12 mm coverslips coated with poly-L-lysine (10 
μg/ml) and laminin (10 μg/ml) in neuron seeding media in 4-well dishes. Media was changed to 
neurobasal complete media after neurons attached to the coverslips (~2h). Cultures were 
maintained at 37°C in a humidified incubator with 5% CO2. Every 5-7 days, 10% culture media 
was added into the dish to maintain the culture.  
2.2.2 Postnatal electroporation  
P2 mice pups were anesthetized with isofluorane (0.6 L/min). Using a pulled glass capillary (O.D. 
1.5 mm, I.D. 0.86 mm), 1-2 μl of 1 μg/μl pCX-EGFP plasmid (a kind gift from Dr. Masaru Okabe 
and Jun-ichi Miyazaki, Osaka University, Japan) or pCAG-IRES-GFP (for floxed mice 
experiments) was injected into the right ventricle. Animals were then subjected to five electrical 
pulses of 100 V for 50 ms with 850 ms intervals using the ECM 830 Square Wave Electroporation 
System (Harvard Apparatus, USA) and 5 mm tweezer electrodes coated with conductive gel 
(CEFAR, France). Animals were then reanimated under oxygen and returned to their mother. 
2.2.3 Migration assays 
Explant migration assay 
RMS explants were embedded in growth factor-reduced phenol red free Matrigel (BD) on sterile 
glass coverslips and allowed to migrate for 6/24 hours in Neurobasal complete medium at 
37°C/5% CO2. Drugs were added to the Matrigel solution as well as the culture media and were 
present throughout the incubation period. Images of fixed and immunostained explants were 
captured on the Zeiss Apotome at 5X, 10X and 20X objectives. Distance migrated, the distance 
from the edge of the explant to the furthest migrated neuroblast perpendicular to the edge, was 
measured at 6 points around the periphery of the explant using ImageJ software. Approximately 
15 to 20 explants were measured for each independent experiment. Explants in direct contact 
with other explants were excluded from the analysis. 
For live imaging of explant migration, RMS explants were embedded in Matrigel in a 4 chamber 
35mm Hi-Q4 culture dish (Nikon). Images were captured on the Nikon Biostation (an automatic 
multipoint time-lapse imaging system with controlled environment maintained at 37°C/5% CO2) 
with 20X and 40X objectives every 3 minutes for 24 hours. Frames were played at a frequency of 
10 frames per second. Tracking analysis was performed using Volocity software (Perkin Elmer), 
and limited to the first 9 hours of filming. Since neuroblasts from within the explant emerged at 
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different times during the filming period, cells were tracked for the first 4 hours of migration upon 
exiting the explant core. At least 40 cells were tracked for each condition in each experiment. 
Migration in cultured brain slices 
5-7 days post-electroporation, animals were sacrificed by cervical dislocation followed by 
decapitation. Brains were hemisected, and the right hemisphere (electroporated side) was 
mounted (midline face down) onto the Vibratome holder (Leica) using glue (Roti Coll). Brains 
were cut into 300 μm-thick sagittal sections in Gey’s Balanced Salt Solution supplemented with 
1% glucose (Invitrogen) using Vibratome (Leica), and slices containing the olfactory bulb were 
examined under a microscope for GFP positivity along the RMS. Slices with GFP signal were 
cultured on a Millicell insert (30 mm Organotypic PTFE 0.4 μm; Millipore) submerged in brain slice 
imaging media (with or without drugs) in a p35 glass bottom dish (MatTek) for 2 hours. The slices 
were then imaged at 37°C for 3 h using Perkin Elmer UltraView VoX spinning disk system 
equipped with an inverted Nikon Ti-E microscope using a Nikon CFI Super Plan Fluor ELWD 
20X/0.45 objective and a 14 Hamamatsu Orca R2 camera. Frames were taken over a 100 to 150 
μm interval at 2-4 μm z-steps every 3 min. Images were acquired using the Perkin Elmer Volocity 
acquisition software. 
2.2.4 Transfection  
For cell lines 
Transfections of the cell lines with the constructs were carried out using the FuGene HD 
transfection reagent (Promega) in 6-well dish according to the FuGene HD protocol database. In 
brief, the cells were plated the day before transfection at a density of ~2 X 105 cells per well of a 
6-well plate in 3 ml of complete cell medium. For the transfections, 3.3µg of DNA was added into 
OPTI-MEM media (Life Technology) to make total volume of 153µl, and then 12 µl of FuGene HD 
reagent was added. This was mixed carefully by vortexing briefly and incubating for 10-15 min at 
room temperature. Finally 150 µl of complex per well was added to the cells and mixed thoroughly. 
The cells were cultured overnight at 37°C and 5% CO2. 24 hours after transfection, cells were 
generally trypsinised and seeded into 24 well plates for ICC/IF (described below) or in 6 well 
plates/10cm dishes for Western blotting analysis.  
For hippocampal neurons 
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Hippocampal neurons were transfected using the NeuroMag Magnetofection system according to 
manufacturer’s instruction. In brief, the indicated quantity of DNA was diluted in culture medium 
without serum and supplement (~1µg DNA in 50 µl medium). The DNA solution was added to the 
NeuroMag solutions by vigorous pipetting or brief vortexing and incubated at room temperature 
for 15 to 20 min. The NeuroMag/DNA complexes were added onto cells drop by drop and gently 
rocking the plate to ensure a uniform distribution. The cell culture plate was then placed on the 
magnetic plate for 15 min. Transgene expression was evaluated from 24 h to 7 days.  
2.2.5 Receptor internalization and trafficking assay 
Antibody feeding and receptor internalization assay in cell line 
24 hours after transfection of HEK293/COS-7 cells with extracellular tagged constructs, an 
antibody against the extracellular epitope tag was added into the medium (DMEM supplemented 
with 25 mM HEPES and 0.5% BSA, pH 7.4) of live cells for 20 min at 4°C, the cells were then 
gently washed in PBS to remove unbound antibody and either fixed for a zero time point control 
or returned to the incubator for various times for internalization. Cells were then briefly fixed with 4% 
PFA and a fluorophore conjugated secondary antibody was used to label the antibodies that 
associate with the surface pool of the target protein. Cells were then permeabilized with 0.2% 
TritonX-100 and subsequently another fluorophore conjugated secondary antibody was used to 
label the extracellular tag associated with the internalized pool of the target protein. Images were 
taken by Zeiss LSM710 confocal microscopy by collecting random fields from various regions of 
the coverslip and analysed using ImageJ software.  
Antibody feeding and receptor internalization assay in hippocampal neurons 
Cultured hippocampal neurons were live labelled at room temperature instead of at 4°C due to the 
intolerance of neurons to low temperature and antibodies were incubated in neuron specific 
medium. Apart from these, the procedures for the assay are the same as for the cell lines.  
Receptor recycling assay  
COS-7 cells expressing HA-DAGLα were live labelled with rat anti-HA tag antibody (Roche) for 30 
min at RT. The cells were either washed and fixed directly for a control or washed in a DMEM 
buffer (pH 3.0-3.5) before fixation to check acid wash efficiency. An anti-rat 488 secondary 
antibody was then used to detect the anti-HA antibody on the cell surface. Another group of COS-
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7 cells were live labelled and PBS washed and returned back to the incubator for uptake for 30 
min. After incubation, the cells were washed in acid buffer and either fixed (to test if the 
internalized antibody-enzyme complexes could still be detected after this acid wash step) or 
returned back to the incubator for another 30 min for the internalized antibody-enzyme complexes 
to recycle before fixation. An anti-rat 488 secondary antibody was used to detect the anti-HA 
antibodies that remained on the cell surface. After permeabilization, an anti-rat 594 secondary 
antibody was used to detect the anti-HA antibodies associated with the internalized HA-DAGLα. 
Images were taken by Zeiss LSM710 confocal microscopy by collecting random fields from 
various regions of the coverslip. 
2.2.6 Immunohistochemistry 
Gelatin-embedded sections 
Electroporated brains were hemisected, fixed in 4% PFA overnight at 4°C, and then embedded in 
8% gelatine, which was left to set overnight at 4°C. Gelatin-embedded brains were fixed in 4% 
PFA overnight at 4°C to harden the gelatin, and then cut on a Vibratome (Leica) into 70 μm-thick 
sagittal sections. Slices were blocked and permeabilised for 1 hour at room temperature in 5% 
BSA, 0.2% Triton-X, 0.01% sodium azide in PBS, and incubated with primary antibody overnight 
at 4°C in the same solution. Secondary antibodies were also diluted in the same solution and 
incubated for 2 hours at room temperature. Slices were washed in PBS, mounted onto glass 
slides using Dako mounting media, and covered with a 22x50 mm coverslip. Z-stack (every 1–2 
μm) images of the stream were captured on a Zeiss LSM 710 confocal microscope using a 40X 
objective.  
For the purpose of quantification, the RMS was classified into four anatomically distinct regions 
(Region A: descending arm of the RMS excluding the injection site; Region B: "elbow" of the 
RMS; Region C: region just after the elbow; D: RMS just before the OB) as previously described 
(Belvindrah et al, 2011). Process length was measured as the distance from the base of the cell 
body to the tip of the leading process using ImageJ software. Measurements were taken from all 
cells in each image. To determine orientation, all cells with their leading process outside a 180° 
angle relative to the position of the OB were considered to be disoriented. 
2.2.7 Data analysis  
Cell tracking of the time-lapse imaging 
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Volocity 6.0 software (Perkin Elmer) was used to track all the moving cells. Within each slice, 20-
40 cells were tracked. Volocity software directly generates the value for the total distance (the 
sum of the distance between each time point) and the net distance (displacement: the distance 
between start and end point) and the value for the average speed for each cell travelled over 3 h. 
Only the cells that migrated a certain distance (total distance ≥ 100 μm) were considered as 
moving cells and included for statistical analysis (Nam et al, 2007). For cell migratory behaviour, 
the displacement/total distance ratio was calculated for each cell. According to this ratio, cells 
were classified as random (ratio: 0-0.4), intermediate (ratio: 0.4-0.6) or directed (ratio: 0.6-1) 
(Nam et al, 2007). For each treatment group the percentage of cells in each category was 
counted and the average calculated. For the speed of cell migration analysis, the average speed 
for each cell was calculated over a 3 h period by Volocity 6.0, the average of all the cells from 
each movie was then calculated, with this value averaged from all the movies for the same 
treatment condition and expressed with the SEM.  
2.2.8 Statistical Analysis  
Student’s 2-tailed t-test and One-way or Two-way ANOVA followed by Bonferroni's post-tests 
were used for all statistical analysis. Where shown, * p<0.05, ** p<0.01, *** p <0.001 (all relative 
to control). For all graphs, each bar represents the mean ± SEM. 
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Chapter 3 Endocannabinoid signalling is required for directed 
cell migration within the RMS 
3.1 Introduction 
SVZ-derived neuroblasts can migrate to injured areas of the brain where they might limit damage 
and restore function (Arvidsson et al, 2002; Christie & Turnley, 2012; Young et al, 2011). 
Therefore understanding the molecular pathways regulating neuroblast migration is very 
important. Previous work has shown that the eCB system can regulate proliferation of neural stem 
cells in the SVZ (Gao et al, 2010; Goncalves et al, 2008) and the migration of their progeny 
neuroblasts out of RMS explants (Oudin et al, 2011a). It has been shown that the migrating 
neuroblasts in the RMS express components of the eCB system, including CB receptors, DAGLα, 
and MAGL (Oudin et al, 2011b). Detailed analysis of the eCB system using explant cultures of the 
RMS revealed that CB1 antagonists, CB2 antagonists, and DAGL inhibitors, were all capable of 
inhibiting neuroblast migration in vitro (Oudin et al, 2011a). Both CB1 and CB2 agonists (ACEA 
and JWH-133 respectively) significantly promoted the migration of RMS neuroblasts from the 
explants, and this effect was inhibited by their respective antagonists AM251 and JTE-907. 
Although combined addition of both CB1 and CB2 agonists enhanced migration out of explants, 
this effect was not greater than either one of the agonists on their own (Oudin et al, 2011a). 
Treatment of young mice with a single injection of CB1 or CB2 antagonists 24 hr before sacrifice 
decreases the length of the leading process of RMS neuroblasts in vivo (Oudin et al, 2011a). 
These results provided the first evidence that the eCB system is important for neuroblast 
migration in the RMS and also suggest that RMS neuroblast migration can be regulated by both 
CB1 and CB2 receptors (Oudin et al, 2011a).  
However, the major body of the above work was on explant cultures where the polarity of the 
stream is lost thus making it difficult to determine if eCBs simply have a motogenic function or 
whether they also regulate guidance within or along the RMS. Also, the single in vivo experiment 
on neuroblast morphology examined in fixed brain slices was not able to provide dynamic 
information on neuroblast migration. A better understanding of migration dynamics can be 
obtained by real time imaging of neuroblasts within the relatively intact RMS in brain slice cultures 
(Nam et al, 2007). This can be used to identify factors that affect motility and local guidance, and 
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to determine if pathways operate in a regionally specific manner at the beginning or end of the 
stream.  
The goal of the first part of this project was to test if eCB signalling regulates neuroblast migration 
in the relatively intact RMS by using time-lapse imaging in cultured brain slices. By doing so I also 
wanted to gain a better understanding of the dynamic role that the eCBs play in regulating local 
and longer-range guidance within the stream. In brief, in vivo electroporation was used to 
fluorescently label SVZ-derived neuroblasts in the post-natal mouse brain, acute brain slices were 
then prepared and cultured in the presence and absence of a wide array of pharmacological tools 
targeting the eCB system. Time-lapse imaging was then performed followed by analysis to study 
the neuroblast migration along the RMS (Sonego et al, 2013b). Our results show that the eCB 
signalling is required for both motility and guidance throughout the RMS.  
3.2 Results 
3.2.1 Cannabinoid antagonists perturb neuroblast migration in the RMS  
In order to test the importance of the eCB system for neuroblast migration in the RMS, firstly we 
used a combination of CB1/2 antagonists (AM251 and JTE-907) in cultured brain slices as 
previous work has shown both CB1 and CB2 receptors play a role in neuroblast migration from 
RMS explant cultures (Oudin et al, 2011a). P2 mice pups were electroporated with pCX-EGFP to 
label stem cells in the ventral wall as described resulting in the presence of GFP-labelled 
neuroblasts within the stream 5-7 days later. Slices were equilibrated for 2 hours in control 
medium or medium containing a combination of CB1/2 antagonists (AM251 and JTE-907, both at 
1 µM) before being imaged for 3 h. In our initial analysis we focused our attention on the 
descending arm of the RMS before the “elbow” region (region 1 in Figure 3-3). Individual 
neuroblasts were tracked and migration analysed. Representative images of migrating 
neuroblasts, tracked for 3 hours, for control and CB1/2 antagonist-treated slices are shown in 
Figure 3-1A,B. The white and red arrows highlight the position of two neuroblasts in each 
condition over the 3 hours period. Control neuroblasts migrated over longer distances towards the 
OB compared to neuroblasts in slices treated with the CB1/2 antagonists (Figure 3-1A,B). In 
addition, control cells displayed a predominant unipolar morphology usually oriented towards the 
OB, while cells treated with cannabinoid antagonists often displayed branched processes 
extending in all directions (Figure 3-1A,B, insets). The migration tracks of individual neuroblasts 
from representative slices are shown in Figure 3-1C-D). Under control conditions neuroblasts 
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tended to follow a similar path towards the OB (Figure 3-1C). Remarkably, when the CB receptors 
were inhibited, the cells could still move, but migration was clearly less directed (Figure 3-1D). 
A detailed statistical analysis of cell migration dynamics in these experiments is summarised in 
Figure 3-2A-C. In control slices, neuroblasts were immobile (nucleus moved less than 2 µm) 
~25% of their time, but this increased to almost 45% (p<0.001) when CB1/2 receptors were 
inhibited (Figure 3-2A). Interestingly when the cells did move in the presence of the CB1/2 
antagonists they did so at a similar speed to control cells (60.5 ± 3.5 and 58.4 ± 3.4 µm/h, 
respectively). In agreement with a recent study (Bagley & Belluscio, 2010), when imaging over a 3 
h period, ~70% of neuroblasts show net migration towards the OB in control medium (Figure 
3-2B), and this was significantly reduced by treatment with the cannabinoid receptor antagonists 
to around 40% (Figure 3-2B). Total cell displacement was also substantially reduced (96.6 ± 7.9 
µm for control and 69.6 ± 7.2 for treated) (Figure 3-2C). In summary, based on the measurement 
of several key indices of migration, the above results clearly support the hypothesis that the 
CB1/2 receptors regulate neuroblast migration in the intact RMS.  
3.2.2 eCB signalling is required for directed cell migration within the RMS 
Although the above results provide clear evidence of an important role for the eCB system in the 
regulation of neuroblast migration within the RMS, they do not address the important question as 
to whether this is important at both ends of the stream. To look for regional differences within the 
RMS, we analysed populations of neuroblasts sampled towards the beginning or end of the RMS 
as indexed by region 1 and region 2 in Figure 3-3A. Here we monitored the directionality of 
neuroblast migration by calculating the “meandering” index, i.e. the ratio between net 
displacement and total distance covered over the 3 h time period. According to this ratio, 
neuroblast movement can be classified as exploratory (ratio < 0.4), directed (ratio > 0.6), or 
intermediate (0.4 – 0.6) (Nam et al, 2007). In the RMS, close to the SVZ (Figure 3-3A), treatment 
with CB receptor antagonists resulted in a near two-fold increase in the number of exploratory 
neuroblasts at the expense of a near two-fold decrease in the number of cells migrating in a 
directed manner (Figure 3-3B). Very similar results were observed when neuroblasts were 
analysed in the RMS close to the OB (Figure 3-3C). Thus, we can conclude that eCB signalling is 
required for neuroblast motility and guidance within the RMS and that this pathway operates all 











Figure 3-1 eCB antagonists perturb neuroblast migration in the RMS 
Sagittal mouse brain slices with GFP-labeled neuroblasts were prepared 5-7 days after in vivo 
postnatal electroporation of P2 mice with pCX-EGFP. Slices were cultured with vehicle or drugs 
(as indicated) for 2 hours and subsequently imaged for 3 hours in the same medium. Time-lapse 
movies were made from the descending arm of the RMS in slices treated with drugs targeting the 
eCB system (the CB1/2 antagonists AM251+JTE-907, both at 1 µM) were analyzed using 
Volocity. Representative pictures of slices treated with vehicle (A) or the CB1/2 antagonists 
AM251+JTE-907 (B) are shown. Arrows follow two neuroblasts in each frame. Insets show 
magnifications of the neuroblast indicated by the white arrows (A) or red arrow (B). Cells migrate 
towards OB with time in control slice while AM251+JTE-907 treated cells show less directed 
movements. Representative migratory tracks of 15 cells over 3 hours from a control (C) or CB1/2 
antagonist-treated brain slice (D). White stars mark the tracking end point of each cell. The OB 





Figure 3-2 eCB antagonists perturb neuroblast migration in the RMS 
Quantification of cell migration from control slices or slices treated with the CB1/2 antagonists 
AM251+JTE-907 (all at 1 µM). Time-lapse movies were all made from the descending arm of the 
RMS. Cells treated with the CB1/CB2 antagonists spent more time immobile (A). Incubation with 
CB antagonists also significantly decreased the percentage of neuroblasts migrating towards the 
OB (B) and the overall cell displacement of the cells (C). Graphs show mean ± s.e.m. (n=7 brain 




Figure 3-3 Inhibiting eCB signalling perturbs neuroblast migration at both ends of the RMS 
Five to seven days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were 
cultured with vehicle or drugs as indicated for 2 h followed by time-lapse imaging for 3 h in the 
same medium. (A) A typical sagittal brain slice showing labelled neuroblasts. The two red 
rectangular boxes labelled 1 and 2 indicate the imaging sites in the beginning (caudal) and end 
(rostral) of the RMS respectively. Incubation with CB1 and CB2 antagonists (AM251 + JTE-907, 
both at 1 μM) significantly increased the percentage of exploratory neuroblasts at the expense of 
directed neuroblasts in both regions of the RMS (B, caudal RMS; C, rostral RMS). Graphs show 
mean ± s.e.m. (n= 6 brain slices for each condition, ~15–30 cells analysed per slice); * p<0.05, ** 
p<0.01, *** p<0.001. Bar, 400 μm.  
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3.2.3 DAGL inhibitor perturb neuroblast migration in the RMS 
The above results provide clear evidence for eCB signalling regulating migration, but they do not 
address the nature of the eCB driving the response. As discussed previously, there is 
considerable evidence for 2-AG being the principle eCB for the central nervous system, and 
DAGLs (especially DAGLα) have been identified as the major enzymes for 2-AG synthesis in the 
brain (Bisogno et al, 2003; Gao et al, 2010). Therefore, to test if DAGL activity is required for 
neuroblast migration in the RMS, a DAGL inhibitor, OMDM-188 (Ortar et al, 2008) was added to 
the cultured brain slices. As before, P2 mice pups were electroporated with pCX-EGFP and slice 
cultures containing GFP-labelled neuroblasts within the stream were established 5-7 days later. 
Slices were equilibrated for 2 h in control medium or medium containing OMDM-188 (1 µM) 
before being imaged for 3 h. Again, our initial analysis was focused on the descending arm of the 
RMS before the “elbow” region (region 1 in Figure 3-3A). Individual neuroblasts were then tracked 
and migration analysed. The migration tracks of individual neuroblasts from control and DAGL 
inhibitor-treated slices are shown in Figure 3-4A,B. Control neuroblasts migrated over longer 
distances towards the OB compared to neuroblasts in slices treated with the DAGL inhibitor 
(Figure 3-4A,B). Under control conditions neuroblasts tended to follow a similar path towards the 
OB (Figure 3-4A). Remarkably, when DAGL was inhibited, the cells could still move, but migration 
was clearly less directed and the cells tends to have shorter migration tracks (Figure 3-4B). A 
detailed statistical analysis of cell migration dynamics in these experiments is summarised in 
Figure 3-4C-E. In control slices, neuroblasts were immobile (nucleus moved less than 2 µm) 
~25% of their time, similar to CB receptor antagonists treated slices, this increased to almost 50% 
(p<0.001) when the DAGL enzymes were inhibited (Figure 3-4C). In control medium, ~70% of 
neuroblasts show net migration towards the OB (Figure 3-4D), and this was significantly reduced 
by treatment with the DAGL inhibitor to around 50% (Figure 3-4D). Total cell displacement was 
also substantially reduced (Figure 3-4E).  
3.2.4 DAGL signalling is required for directed cell migration within the RMS 
To look for regional differences within the RMS, we analysed populations of neuroblasts sampled 
towards the beginning or end of the RMS as indexed by region 1 and region 2 in Figure 3-3A. 
Again, we monitored the directionality of neuroblast migration by calculating the “meandering” 
index, i.e. the ratio between net displacement and total distance covered over the 3 h time period. 
Similar results were obtained in both regions of the stream when DAGL activity was inhibited 
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compare to the CB receptor antagonists’ treatment (Figure 3-5). More specifically, close to the 
SVZ in the RMS (Figure 3-5A, region 1), treatment with the DAGL inhibitor resulted in a near two-
fold increase in the number of exploratory neuroblasts at the expense of a near two-fold decrease 
in the number of cells migrating in a directed manner (Figure 3-5B). A significant effect was also 
observed when neuroblasts were analysed in the RMS close to the OB (Figure 3-5C), treatment 
with the DAGL inhibitor resulted in a near three-fold increase in the number of exploratory 
neuroblasts at the expense of a near two-fold decrease in the number of cells migrating in a 
directed manner (Figure 3-5C). Thus, we can conclude that DAGL-dependent eCB signalling is 
required for neuroblast motility and guidance within the RMS and that this pathway operates all 
along the RMS. 
3.2.5 eCB agonists increase cell motility without disrupting directionality in the RMS 
In the above experiments we have tested the effects of inhibiting eCB signalling on neuroblast 
migration within the RMS. There are also some excellent small molecule agonists for the CB1 and 
CB2 receptors, and although it is perhaps not clear what they might do to migration in brain slices, 
it was nonetheless of interest to test this. The CB receptor agonists have been shown to increase 
neuroblast motility and promote cell migration out the explant of the RMS in vitro (Oudin et al, 
2011a). To test whether the CB receptor agonists simply have a motogenic function or whether 
they also regulate guidance along the RMS, we used a combination of CB1/2 agonists (ACEA 
and JWH-133) in cultured brain slices. P2 mice pups were electroporated with pCX-EGFP and 
slice cultures containing GFP-labelled neuroblasts within the stream were established 5-7 days 
later. Slices were equilibrated for 2 h in control medium or medium containing ACEA and JWH-
133 (both at 1 µM) before being imaged for 3 h. Our initial analysis was focused on the 
descending arm of the RMS before the “elbow” region. Individual neuroblasts were then tracked 
and migration analysed. Quantification of cell migration from control slices or slices treated with 
the CB1/2 agonists ACEA+JWH-133 is shown in Figure 3-6. Cells treated with the CB1/2 agonists 
migrate at a higher speed (67.02 ± 2.9 µm/h) compared to control cells (57.11 ± 1.9 µm/h) 
suggesting that the receptors are not maximally active under control conditions (Figure 3-6A). 
Interestingly, incubation with CB agonists does not significantly alter the percentage of 
neuroblasts migrating towards the OB (Figure 3-6B). We then analysed the populations of 
neuroblasts sampled towards the beginning or end of the RMS to look at the guidance effect of 
CB agonists along the RMS, again no significant difference were found between treated and 
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control brain slices (Figure 3-6C, pooled from beginning and end of the RMS). Thus we conclude 
that the eCB agonists increase the cell motility, albeit by a relatively small amount. However, 
perhaps the key observation from this section is that the agonists do not have any significant 
effect on guidance within the stream. This result will be discussed in detail below, but it provides 
substantive evidence against the notion that long range eCB gradients might operate along the 





Figure 3-4 A DAGL inhibitor perturbs neuroblast migration in the RMS 
Time-lapse movies made from the descending arm of the RMS in slices treated with a DAGL 
inhibitor (OMDM-188) were analyzed using Volocity. Representative migratory tracks of 15 cells 
over 3 hours from a control (A) or DAGL inhibitor-treated (OMDM-188 at 1 μM) brain slice (B). 
White stars mark the tracking end point of each cell. The OB label shows the location of the 
olfactory bulb in each brain slice. Cells migrate towards OB with time in control slice while 
OMDM188 treated cells show less directed movements. (C-E) shows quantification of cell 
migration from control slicesor slices treated with OMDM-188 at 1 μM. Cells treated with the 
DAGL inhibitor spent more time immobile (C). Incubation with the DAGL inhibitor also significantly 
decreased the percentage of neuroblasts migrating towards the OB (D) and the overall cell 
displacement (E). Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 15-30 cells 




Figure 3-5 Inhibiting DAGL perturbs neuroblast directionality along the RMS 
Five to seven days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were 
cultured with vehicle or drugs for 2 h followed by time-lapse imaging for 3 h in the same medium. 
(A) A typical sagittal brain slice showing labelled neuroblasts. The two red rectangular boxes 
labelled 1 and 2 indicate the imaging sites in the beginning (caudal) and end (rostral) of RMS, 
respectively. Incubation with a DAGL inhibitor (OMDM-188, 1 μM) significantly increased the 
percentage of exploratory neuroblasts at the expense of directed neuroblasts in both regions of 
the RMS (B, caudal RMS; C, rostral RMS). Graphs show mean ± s.e.m. (n= 6 brain slices for 
control and 4 for treated, ~15–30 cells analysed per slice); * p<0.05, ** p<0.01, *** p<0.001. Bar, 
400 μm.  
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Figure 3-6 The effects of eCB agonists on neuroblast migration in the RMS  
Quantification of cell migration from control slices or slices treated with the CB1/2 agonists 
ACEA+JWH-133 (both at 1 µM). Time-lapse movies were all made from the descending arm of 
the RMS. Cells treated with the CB1/2 agonists migrate at a higher speed compared to control 
cells (A). Incubation with CB agonists does not significantly decrease the percentage of 
neuroblasts migrating towards the OB (B) and does not significantly disrupt the directionality (C). 
Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 15-30 cells analyzed per 
slice); * p<0.05, ** p<0.01, *** p<0.001.   
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Chapter 4 FGFR signalling is required for directed cell migration 
at the beginning of RMS 
4.1 Introduction 
In the last chapter, we used time-lapse imaging to characterise the role of the eCB system in the 
regulation of neuroblast migration and concluded that the eCB system is required for neuroblast 
motility and guidance within the RMS and that this pathway operates all along the RMS. Although 
we know the eCB system plays a role in the RMS, we don’t know its’ relative importance 
compared to other signalling pathways that also operate in the RMS. Indeed, most studies tend to 
focus on a single signalling system at a time, and examples include BDNF, GABA, integrin, and 
slits (Bagley & Belluscio, 2010; Bolteus & Bordey, 2004; Chiaramello et al, 2007; Mobley & 
McCarty, 2011; Nguyen-Ba-Charvet et al, 2004; Snapyan et al, 2009). Therefore, despite the fact 
that numerous molecules have been found to be important for neuroblast migration in the RMS, 
how they relate to each other and integrate their signalling pathways is far from fully understood 
(Ming & Song, 2011). The eCB pathway is well suited to directly cross-talk with receptor tyrosine 
kinases and other receptors that stimulate the synthesis of DAG, the DAGL-substrate. Insights 
into possible interactions can be gleaned by directly comparing the relative importance of the eCB 
signalling to that of other putative guidance cues on the migration of the neuroblast in the RMS. In 
this context we have treated brain slices with tools to perturb fibroblast growth factor receptor 
(FGFR) signalling and TrkB signalling as both can cross-talk to the eCB pathway (discussed 
below). In this chapter, we report on FGFR signalling system while the TrkB results will be 
discussed in the next chapter.  
Previous studies in our lab have provided evidence for direct cross-talk between the eCB system 
and FGFRs (Williams et al, 2003). Evidence was obtained that supports the hypothesis that 
activation of FGFR signalling can lead to activation of PLC to synthesize DAG, with DAGL then 
using this substrate to generate 2-AG to activate the CB1 receptors. This direct cross-talk 
between the FGFR and the CB1 receptor promotes axonal growth, a biological response that 
shares many features with cell migration (Williams et al, 2003). It is also possible that activation of 
FGFR signalling might lead to direct cross-talk with eCB signalling via the same PLC dependent 
mechanism for neuroblast migration in the RMS as has been reported for axonal growth.  
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The FGF/FGFR signalling superfamily comprises four closely related receptors (FGFR1-4), and 
numerous growth factor ligands. The amino acid sequences of the FGFRs are highly conserved 
between different members of the family and throughout evolution (Burke et al, 1998). Studies in 
the past two decades have clearly shown that FGFs and their receptors play key roles in multiple 
biological processes including tissue repair, haematopoiesis, angiogenesis, embryonic 
development and neural proliferation (Reuss & von Bohlen und Halbach, 2003). At least 18 FGFs 
have been found to date, although not all the FGF subtypes can be detected in the central 
nervous system or in all species. The important role of FGFs on cognitive process and neural 
proliferation in the adult brain has been demonstrated (Reuss & von Bohlen und Halbach, 2003). 
More pertinent to this study, it has been shown that in the SVZ, the proliferating precursor cells 
express mRNA for both FGFR1 and FGFR2, and may respond to FGF-2 released by a non-
proliferating cell type present in the SVZ (Frinchi et al, 2008). Another study using immunostaining 
for FGF-2 revealed a caudal-rostral expression gradient along the RMS, with stronger labelling in 
the SVZ region than the OB. Analysis of transcript levels by qPCR revealed higher levels of 
FGFR1 and 2 than FGFR3 in the postnatal SVZ, with very low expression of FGFR4 detected 
(Garcia-Gonzalez et al, 2010). In addition, the FGFR1 has been shown to be expressed by SVZ 
derived neuroblasts in culture, and treatment of SVZ derived explant cultures with FGF-2 
significantly increased migration from the explants, and this effect was suggested to be mediated 
by the FGFR1(Garcia-Gonzalez et al, 2010).  
The hypothesis that a caudal-rostral FGF-2 gradient along the SVZ and RMS drives the migration 
of neuroblasts by working on FGFR1 and its downstream pathways has not been critically tested 
in vivo. In this study, postnatal electroporation and real-time imaging methods are applied to test if 
FGFR signalling regulates neuroblast motility and guidance in the RMS slice culture model, and 
whether this pathway operates in a regional specific manner. Administration of an FGFR inhibitor 
to living animals was also used to test the effect of FGFR signalling on neuroblast migration in 
vivo. I have also characterised neuroblast migration in the RMS in mice that have a conditional 
deletion of FGFR1/2 to compare the consequence of chronic loss of the receptors with acute loss 
of receptor function. Our results show that directly targeting FGFR signalling with drugs perturbs 
neuroblast migration in the RMS. This was seen following treatments with agents that inhibit 
activity of the receptor, agents that compromise the function of conventional receptor ligands, and 
also by application of excess amounts of exogenous FGF-2 to the slice culture that might be 
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expected to “flatten” the putative gradient of FGF-2 reported by others. In all instances the 
migration of the neuroblasts becomes more random rather than directed. Interestingly, this effect 
on migratory neuroblasts is only seen at the beginning of the RMS, with the same treatments 
having no effect on cells within the end of the RMS. These results support the hypothesis the 
caudal-rostral FGF-2 gradient along the SVZ and RMS drives the migration of neuroblasts by 
working on FGFR to activate its downstream signalling pathways. Surprisingly, studies with the 
FGFR1/2 conditional knockout animals did not support the hypothesis, but this might be 
accounted for by established redundancy in the MAPK pathway downstream of the FGFR in the 
neural stem cell lineage (Sutterlin et al, 2013) and this is discussed in detail below. 
4.2 Results 
4.2.1 FGFR inhibitors perturb neuroblast migration in the RMS 
To test the importance of FGFR activity for neuroblast migration in the RMS, we first used two 
highly selective FGFR inhibitors, AZD4547 and PD173074 that inhibit receptor activity by 
competing for ATP binding to the activated receptor (Gavine et al, 2012; Mohammadi et al, 1998). 
P2 mice pups were electroporated with pCX-EGFP to label stem cells in the ventral wall resulting 
in the presence of GFP-labelled neuroblasts within the stream 5-7 days later. Brain slice cultures 
were equilibrated for 2 h in control medium or medium containing AZD4547 or PD173074 (both at 
1 µM) before being imaged for 3 h. Again, we initially focused our attention on the descending 
arm of the RMS before the “elbow” region (region 1 in Figure 4-2). Individual neuroblasts were 
tracked and migration analysed. Visual inspection of neuroblast migration tracks showed a very 
clear reduction in displacement and a loss of guidance when the FGFR inhibitors were present. 
The migration tracks of individual neuroblasts from representative slices are shown in Figure 
4-1A-C. Under control conditions neuroblasts tended to follow a similar path towards the OB 
(Figure 4-1A), while the cells in the slices treated with FGFR inhibitors clearly migrate in a less 
directed manner (Figure 4-1B-C). 
A detailed statistical analysis of cell migration dynamics in these experiments is summarised in 
Figure 4-1D-F. In control slices, neuroblasts were immobile (nucleus moved less than 2 µm) 
~32% of their time, but this increased to ~40% (p<0.05) and ~50% (p<0.001) in the presence of 
AZD4547 and PD173074 respectively (Figure 4-1D). In control medium, ~75% of neuroblasts 
show net migration towards the OB (Figure 4-1E), and this was significantly reduced by treatment 
with the AZD4547 to around 50% (Figure 4-1E). Moreover, total cell displacement was also 
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substantially reduced (113.8 ± 7.1 µm for control, 80.2 ± 6.6µm and 73.9 ± 9.4 µm for AZD4547 
and PD173074 treated) (Figure 4-1F). In summary, based on the measurement above, the results 
clearly support the hypothesis that FGFR signalling regulates neuroblast migration in the intact 
RMS.  
4.2.2 FGFR inhibitors perturb directed cell migration at beginning but not end of the RMS 
Next we determined whether FGFR is important at both ends of the stream by analysing 
populations of neuroblasts sampled towards the beginning or end of the RMS as indexed by 
region 1 and region 2 in Figure 4-2A. Again we monitored the directionality of neuroblast 
migration by calculating the “meandering” index, i.e. the ratio between net displacement and total 
distance covered over the 3 h time period. Our results showed that close to the SVZ in the RMS 
(Figure 4-2A), treatment with both FGFR inhibitors resulted in a significant reduction in the 
number of neuroblasts showing directed migration with a corresponding increase of exploratory 
neuroblasts and neuroblasts in the intermediate group. Remarkably, this effect was only seen with 
neuroblasts sampled at the beginning of the RMS, with no significant effects seen on any of the 
measured parameters with neuroblasts sampled at the end of RMS (Figure 4-2C). Thus, it would 
appear that FGFR signalling is required for neuroblast motility and guidance in the RMS, but 





Figure 4-1 FGFR inhibitors perturb neuroblast migration in the RMS 
Time-lapse movies made from the descending arm of the RMS in control slices and slices treated 
with FGFR inhibitors (AZD4547 and PD173074) were analyzed using Volocity. Representative 
migratory tracks of 15 cells over 3 hours from a control (A) or AZD4547 (B) or PD173074-treated 
(both at 1 μM) brain slice (C). White stars mark the tracking end point of each cell. The OB label 
shows the location of the olfactory bulb in each brain slice. Cells migrate towards the OB with time 
in control slices while inhibiting FGFR signalling results in less directed cell movements. (D-F) 
shows quantification of cell migration from control slices or slices treated with AZD4547 or 
PD173074. Cells treated with the FGFR inhibitors significantly increase the percentage of time 
spend immobile (D). Incubation with AZD4547 or PD173074 also significantly decreased the 
percentage of neuroblasts migrating towards the OB (E) and the overall cell displacement (F). 
Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 15-30 cells analyzed per 
slice); * p<0.05, ** p<0.01, *** p<0.001.  
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Figure 4-2 FGFR inhibitors perturb neuroblast migration at the beginning but not the end 
of the RMS 
Five days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were cultured with 
vehicle or AZD4547 or PD173074 (both at 1 µM) for 2 h followed by time-lapse imaging for 3 h in 
the same medium. Neuroblast migration was filmed and analysed in the beginning and end of 
RMS (regions 1 and 2 in A). Incubation with AZD4547 or PD173074 significantly increased the 
percentage of exploratory neuroblasts at the expense of directed neuroblasts towards the 
beginning of the RMS (B), while the same treatments do not have any significant effect at the end 
of the RMS compared to control (C). Graphs show mean ± s.e.m. (n=6-8 brain slices for each 
condition, ~15-30 cells analysed per slice); * p<0.05, ** p<0.01, *** p<0.001. Bar, 400 μm   
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4.2.3 A FGFR1-Fc perturb neuroblast migration in the RMS 
The results above clearly support the role of FGFR activity regulating migration at the beginning 
of the RMS, but give no insights into the nature of the ligand(s) that might activate the FGFR(s). 
Previous studies have shown that the FGFRs can be directly activated by the “conventional” FGF 
ligands; however a more recent body of work has established that a number of cell adhesion 
molecules can act as “surrogate” ligands and also activate FGFRs independently of the 
conventional ligands (Boscher & Mege, 2008; Cavallaro et al, 2001; Doherty & Walsh, 1996; 
Saffell et al, 1997; Sanchez-Heras et al, 2006; Turner & Grose, 2010; Williams et al, 1994a; 
Williams et al, 2001). The recombinant human FGFR1 Fc chimera (FGFR1-Fc) is a chimeric 
molecule consisting of the Fc region of human IgG1 fused to the extracellular domains of FGFR1 
alpha (IIIc) (Martinez-Torrecuadrada et al, 2005). It will bind FGFR1 ligands like FGF-2 and 
prevent them from interacting with the cell expressed receptors. Therefore we used a FGFR1-Fc 
chimera to trap any FGFR1 ligands present within the RMS. As before, P2 mice pups were 
electroporated with pCX-EGFP and slice cultures containing GFP-labelled neuroblasts within the 
stream were established 5-7 days later. Slices were equilibrated for 2 h in control medium or 
medium containing FGFR1-Fc (1 μg/ml) before being imaged for 3 h. Our initial analysis was 
focused on the descending arm of the RMS before the “elbow” region (region 1 in Figure 4-2). 
Individual neuroblasts were then tracked and migration analysed. The migration tracks of 
individual neuroblasts from control and FGFR1-Fc-treated slices are shown in Figure 4-3A,B. 
Control neuroblasts migrated over longer distances towards the OB compared to neuroblasts in 
slices treated with the FGFR1-Fc (Figure 4-3A,B). Under control conditions neuroblasts tended to 
follow a similar path towards the OB (Figure 4-3A). When the FGFR1-Fc was added to the brain 
slices, the cells moved in less directed manner and they tended to have shorter migration tracks 
(Figure 4-3B). A detailed statistical analysis of cell migration dynamics in these experiments is 
summarised in Figure 4-3C-E. In control slices, neuroblasts were immobile (nucleus moved less 
than 2 µm) ~28% of their time, this increased to almost 45% (p<0.05) when treated with FGFR1-
Fc (Figure 4-3C). In control medium, ~75% of neuroblasts show net migration towards the OB 
(Figure 4-3D), and this was significantly reduced by treatment with the FGFR1-Fc to ~60% 
(Figure 4-3D). Total cell displacement was also significantly reduced (Figure 4-3E).  
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4.2.4 FGFR1-Fc perturb directed cell migration within the RMS 
Next we wanted to test for regional differences of the FGFR1-Fc effect within the RMS. 
Populations of neuroblasts sampled towards the beginning or end of the RMS were analysed as 
indexed by region 1 and region 2 in Figure 4-2A. Again, we monitored the directionality of 
neuroblast migration by calculating the “meandering” index. The results showed that the FGFR1-
Fc treatment had a significant effect towards the beginning of the RMS, but no significant effect 
has been seen in the end of the RMS. More specifically, close to the SVZ in the RMS (Figure 
4-4A, region 1), treatment with FGFR1-Fc resulted in a significant decrease in the number of cells 
migrating in a directed manner with a trend of increasing the number of exploratory neuroblasts 
(Figure 4-4B). No significant effect was observed when neuroblasts were analysed in the RMS 
close to the OB (Figure 4-4C), treatment with FGFR1-Fc even resulted in a small trend to 
decrease the number of cells migrating in an exploratory manner at the expense of increasing the 
number of directed neuroblasts (Figure 4-4C). Thus, we can conclude that FGFR ligand(s) drive 
neuroblast migration and guidance at the beginning but not the end of the RMS. At first sight this 
might point to the conventional FGFR1 ligands driving the response, but the ability of the soluble 






Figure 4-3 An FGFR1-Fc perturbs neuroblast migration in the RMS 
Time-lapse movies made from the descending arm of the RMS in slices treated with an FGFR1-
Fc and were analyzed using Volocity. Representative migratory tracks of 15 cells over 3 hours 
from a control (A) or FGFR1-Fc-treated (1 μg/ml) brain slice (B). White stars mark the tracking 
end point of each cell. The OB label shows the location of the olfactory bulb in each brain slice. 
Cells migrate towards the OB with time in control slices, while cells treated with the FGFR1-Fc 
show less directed movements. (C-E) shows quantification of cell migration from control slices or 
slices treated with FGFR1-Fc. Cells with treated with the FGFR1-Fc significantly increase the 
percentage of time spend immobile (C). Incubation with FGFR1-Fc also significantly decreased 
the percentage of neuroblasts migrating towards the OB (D) and the overall cell displacement (E). 
Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 15-30 cells analyzed per 
slice); * p<0.05, ** p<0.01, *** p<0.001.  
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Figure 4-4 An FGFR1-Fc perturbs neuroblast directionality at the beginning but not the end 
of the RMS 
Five days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were cultured with 
vehicle or an FGFR1-Fc (1 μg/ml) for 2 h followed by time-lapse imaging for 3 h in the same 
medium. Neuroblast migration was filmed and analysed in the beginning and end of RMS (regions 
1 and 2 in A). Incubation with FGFR1-Fc significantly increased the percentage of exploratory 
neuroblasts at the expense of directed neuroblasts towards the beginning of the RMS (B), while 
the same treatment does not have significant effect compared to control slices and end of the 
RMS (C). Graphs show mean ± s.e.m. (n=6-8 brain slices for each condition, ~15-30 cells 
analysed per slice); * p<0.05, ** p<0.01, *** p<0.001. Bar, 400 μm   
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4.2.5 Disruption of FGF-2 signalling in the RMS perturb neuroblast migration at the 
beginning but not end of the RMS 
The FGFR1-Fc would be expected to inhibit the function of FGF-2 and it has been reported that 
both FGF-2 and FGFR1 are expressed in the SVZ as well as in the OB and FGF-2 can promote 
migration from the explant in vitro (Garcia-Gonzalez et al, 2010; Hebert et al, 2003; Mudo et al, 
2007). Moreover, a caudual-rostral gradient of FGF-2 has been reported within the RMS (Garcia-
Gonzalez et al, 2010). Therefore, it’s very likely that FGF-2 signalling through FGFR1 is 
responsible for the gradient effect we reported above. To test whether FGF-2 is important for 
neuroblast migration, we first inhibited FGF-2 in the RMS by using a specific FGF-2 blocking 
antibody bFM-1 (Matsuzaki et al, 1989). Also we wanted to test whether a gradient of 
endogenous FGF-2 might be playing an instructive role in migration as suggested by others 
(Garcia-Gonzalez et al, 2010). Therefore, we treated the slice cultures with a relatively high 
concentration of exogenous FGF-2 (50 ng/ml) to “flatten” any FGF-2 gradient. P2 mice pups were 
used for electroporation, and slice cultures were prepared 5-7 days after electroporation. Slices 
were equilibrated for 2 h in control medium or medium containing bFM-1 (10 µg/ml) or FGF-2 (50 
ng/ml) before being imaged for 3 h. Populations of neuroblasts sampled towards the beginning or 
end of the RMS were analysed as indexed by region 1 and region 2 in Figure 4-5A. Again, we 
monitored the directionality of neuroblast migration by calculating the “meandering” index over the 
3 h time period. Visual inspection of neuroblast migration tracks showed a very clear reduction in 
displacement and a loss of guidance when the FGF-2 neutralizing antibody was present or when 
high concentration of exogenous FGF-2 was added, and again these effects were only seen at 
the beginning of the RMS. Detailed analysis on the meandering index is shown in Figure 4-5B,C. 
Both treatments resulted in a significant decrease in the number of cells migrating in a directed 
manner with a trend seen of increasing the number of cells in the “exploratory” and “intermediate” 
groups at the beginning of the RMS (Figure 4-5B). In contrast, we again failed to detect a 
significant effect of the treatments on the migratory parameters in neuroblasts sampled at the end 
of the stream (Figure 4-5C). Thus, based on the result with the blocking antibody we can propose 
that FGF-2 / FGFR signalling is important for the directed migration of the neuroblasts in the RMS, 
but in contrast to eCB signalling, this pathway only operates towards the beginning of the RMS. 
The results from the exogenous FGF-2 suggested that the “correct” concentration of FGF-2 is 
important in the RMS; these results support the hypothesis that endogenous FGF-2 might form a 
gradient in the RMS to guide neuroblast migration.  
88 
4.2.6 Targeting FGFR signalling affects cell displacement at the beginning but not end of 
the RMS 
In order to substantiate the above results we also analyzed the cell displacements (the distance 
between begin and end point of a migrating cell) at both the beginning and end of the RMS for all 
the treatments that target the FGF-2/FGFR pathway. In this context we compared the effects of 
the two FGFR inhibitors, the FGFR1-Fc, the FGF-2 neutralizing antibody and treatment with an 
“excess” of exogenous FGF-2 on the cell displacement at both ends of the RMS (Figure 4-6). 
Consistent with the results shown above, all treatments significantly decrease the cell 
displacement at the beginning of the RMS, but none affected displacement towards the end of the 
RMS (Figure 4-6). These results, together with those reported above, provide very substantial 
support for an important role for FGFR signalling in the regulation of directed neuroblast migration 
at the beginning of the RMS, and suggest that this is driven by FGF-2 acting on the FGFR1 in the 
migratory neuroblasts. Furthermore, they show that this pathway operates in a regionally 




Figure 4-5 Targeting FGF-2 signalling affects neuroblast migration in the beginning but not 
the end of the RMS 
Acute mouse brain slices containing GFP-labelled neuroblasts were prepared 5–7 days after in 
vivo electroporation of pCX-EGFP, cultured with vehicle or drugs for 2 h and imaged for 3 h in the 
same medium. FGF-2 signalling was targeted using an FGF-2 neutralizing antibody (bFM-1at 10 
µg/ml), or by treatment with FGF-2 (at 50 ng/ml). Both treatments decreased the percentage of 
cells migrating in a directed fashion and increased the amount of exploratory neuroblasts in the 
beginning (A) but not in the end of RMS relative to the vehicle control (B). Graphs show mean ± 
s.e.m. (n= 5–8 brain slices for each condition, ~15–30 cells analysed per slice); * p<0.05, ** 
p<0.01, *** p<0.001.  
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Figure 4-6 Targeting FGFR signalling affects cell displacement at the beginning but not 
end of the RMS 
Quantification of total cell displacement the neuroblast migrated over 3 h period at the beginning 
(A) and end of the RMS (B) (regions 1 and 2 in Figure 4-5A). FGFR signalling was targeted using 
AZD4547, PD173074 (both at 1 μM) or an FGFR1-Fc (1 μg/ml) in brain slice cultures. A FGF-2 
neutralizing antibody bFM-1 (10 μg/ml) or FGF-2 (50 ng/ml) were also added to the slice cultures 
followed by time-lapse imaging. All treatments significantly decrease the overall cell displacement 
at the beginning of the RMS relative to vehicle treated slices (A) while the cell displacement at the 
end of the RMS is not significantly disrupted by any of the treatments (B). Graphs show mean ± 
s.e.m. (n=5-7 brain slices for each condition, ~ 15-30 cells analyzed per slice); * p<0.05, ** 
p<0.01, *** p<0.001  
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4.2.7 Regional effects of an FGFR inhibitor on neuroblast morphology in vivo  
We have shown that inhibiting FGFR signalling can disrupt neuroblast migration in the acute brain 
slice cultures. To further test the role of FGFR signalling in the RMS, we also treated P7 mice 
(same source and species of mice as used above for slice cultures) by I.P. administration of the 
FGFR inhibitor AZD4547 to determine if there is any evidence that the neuroblast migration can 
be comprimised by inhibiting the FGFR in vivo. The mouse pups were electroporated with pCX-
EGFP at P2 and 5 days later treated with the FGFR inhibitor AZD4547 (12.5 mg/kg I.P., two 
doses with a 12 hour interval). After 24 h, brains were removed, fixed, sliced and immunostained 
for GFP. Representative pictures of neuroblasts in animals treated with vehicle (Figure 4-7A) and 
AZD4547 (Figure 4-7B) in the descending arm of RMS are shown in Figure 4-7. Visual inspection 
of the neuroblasts in the RMS treated with AZD4547 suggested a decrease in the length of the 
leading process (Figure 4-7B). Morphometric analysis of this parameter measured on neuroblasts 
sampled throughout the entire RMS revealed that there was a significant decrease of the length of 
the leading process (Figure 4-7C). Detailed analysis of neuroblasts sampled in different regions of 
the RMS (see cartoon in Figure 4-8) showed that treatment with AZD4547 significantly reduced 
the length of the leading process towards the beginning and not the end of the RMS (Figure 4-8). 
These results provides evidence for FGFR signalling regulating neuroblast morphology in vivo, 
and supports the conclusion made with slice cultures pointing to regional differences in FGFR 




Figure 4-7 An FGFR inhibitor alters the morphology of neuroblasts within the RMS in vivo 
P2 mouse pups were electroporated with pCX-EGFP and 5 days later treated with the FGFR 
inhibitor AZD4547 (12.5 mg/kg I.P., two doses with a 12 hour interval). After 24 h, brains were 
fixed, sliced and stained for GFP. Representative pictures of migrating neuroblasts in animals 
treated with vehicle (A) and AZD4547 (B) in the descending arm of RMS are shown. Treatment 
with the FGFR inhibitor significantly decreased the process length of migrating neuroblasts in the 
RMS (C, data pooled from the whole RMS). Graphs show mean ± s.e.m. (n= 4 animals for control 
and 3 for drug treated, 6 consecutive slices were analysed per brain, ~100 cells analysed per 
brain); *p< 0.05, **p<0.01. Bar, 50 µm for (A-B).  
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Figure 4-8 Regional effects of the FGFR inhibitor on neuroblast morphology in the RMS in 
vivo  
P2 mouse pups were electroporated with pCX-EGFP and 5 days later treated with the FGFR 
inhibitor AZD4547 (12.5 mg/kg I.P., two doses with a 12 hour interval). After 24 h, brains were 
fixed, sliced and stained for GFP. Representative pictures of migrating neuroblasts in animals 
treated with vehicle (A) and AZD4547 (B) in 4 different regions along the RMS (labelled 1-4 as 
depicted in the cartoon). Treatment with the FGFR inhibitor significantly decreased the process 
length of migrating neuroblasts only in regions 1 and 2 of the RMS (C). Graphs show mean ± 
s.e.m., (n= 4 animals for control and 3 for drug treated, 6 consecutive slices were analysed per 
brain, ~100–200 cells analysed per region); *p< 0.05, **p<0.01. Bar, 50 µm for (A-B).  
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4.2.8 FGF-2 and FGFR1 transcript expression in the SVZ and OB of the postnatal mice 
The above results clearly support a role for FGF-2 and its receptor FGFR1 in the RMS. Although 
a previous study has suggested that a caudal-rostral gradient of FGF-2 exists in the RMS by 
using an FGF-2 antibody (Garcia-Gonzalez et al, 2010), we have not been able to reproduce this 
finding using some of the available anti-FGF-2 antibodies (results not shown). We therefore 
turned to the quantification of the level of receptor and ligand transcripts to see if we could find a 
basis for the existence of the putative gradient. To address this, we dissected tissue from the SVZ 
and OB of P7 mice pups (Figure 4-9) followed by mRNA extraction and RT-qPCR quantification. 
The level of FGFR1 and FGF-2 transcripts were normalized to the internal control GAPDH (Figure 
4-9B). Transcripts encoding FGF-2 and FGFR1 were detectable both in SVZ and OB. However, 
the expression levels of FGF-2 were ~20% lower in the OB compared with SVZ, while the 
expression level of FGFR1 showed no significant difference (Figure 4-9). Thus results showed 
here might provide the basis for a caudal-rostral FGF-2 gradient in the RMS; however a very 
accurate determination of ligand levels along the RMS would be required to substantiate this as it 
is not clear if a 20% reduction in transcript levels would provide a clear basis for establishment of 




Figure 4-9 FGF-2 and FGFR1 transcript levels in the SVZ and OB of the postnatal mice 
Brains from P7 mice pups were sliced and dissected for RNA extraction followed by RT-qPCR 
analysis. A sagittal section with coronal view of relative dissected area of a postnatal mouse 
forebrain (A, adapted from (Chiaramello et al, 2007). Red areas on coronal sections indicate two 
regions that were micro dissected for mRNA extraction. RT-qPCR results showing the expression 
levels of FGF-2 and FGFR1 compared to internal control GAPDH using Taqman gene expression 
assay (B). Transcripts encoding FGF-2 and FGFR1 were detectable both in the SVZ and the OB. 
However, the expression levels of FGF-2 were lower in the OB compared with the SVZ. Graph 
shows mean ± SEM (n=4, numbers of RT-qPCR experiments. 1-2 brains were used per 
dissection); **P<0.01, Two-way ANOVA followed by Bonferroni post-tests. 
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4.2.9 Neuroblast migration in the RMS is not obviously altered in mice lacking both the 
FGFR1 and FGFR2 
The results above using acute perturbation of FGF-2/FGFR signalling support the hypothesis for 
these moleculses regulating neuroblast migration in the RMS. We next tested if conditional 
deletion of both FGFR1 and 2 would result in disruption of neuroblast migration in the stream. 
Conditional Fgfr1/2 knock-out mice employing the Cre-LoxP system are extremely useful for 
studying FGFR1/2 function as both genes can be deleted from the genome by introducing Cre 
recombinase (Chakkalakal et al, 2012; Xu et al, 2002; Yu et al, 2003; Yu et al, 2011). In the 
present study I have attempted to remove both receptors from the proliferating neuroblasts in the 
SVZ by electroporating a Cre-containing plasmid into the lateral ventricle of Fgfr1/2 flox/flox mice. 
Briefly, Fgfr1 and Fgfr2 conditional knock out mice lines were crossed to generate Fgfr1/2 flox/flox 
mice line and tail DNA preparations were subsequently genotyped by PCR (Xu et al, 2002; Yu et 
al, 2003; Yu et al, 2011). They were bred and genotyped by Dr Kieran M. Jones (Dr M. Albert 
Basson group, Department of Craniofacial Development and Stem Cell Biology, King’s College 
London). This mouse line was maintained on a mixed genetic background and only mouse pups 
which have both homozygous Fgfr1 flox/flox and Fgfr1/2 flox/flox alleles confirmed by genotyping were 
used. P2 Fgfr1/2 flox/flox mouse pups were electroporated with either a control GFP or pCAG-Cre-
IRES-GFP (to conditionally knock out Fgfr1/2 genes) plasmids, brains were fixed, sliced and 
stained for GFP 5 or 10 days later. Representative images of migrating neuroblasts in animals 
electroporated with control GFP or pCAG-Cre-IRES-GFP in the descending arm of RMS are 
shown in Figure 4-10A. Detailed analysis of the process length of the neuroblasts from the RMS 
is shown in Figure 4-10B. The results showed no significant difference on the process length of 
migrating neuroblasts in pCAG-Cre-IRES-GFP electroporated groups, either 5 days or 10 days 
after electroporation (Figure 4-10B). Detailed analysis on process length in different regions of the 
RMS was shown in Figure 4-11. Again, no significant results were seen at either 5 days (Figure 
4-11A) or 10 days (Figure 4-11B) after pCAG-Cre-IRES-GFP electroporation. Thus a treatment 
that should result in the conditional knock out of FGFR1/2 in the postnatal mice didn’t obviously 
change the morphology of the migrating neuroblasts in the RMS and I will discuss these results in 











Figure 4-10 Conditional knock out of Fgfr1/2 in postnatal mice does not have a significant 
effect on neuroblast morphology 
P2 Fgfr1/2 flox/flox mouse pups were electroporated with control GFP or pCAG-Cre-IRES-GFP 
plasmids, brains were fixed, sliced and stained for GFP 5 or 10 days later. Representative images 
of migrating neuroblasts in animals electroporated with control GFP or pCAG-Cre-IRES-GFP in 
the descending arm of RMS are shown in (A). Graph shows conditional knock out of FGFR1/2 
does not have significant effect on the process length of migrating neuroblasts in the RMS (B). 
Graphs show mean ± s.e.m. (n= 2-3 animals for each group, 6 consecutive slices were analysed 
per brain); dpe, days post electroporation. Bar, 50 µm.   
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Figure 4-11 Conditional knock out of Fgfr1/2 in postnatal mice does not have a significant 
effect on neuroblast morphology in different regions of RMS 
P2 Fgfr1/2 flox/flox mouse pups were electroporated with a control GFP or pCAG-Cre-IRES-GFP 
plasmid, brains were fixed, sliced and stained for GFP 5 or 10 days later. Graphs showing the 
quantification of process lengths of migrating neuroblasts in animals electroporated with control 
GFP and pCAG-Cre-IRES-GFP in 4 different regions along the RMS (labelled 1-4 as depicted in 
the cartoon in Figure 4-8) of dpe5 (A) and dpe10 (B). Results show conditional knock out of 
FGFR1/2 does not have significant effect on the process length of migrating neuroblasts along the 
RMS. Graphs show mean ± s.e.m. (n= 2-3 animals for each group, 6 consecutive slices were 
analysed per brain).  
100 
4.2.10 ROSA26-YFP mice for prolonged labelling of neuroblast in the RMS 
Neurogenesis in the SVZ is a life-long process in mammals and the neuroblast migration in the 
RMS persists to the adulthood, at least in rodents (Ming & Song, 2011). The results above were 
all obtained from young postnatal mice, and future studies will be required to test if the FGFR 
signalling is also required for neuroblast migration in the RMS in adult mice. In this study I wanted 
to do some preliminary experiments to determine the feasibility of establishing a model that would 
allow for detailed studies on migration within the RMS in young adult animals. The paradigm that 
we have used so far is limited to the study of young postnatal animals by the fact that the GFP 
expressing plasmids expressed in the P2/3 SVZ progenitors cells are realtively short-lived due to 
dilution within the rapidly proliferating progenitor cells. The technique of electroporation into adult 
mice is very low-efficient (Barnabe-Heider et al, 2008) and unlikely to result in the labelling of 
sufficient numbers of migratory neuroblasts. Therefore better methods are needed to label the 
migratory neuroblasts in adult mice. A commonly used approach in adult neurogenesis study is 
transgenic mice employing the Cre-LoxP site-specific recombination system (Lacar et al, 2010). A 
transgenic mouse line, ROSA26-YFP, has been generated that contains an YFP reporter within 
the genome that is normally silent due to a Stop sequence flanked by LoxP under the ubiquitous 
Rosa26 promoter (Lacar et al, 2010; Platel et al, 2010). Genomic expression of the YFP can be 
induced by excising the Stop sequence using Cre recombinase. Thus electroporation of Cre-
expressing plasmids into the SVZ of young ROSA26-YFP pups can induce the stable expression 
of YFP in stem cells and their progeny. For example, electroporation of a Cre-containing plasmids 
on young ROSA26-YFP mice has been reported to be able to label the cells throughout the RMS 
and OB in adult mice (Lacar et al, 2010; Platel et al, 2010). In the present study we have tested 
this strategy for prolonged labelling of neurobast in the RMS. P2 ROSA26-YFP mouse pups were 
electroporated with a pCAG-Cre-IRES-EGFP plasmid and 1, 2, 4 or 8 weeks later, brains were 
dissected out and fixed, sliced and immunostained for the reporter construct (Figure 4-12). 
Sagittal sections of the brain slices showing cells in the RMS electroporated with Cre plasmids 
stay labelled up to 8 weeks (6 weeks old mice is defined as young adult), and the labelled 
neuroblasts keep migrating towards OB and populate into neurons in the OB (Figure 4-12). Visual 
inspection of the labelled neuroblasts in different ages of the ROSA26-YFP mice revealed no 
obvious difference in the morphology of the cells. Importantly, labelled cells could be seen at both 
ends of the RMS even 8 weeks after the electroporation illustrating the continuous production of 
“genetically” labelled migratory neuroblasts into adulthood (Figure 4-13). Neurogenesis declines 
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rapidly with age (Kuhn et al, 1996; Ming & Song, 2011), and as expected there was a clear 
decline in the number of cells entering the stream in the older pups (Figure 4-13).Thus 
electroporation of ROSA26-YFP mice with a Cre-containing plasmid in postnatal mice can 
probably lead to life-long genetic labelling of neural stem cells and their progeny allowing for the 
study of neuroblast migration in adult mice.  
4.2.11 The effects of inhibiting FGFR signalling on neuroblast morphology in young adult 
mice 
By using the above labelling paradigm in ROSA26-YFP mice, we conducted a preliminary study 
to test whether FGFR signalling regulates neuroblast migration in the RMS in young adult animals. 
P2 ROSA26-YFP mouse pups were electroporated with pCAG-Cre-IRES-EGFP and 6 weeks 
later treated with the FGFR inhibitor AZD4547 (12.5 mg/kg I.P., two doses with a 12 hour interval) 
essentially as previously described for the studies on young animals. After 24 h of AZD4547 
treatment, animals were sacrificed and brains were fixed, sliced and stained for YFP. Images 
show representative neuroblasts in animals treated with vehicle (Figure 4-14A) or AZD4547 
(Figure 4-14B) in the descending arm of RMS. Visual inspection of AZD4547 treated neuroblast 
revealed that treated cells tended to have shorter process length and a more branched leading 
process (Figure 4-14B). However, although detailed quantitative analysis confirmed this trend, the 
difference did not reach statistical significance (Figure 4-14C, data pooled from the whole RMS). 
Nonetheless, these preliminary studies show that it is feasible to conduct migratory studies in the 
RMS in young adult animals, however, the studies would clearly have to be powered with more 











Figure 4-12 ROSA26-YFP mice for prolonged labelling of neuroblast in the RMS 
P2 ROSA26-YFP mouse pups were electroporated with pCAG-Cre-IRES-EGFP and 1, 2, 4 or 8 
weeks later, mice were sacrificed, brains were fixed, and slices containing the SVZ and RMS 
were immunostained for YFP. YFP positive cells are detectable at up to 8 weeks. Sagittal 
sections showing the labelled neuroblasts keep migrating towards OB and populate into neurons 
in the OB up to 8 weeks. Bar 500 µm.  
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Figure 4-13 The morphology of neuroblasts in the RMS is not obviously different in 1 week 
old and 8 week old ROSA26-YFP mice 
P2 ROSA26-YFP mouse pups were electroporated with pCAG-Cre-IRES-EGFP and 1 week or 8 
weeks later, brains were fixed, sliced and stained for YFP. Representative images showing 
neuroblasts in the descending arm of RMS after 1 week (left) or 8 weeks (right) of electroporation. 
The number of labelled neuroblasts was reduced at 8 weeks due to the reduced rate of 
neurogenesis in the adult mice. However, cells in both groups exhibit typical migrating neuroblast 
morphology with a single leading process pointing towards the OB. Visual inspection of the 




Figure 4-14 Preliminary data showing inhibiting FGFR signalling affects neuroblast 
morphology in young adult mice 
P2 ROSA26-YFP mouse pups were electroporated with pCAG-Cre-IRES-EGFP and 6 weeks 
later treated with the FGFR inhibitor AZD4547 (12.5 mg/kg I.P., two doses with a 12 hour interval). 
After 24 h, brains were fixed, sliced and stained for YFP. Images show representative migrating 
neuroblasts in animals treated with vehicle (A) and AZD4547 (B) in the descending arm of RMS. 
AZD4547 treated neuroblasts tend to have shorter process length and branched leading process. 
Inhibiting FGFR signalling has a trend to decrease the process length of migrating neuroblasts in 
the RMS (C, data pooled from the whole RMS). Graphs show mean ± s.e.m. (n= 2 animals for 
control and drug treated, 6 consecutive slices were analysed per brain, ~50 cells analysed per 
brain); Bar, 50 µm for (A-B). 
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Chapter 5 TrkB signalling is required for directed cell migration 
within the RMS 
5.1 Introduction 
In the last chapters, we used time-lapse imaging to characterise the role of eCB and FGFR 
signalling systems in the regulation of neuroblast migration and found both similarities and 
differences between these two systems regulating migration in different regions of the RMS. The 
eCB signalling regulates neuroblast motility and guidance all along the RMS while the FGFR 
system is important at the beginning but not end of the RMS. However, by comparing the effects 
of these two systems at the beginning of the RMS, we didn’t see any particular ‘rank’ of these two 
systems in regulating neuroblast migration. To further compare the relative importance of the eCB 
signalling to other putative signalling systems that govern neuroblast migration in the RMS, we 
have also treated the brain slices with tools to perturb TrkB signalling. TrkB or Tyrosine receptor 
kinase B is the main receptor for brain-derived neurotrophic factor (BDNF) (Acheson et al, 1995; 
Huang & Reichardt, 2001; Yamada & Nabeshima, 2003). Effects of BDNF/TrkB signalling in SVZ 
neurogenesis and RMS neuroblast migration have been reported previously (Bath et al, 2008; 
Chiaramello et al, 2007; Snapyan et al, 2009). However, controversial results have been reported 
on the role of BDNF/TrkB signalling in regulating neuroblast migration (Bagley & Belluscio, 2010; 
Snapyan et al, 2009), therefore it was interesting to re-investigate the role of this signalling 
system on neuroblast migration along the entire intact stream. 
As mentioned in chapter 3, there is lots of evidence for direct cross-talk between the TrkB, its 
ligand BDNF and eCB signalling (Aso et al, 2008; Berghuis et al, 2005; Blazquez et al, 2015; 
Lemtiri-Chlieh & Levine, 2010; Maison et al, 2009). Previous studies also show that BDNF and its 
receptor - TrkB are expressed throughout the SVZ-OB system, also BDNF has a motogenic effect 
on neuroblasts in RMS explant cultures (Chiaramello et al, 2007), indicating an important role for 
BDNF and TrkB in the RMS. However, conflicting studies have appeared on the role of BDNF 
signalling in the RMS. For example, blocking BDNF function with an antibody has been reported 
to increase both the speed of migration and the number of neuroblasts migrating towards the OB 
(Bagley & Belluscio, 2010). However, another study found that neuroblast migration in acute brain 
slices from adult mice is inhibited by incubation with a TrkB-Fc that in principle should act in a 
similar way to a BDNF blocking antibody (Snapyan et al, 2009). To try to clarify this issue we have 
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revisited this question by determining the effect of a TrkB-Fc on neuroblast motility and guidance 
along the stream.  
The TrkB-Fc is a chimeric molecule consisting of a human Fc fused to the ligand binding domain 
of the neurotrophin receptor; it will bind the TrkB ligands BDNF and NT4 and prevent them from 
interacting with the cell expressed receptors (Binder et al, 1999; Snapyan et al, 2009). Our results 
suggest that TrkB signalling does indeed regulate neuroblast migration throughout the stream. By 
comparing with the slices treated with the eCB inhibitors, the treatment with TrkB-Fc was seen to 
have a remarkably similar effect on the neuroblast migration in the RMS since it disrupts both 
motility and guidance, and it operates along both ends of the RMS. Non-specific effects of the 
TrkB-Fc can be excluded based on the observation that a TrkA-Fc had no significant effect on 
neuroblast migration in the RMS.  
5.2 Results 
5.2.1 A TrkB-Fc perturbs neuroblast migration in the RMS 
In order to test the importance of the TrkB receptor for neuroblast migration in the RMS, we 
added a TrkB-Fc to the cultured brain slices as this reagent will bind BDNF, and NT4, and prevent 
them from interacting with TrkB (Binder et al, 1999; Snapyan et al, 2009). P2 mice pups were 
electroporated with pCX-EGFP to label stem cells in the ventral wall resulting in the presence of 
GFP-labelled neuroblasts within the stream 5-7 days later. Slices were equilibrated for 2 h in 
control medium or medium containing TrkB-Fc (1 µg/ml) before being imaged for 3 h. In our initial 
analysis we focused our attention on the descending arm of the RMS before the “elbow” region 
(region 1 in Figure 5-3). Individual neuroblasts were tracked and migration analysed. 
Representative images of migrating neuroblasts, tracked for 3 hrs, for control and TrkB-Fc-treated 
slices are shown in Figure 5-1A,B. The red and blue arrows highlight the position of two 
neuroblasts in each condition over the 3 h period. Control neuroblasts migrated over longer 
distances towards the OB compared to neuroblasts in slices treated with the TrkB-Fc (Figure 
5-1A,B). In addition, control cells often display a predominant unipolar morphology oriented 
towards the OB, while cells treated with TrkB-Fc displayed branched processes extending in all 
directions (Figure 5-1A,B). The migration tracks of individual neuroblasts from representative 
slices are shown in Figure 5-1C-D. Under control conditions neuroblasts tended to follow a similar 
path towards the OB (Figure 5-1C), while the cells in the slices treated with TrkB-Fc clearly 
migrate in a less directed manner (Figure 5-1D). 
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A detailed statistical analysis of cell migration dynamics in these experiments is summarised in 
Figure 5-2A-C. In control slices, neuroblasts were immobile (nucleus moved less than 2 µm) 
~22% of their time, but this increased to ~31% (p<0.01) in the presence of TrkB-Fc (Figure 5-2A). 
In control medium, ~70% of neuroblasts show net migration towards the OB (Figure 5-2B), and 
this was significantly reduced by treatment with the TrkB-Fc to around 40% (Figure 5-2B). 
Moreover, total cell displacement was also substantially reduced (103.0 ± 6.4 µm for control and 
72.9 ± 2.9 for treated) (Figure 5-2C). There was a relatively small effect on the average speed of 
TrkB-Fc-treated cells (control 61.2 ± 1.8 µm/h, and TrkB-Fc 51.6 ± 2.7 µm/h, P<0.05). In 
summary, based on the measurement above, the results clearly support the hypothesis that TrkB 
signalling regulates neuroblast migration in the intact RMS.  
5.2.2 A TrkB-Fc perturbs directed cell migration at both ends of the RMS 
Next we wanted to address the important question as to whether TrkB is important at both ends of 
the stream. To quantitatively examine the effect of inhibiting TrkB signalling on the directionality of 
neuroblast migration towards the beginning and end of the RMS, again we analysed populations 
of neuroblasts sampled towards the beginning or end of the RMS as indexed by region 1 and 
region 2 in Figure 5-3A. Again we monitored the directionality of neuroblast migration by 
calculating the “meandering” index, i.e. the ratio between net displacement and total distance 
covered over the 3 h time period. Our results showed that in the RMS, close to the SVZ (Figure 
5-3A), treatment with TrkB-Fc resulted in a significant reduction in the number of neuroblasts 
showing directed migration with significant increase of exploratory neuroblasts. And importantly 
this was apparent at both ends of the stream (Figure 5-3). Thus, we can conclude that TrkB 
signalling is required for neuroblast motility and guidance within the RMS and that this pathway 











Figure 5-1 A TrkB-Fc perturbs neuroblast migration in the RMS 
Sagittal mouse brain slices with GFP-labeled neuroblasts were prepared 5-7 days after in vivo 
postnatal electroporation of P2 mice with pCX-EGFP, cultured with vehicle or a TrkB-Fc for 2 
hours and subsequently imaged for 3 hours in the same medium. Time-lapse movies made from 
the descending arm of the RMS in slices treated with a TrkB-Fc at 1 µg/ml were analyzed using 
Volocity. Representative pictures of slices treated with vehicle (A) or the TrkB-Fc (B) are shown. 
Arrows follow two neuroblasts in each frame. Representative migratory tracks of 15 cells over a 3 
hour period from a control (C) and a TrkB-Fc-treated brain slice (D). White stars mark the end 
point of each migration track. OB shows the location of the olfactory bulb in each brain slice. Cells 
migrate towards OB with time in control slice while TrkB-Fc treated cells show less directed 




Figure 5-2 The TrkB-Fc perturbs neuroblast migration in the RMS 
Quantification of cell migration from control slices or slices treated with a TrkB-Fc (1 µg/ml). Time-
lapse movies all made from the descending arm of the RMS. Treatment with the TrkB-Fc 
increased the percentage of time neuroblasts spent immobile (A). Incubation with the TrkB-Fc 
also significantly decreased the percentage of neuroblasts migrating towards the OB (B) and the 
overall cell displacement (C). Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 




Figure 5-3 TrkB-Fc perturbs neuroblast directionality along the RMS 
Five days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were cultured with 
vehicle or TrkB-Fc (1 µg/ml) for 2 h followed by time-lapse imaging for 3 h in the same medium. 
Neuroblast migration was filmed and analysed at the beginning and end of RMS (regions 1 and 2 
in A). Incubation with the TrkB-Fc signifiantly increased the percentage of exploratory neuroblasts 
at the expense of directed neuroblasts towards the beginning (B) and at the end of the RMS (C) 
compared to control slices. Graphs show mean ± s.e.m. (n=6-8 brain slices for each condition, 
~15-30 cells analyzed per slice); * p<0.05, ** p<0.01, *** p<0.001.  
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5.2.3 A TrkA-Fc does not significantly affect neuroblast migration in the RMS 
The above results provide clear evidence of an important role for the TrkB receptor in the 
regulation of neuroblast migration within the RMS. Previous studies have indicated that the BDNF 
and its TrkB receptor are expressed throughout the SVZ-OB system while the effect of the closely 
related TrkA receptor, which is responsive to NGF, on RMS neuroblast migration has not been 
reported (Berghuis et al, 2005; Chiaramello et al, 2007). To investigate a possible role for 
NGF/TrkA in neuroblast migration, we added a TrkA-Fc to the cultured brain slices. P2 mice pups 
were electroporated with pCX-EGFP and slice cultures containing GFP-labelled neuroblasts 
within the stream were established 5-7 days later. Slices were equilibrated for 2 h in control 
medium or medium containing TrkA-Fc (1 µg/ml) before being imaged for 3 h. Again, our initial 
analysis was focused on the descending arm of the RMS before the “elbow” region (region 1 in 
Figure 5-3A). Individual neuroblasts were then tracked and migration analysed. The migration 
tracks of individual neuroblasts from control and TrkA-Fc-treated slices are shown in Figure 
5-4A,B. Visual inspection of the neuroblasts migration tracks in slices treated with the TrkA-Fc 
does not significantly differ from the control slices (Figure 5-4 A,B). Neuroblasts tended to follow a 
similar path towards the OB both in control and TrkA-Fc treated slices (Figure 5-4A,B). A detailed 
statistical analysis of cell migration dynamics in these experiments is summarised in Figure 5-4C-
E. Neuroblasts were immobile (nucleus moved less than 2 µm) ~22% and 17% of their time in 
control and treated slices respectively (P>0.5) (Figure 5-4C). In control medium, ~70% of 
neuroblasts show net migration towards the OB (Figure 5-4D), and this was not significantly 
reduced by TrkA-Fc treatment (61%, P>0.5) (Figure 5-4D). Total cell displacement was also not 
significantly affected (103 ± 6.4 µm for control and 106 ± 10.0 µm for TrkA-Fc treated, P>0.5) 
(Figure 5-4E). Addtionally there was no significant effect on the speed of migration (61.2 µm/h for 
control and 67.1 µm/h for TrkA-Fc treated, P>0.5). In summary, the above results suggest that 
NGF and its receptor TrkA do not play a role in regulating neuroblast migration in the intact RMS 
5.2.4 A TrkA-Fc does not affect directed cell migration at both ends of the RMS 
Although the above results argue against a role for the TrkA receptor on neuroblast migration in 
the RMS, for completeness we also analysed populations of neuroblasts sampled towards the 
beginning or end of the RMS as indexed by region 1 and region 2 in Figure 5-3A. Again, we 
monitored the directionality of neuroblast migration by calculating the “meandering” index. Similar 
results were obtained in both regions of the stream when slices were treated with TrkA-Fc, and no 
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significant effects were observed by comparing to the control slices (Figure 5-5B,C). More 
specifically, close to the SVZ in the RMS (Figure 5-5A, region 1), treatment with TrkA-Fc resulted 
in ~24% of exploratory neuroblasts and ~45% of cells migrating in a directed manner, while in 
control slices, it was ~17% of exploratory and 60% directed, respectively and this does not reach 
statistical significance (P>0.05) (Figure 5-5B). Also, no significant effect was observed when 
neuroblasts were analysed in the RMS close to the OB (Figure 5-5C), treatment with TrkA-Fc 
resulted in ~11% of exploratory neuroblasts and ~63% of cells migrating in a directed manner, 
while in control slices, it was ~10% of exploratory and 70% directed, respectively (P>0.05) (Figure 
5-5C). Thus, we can conclude that TrkA-Fc does not significantly affect neuroblast motility and 
guidance along the RMS. These results also serve as a good internal control for the TrkB results 




Figure 5-4 A TrkA-Fc does not significantly effect neuroblast migration in the RMS 
Time-lapse movies made from the descending arm of the RMS in slices treated with a TrkA-Fc 
and were analyzed using Volocity. Representative migratory tracks of 15 cells over 3 hours from 
acontrol (A) or TrkA-Fc-treated (1 μg/ml) brain slices (B). White stars mark the tracking end point 
of each cell. The OB label shows the location of the olfactory bulb in each brain slice. Cells 
migrate towards OB with time in control and TrkA-Fc-treated slices. (C-E) shows quantification of 
cell migration from control slicesor slices treated with the TrkA-Fc. Treatment with TrkA-Fc has no 
significant effect on time spend immobile (C). Incubation with TrkA-Fc does not significantly 
decrease the percentage of neuroblasts migrating towards the OB (D) and the overall cell 
displacement (E). Graphs show mean ± s.e.m. (n=7 brain slices for each condition, ~ 15-30 cells 




Figure 5-5 TrkA-Fc does not have significant effect on neuroblast directionality at both 
ends of the RMS 
Five days after in vivo electroporation of pCX-EGFP in P2 mice, brain slices were cultured with 
vehicle or TrkA-Fc (1 µg/ml) for 2 h followed by time-lapse imaging for 3 h in the same medium. 
Neuroblast migration was analysed at the beginning and end of RMS (regions 1 and 2 in A). 
Incubation with the TrkA-Fc does not significantly affect the percentage of exploratory and 
directed neuroblasts towards the beginning (B) and end of the RMS (C) compared to control 
treatment. Graphs show mean ± s.e.m. (n=6-8 brain slices for each condition, ~15-30 cells 
analysed per slice); * p<0.05, ** p<0.01, *** p<0.001.  
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Chapter 6 Intracellular trafficking of DAGLs 
6.1 Introduction 
In the last chapters we focused our attention on the role of the eCB and other signalling systems 
on neuroblast migration and established an important role for DAGL-dependent eCB signalling in 
the regulation of migration in the RMS. Considering that the DAGLs are also involved in axonal 
growth, guidance and synaptic signalling, I next turned my attention to the mechanisms that might 
govern the function of these key enzymes. As we mentioned in Chapter 3, the DAGLs are the key 
enzymes that produce 2-AG, the main endogenous ligand for the eCB receptors in the brain 
(Bisogno et al, 2003; Gao et al, 2010). Our lab first cloned these two enzymes and showed that 
they were expressed in the right place at the right time to regulate axonal growth and guidance as 
well as retrograde synaptic signalling (Bisogno et al, 2003; Gao et al, 2010). More specifically, 
DAGLs were shown to be expressed in axons during development, but the expression switched to 
and was restricted to dendrites in the adult brain (Bisogno et al, 2003). This switch in the 
expression patterns of DAGLs from axons to dendrites may correlate with a shift in their function 
from axonal growth and fasciculation to synaptic signalling at synapses (Bisogno et al, 2003; 
Oudin et al, 2011b; Yoshida et al, 2006).  
Knock-out mice studies revealed that depolarization-induced suppression of inhibition (DSI) and 
depolarization-induced suppression of excitation (DSE), two related forms of short-term synaptic 
plasticity were lost in hippocampus, cerebellum and striatum in DAGLα-/- but not in DAGLβ-/- 
mice (Gao et al, 2010; Tanimura et al, 2010). These results suggested that DAGLα is responsible 
for retrograde eCB signalling in the CNS. Indeed, the restricted expression of DAGLα to dendritic 
spines in the adult brain was closely related to the pre-synaptic expression of CB1 in axon 
terminals (Bisogno et al, 2003; Oudin et al, 2011b; Yoshida et al, 2006). DAGLα is therefore 
perfectly placed in the right position to synthesis 2-AG to act as a retrograde messenger. This 
highly regulated and specific pre and post-synaptic localization of eCB components in the adult 
brain clearly points to the important role of eCB signalling in synaptic function (Oudin et al, 2011b). 
Therefore, understanding how the localization of DAGLs and other eCB components are 
regulated will be very important in understanding the eCB regulated synaptic plasticity.  
Despite lots of studies that have been done on the function and cellular localization of DAGLs 
(Bisogno et al, 2003; Cecyre et al, 2014; Gao et al, 2010; Reisenberg et al, 2012; Yoshida et al, 
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2006), little is known about their regulation of localization within a cell. A previous study reported 
that DAGLα co-immunoprecipitated with Homer 2 in Neuro-2a cells (Jung et al, 2007). In this 
context Homer is a member of a family of scaffold proteins that help assemble molecular 
complexes in the post-synaptic density (Soloviev et al, 2000). Importantly, the interaction was 
abolished by mutating a consensus Homer-binding motif PPxxF in the C-terminal tail of DAGLα 
(Jung et al, 2007). Therefore Homer may play a role in DAGLα localization to dendritic spines in 
neurons. Interestingly, DAGLα can also directly interact with calcium/calmodulin-dependent 
protein kinase II (CamKII) (Shonesy et al, 2013). Co-immunoprecipitation of CamKII and DAGLα 
(but not DAGLβ) from mouse striatal extracts was reported (Shonesy et al, 2013). Activated 
CamKII can interact with the C-terminal domain of DAGLα by phosphorylation and inhibits its 
activity in vitro. Moreover, enhanced DSE was observed in a transgenic CamKIIα mice line which 
has reduced CamKIIα activity, indicating that CamKIIα is a negative modulator of short-term 
calcium-dependent eCB signalling (Shonesy et al, 2013). Another recent study reported that 
DAGLα mRNA can interact with fragile X mental retardation protein (FMRP), a protein involved in 
Fragile X syndrome, the most common inherited form of mental retardation (O'Donnell & Warren, 
2002). This study also showed that normal perisynaptic co-localization of DAGLα and mGluR5 
was impaired in fmr1-/- mice, a model for Fragile X syndrome which lacks FMRP production, 
suggesting that FMRP is necessary for the correct localization of DAGLα in dendritic spines (Jung 
et al, 2012). Moreover, blocking 2-AG degradation helped to correct key behavioural changes in 
fmr1-/- mice, indicating the localization of DAGLα in dendrites could be a therapeutic target for 
Fragile X syndrome (Jung et al, 2012).  
Our motivation in studying DAGLs intracellular trafficking first comes from the fact that the DAGLs 
are localized to distinct cellular compartments during development and in adult (Bisogno et al, 
2003; Yoshida et al, 2006). DAGLs are localized to axons during development, but are exclusively 
expressed in dendritic spines in the adult brain (Bisogno et al, 2003; Yoshida et al, 2006). This 
highly specific expression pattern is likely to be tightly regulated; however, the underlying 
mechanism is not known. One possible explanation could be the regulating of the intracellular 
trafficking or re-localization of the enzymes. Another fact is that 2-AG has a short half-life and 
does not diffuse over long distances (Rouzer et al, 2002), as the main enzymes for 2-AG 
synthesis, DAGLs must be localized to the right place at the right time to form an eCB signalling 
pool for effective signalling. Misallocated DAGLα at dendritic spine has been implicated in Fragile 
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X syndrome (Jung et al, 2012). Dynamic cycling of the receptor/enzyme is one of the most 
effective methods to regulate signal strength of the cell by regulating the rate of receptor/enzyme 
internalization, examples of this are AMPA and GABA receptor endocytosis at the synapses 
(Kittler et al, 2005; Kittler et al, 2000). Another reason is that DAGLα is expressed in close 
proximity to the CB1 receptor for efficient eCB signalling (Bisogno et al, 2003; Nyilas et al, 2009; 
Oudin et al, 2011b; Uchigashima et al, 2007; Yoshida et al, 2006). Constitutive endocytosis of the 
CB1 receptor has been reported previously and the pathway that mediates the CB1 receptor 
internalization is clathrin and dynamin dependent (Bohn, 2007; Hsieh et al, 1999; McDonald et al, 
2007b). In the CNS, the CB1 receptor is well-positioned towards axons terminals to modulate 
synaptic signalling. Inhibition of CB1 receptor endocytosis by using a dominant-negative dynamin-
1 (K44A) mutant disrupted this polarized localization by leading the cell-surface expressed GFP-
CB1 onto somatodendeitic compartment (McDonald et al, 2007a). Like AMPA, GABA or CB1 
receptors, DAGLα is also localised to the plasma membrane. Is DAGLα also subjected to 
endocytosis and dynamic cycling inside of the cell? To be able to follow DAGLα localisation in 
living cells I developed a new construct with an extracellular epitope tag which allows the surface 
labelling of DAGLα. By expressing this construct in neurons, we found evidence for intracellular 
and cell surface pools of DAGLα co-localised with Homer, a postsynaptic marker. A classical 
antibody feeding assay (Arancibia-Carcamo et al, 2006) revealed that DAGLα undergoes 
constitutive endocytosis in COS-7 cells and cultured hippocampal neurons. Detailed studies 
showed that DAGLα co-localizes with early endosome markers and undergoes recycling back to 
the cell surface in COS-7 cells. These novel findings have led us to postulate that dynamic cycling 
of DAGLα is likely to be a regulatory mechanism that will directly impact on eCB signalling at 
synapses and in other cellular contexts.  
6.2 Results 
6.2.1 Design of extracellular epitope-tagged human DAGLα constructs  
The DAGLα protein consists of an intracellular N-terminal and four transmembrane domain 
(green), followed by a catalytic domain (pink) and a tail at the C-terminus (shown schematically in 
Figure 6-1). Since the N-terminal of DAGLα is intracellular, the way of simply inserting an epitope 
tag sequence into the N-terminal of the protein, the most commonly used way to enable surface 
labelling for GPCRs, is not applicable for live cell imaging. In principle, an epitope tag sequence 
can be inserted into one or other of the two extracellular loops of DAGLα. However, these two 
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extracellular loops are relatively small (20 and 15 amino acid residues respectively). In this 
context, the use of fluorescent protein tags which are relatively large proteins in themselves (for 
example GFP is composed of 238 amino acid residues) was not considered. The HA tag, a 
peptide sequence (YPYDVPDYA) derived from the human influenza hemagglutinin protein, was 
chosen by us because it’s one of the smallest epitope tags available (nine amino acids in total) 
and high-affinity antibodies for western blotting, immunoprecipitation and especially 
immunofluorescence have been developed in many different species (Terpe, 2003). Also the 
presence of HA epitope tag has been reported not to interfere with the CB receptor internalization 
(Atwood et al, 2012). Because the two extracellular loops of DAGLα protein are relatively small, 
we added a linker sequence on each side of the HA sequence to provide flexibility for the 
recombinant regions to better ensure the expression of the epitope tag and the same strategy has 
been reported previously (Prakriya et al, 2006). Therefore, two constructs were designed, a HA 
peptide sequence (YPYDVPDYA) flanked by a glycine-serine-glycine-serine (GSGS) linker on 
either side was inserted into the first (Figure 6-1A) or second (Figure 6-1B) extracellular loop of 
human between H and E (Figure 6-1A) or Y and T (Figure 6-1B) in pcDNA™6.2-
DEST/V5 construct cloned by gateway cloning by Dr Praveen K Singh. The designed constructs 
will have an extracellular HA tag as well as an intracellular V5 tag located on the C-terminal of 
DAGLα. 
6.2.2 Verification of the epitope-tagged human DAGLα constructs 
The insertion of the HA sequence into DAGLα was confirmed by sequencing and western blot 
(data not shown). The constructs were then transfected into the COS-7 cell line to test if the 
constructs were expressed and to determine if anti-HA antibodies were able to recognise the 
epitope tag on the surface of living cells. Preliminary data pointed to the antibodies being able to 
interact better with the tag inserted into the first extracellular loop (Figure 6-1A and data not 
shown). Therefore this construct was used in the following studies and named as HA-DAGLα. The 
HA-DAGLα construct was transfected into COS-7 cells, 24 h later cells were fixed, permeabilized 
and stained for both HA and V5 tags. As expected, co-localization of these two epitope tags can 
be seen in the COS-7 cells (Figure 6-2A). We then wanted to examine if the HA tag can be 
successfully detected on the cell surface of live cells. The HA-DAGLα construct was transfected 
into various cell lines by FuGene transfection kit. 24 h later, a rat anti-HA antibody was added into 
the cell medium of live cells for 20 min at room temperature (RT); the cells were then gently 
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washed to remove unbound antibody and returned to the incubator for 30 min. Cells were then 
briefly fixed and an anti-rat 488 conjugated secondary antibody was used to label the anti-HA 
antibodies that associate with the surface pool of HA-DAGLα. Cells were then permeabilized with 
0.2% TritonX-100 and a rabbit anti-V5 antibody was used and subsequently an anti-rabbit 594 
was used to label the V5 tag associated with the total DAGLα pool. Images were taken by 
LSM710 confocal microscopy and all the images shown are sections through the middle of the 
cells (when the nucleus of the cell is the biggest). As shown in Figure 6-2B, this procedure 
revealed two pools of DAGLα; a cell surface pool labelled only with the anti-HA antibody and an 
intracellular pool detected by anti-V5 antibody. The surface expression of HA-DAGLα was also 
detected in HEK293 and Hela cells (data not shown). Thus we can conclude that the HA-DAGLα 
construct results in the expression of the enzyme in a manner that enables us to detect the 




Figure 6-1 Design of extracellular epitope-tagged human DAGLα constructs  
The DAGLα protein consists of an N-terminal and four transmembrane domains (green), followed 
by a catalytic domain (pink) and a tail at the C-terminus. To enable extracellular labelling of 
DAGLα, a HA peptide sequence (YPYDVPDYA) flanked by a glycine-serine-glycine-serine 
(GSGS) linker on either side was inserted into the first (A) or second (B) extracellular loop of 
Human DAGL alpha between H and E (A) or Y and T (B) in pcDNA™6.2-DEST/V5 construct 




Figure 6-2 Expression of HA-DAGLα and surface labelling of HA tag in COS-7 cells  
COS-7 cells transfected by HA-DAGLα were fixed, permeabilized and stained for HA and V5 tag. 
HA tag was successfully detected and shows co-localization with V5 tag in the COS-7 cells (A). 
Live cultures of COS-7 cells (B) transfected by HA-DAGLα were antibody fed with a rat anti-HA 
antibody for 20 min at RT. Cells were then washed and incubated at 37°C for 30 min and fixed, an 
anti-rat 488 conjugated antibody was used to detect the anti-HA antibodies associated with 
DAGLα on the cell surface. Cells were then permeabilized to stain for the total V5-DAGLα. Far 
right panel shows the intensity profiles along the dotted line drawn across the merged images. 
White arrows in (B) show the surface HA tag signalling which correspond to the green arrows in 
the right intensity profile graph. The HA tag was successfully detected in live cells and localised to 
the surface of COS-7 cells. All images shown are sections through the middle of the cells (same 
as in the following figures unless otherwise stated). Bar 20 µm.  
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6.2.3 DAGLα co-localizes with a dendritic marker, Homer, in rat hippocampal neurons  
DAGLα has been reported to be expressed in dendritic spines in mature neurons including 
hippocampal neurons (Bisogno et al, 2003; Katona et al, 2006; Yoshida et al, 2006). A direct 
interaction between DAGLα and Homer 2, a dendritic marker has also been previously reported 
(Jung et al, 2007). We next wanted to express the HA-DAGLα in neurons to see the expression 
pattern of this construct. Hippocampal neurons were isolated from E18.5 rats and cultured in vitro 
for various time periods. The presence of synapses within our cultures was checked using 
commonly used synaptic markers between 10-14 days in vitro (DIV), the time points that synapse 
maturation has been reported to occur (Ichikawa et al, 1993; Kay et al, 2011). Staining for PSD-
95, a post-synaptic marker (Jaffrey et al, 1998) and Bassoon, a pre-synaptic marker (Davydova et 
al, 2014) revealed punctate staining patterns, suggesting the presence of synapses during this 
time period (data not shown). Based on this, HA-DAGLα was transfected into 10 DIV cultures by 
NeuroMag Magnetofection system and 2 days later, the cultures were fixed and stained for the V5 
epitope tag to label the total DAGLα pool as well as for total Homer (an anti-Homer antibody 
which recognises Homer 1/2/3 was used) (Soloviev et al, 2000) to label post-synaptic densities. 
The results are shown in Figure 6-3. Punctate patterns of staining were seen with both the anti-V5 
and anti-Homer antibodies, and more importantly there was extensive co-localize between these 
DAGLα and Homer in the neuronal dendrites (Figure 6-3). Thus we can conclude that HA-DAGLα 





Figure 6-3 DAGLα co-localizes with Homer in rat hippocampal neurons 
Rat hippocampal neurons were transfected with HA-DAGLα at 10 DIV using NeuroMag 
Magnetofection system and were fixed and permeabilized at 12 DIV. After blocking in 5% horse 
serum with 0.2%Triton X-100 for 20 min, an anti-V5 antibody and an anti-Homer antibody were 
used in the same medium to detect the V5 epitope tag as well as total Homer, a postsynaptic 
marker for neurons. Secondary antibodies with specific fluorophores were then used to 
differentiate total DAGLα pool (shown in green) and Homer (shown in red). The lower panel 
shows the zoomed in views of the white rectangular box areas. White arrows show co-localization 
of V5 and Homer. Extensive DAGLα co-localization with Homer in neuronal dendrites is clearly 
apparent. Scale bar: 10 µm and 1 µm for the zoom in. 
.  
126 
6.2.4 Live and permeabilized cell imaging reveals two pools of DAGLα in hippocampal 
neurons 
Having determined that the HA-DAGLα construct can be successfully expressed on the dendrites 
of hippocampal neurons, we next wanted to determine if there are two pools of DAGLα in the 
dendrites - an intracellular pool and a cell surface pool. Rat hippocampal neurons were 
transfected by HA-DAGLα using NeuroMag Magnetofection system at 10 DIV and 2 days later, 
the rat anti-HA antibody was added to the live culture of the cells at room temperature to detect 
the HA epitope tag on the cell surface. 20 min later, neurons were washed and fixed. An anti-rat 
secondary antibody was used to detect HA epitope tag associated with surface DAGLα (shown in 
green in Figure 6-4). Cells were then permeabilized, an anti-V5 antibody was then used to stain 
for the total DAGLα pool (shown in red in Figure 6-4). Surface DAGLα labelled by HA tag co-
localize well with total DAGLα labelled by V5 tag, and the surface DAGLα pool has a clear 
punctate pattern on dendrites (Figure 6-4). Intracellular pools of DAGLα that were only labelled 
with the anti-V5 antibody were also noticed (see white arrows in Figure 6-4), suggesting the 
existence of two distinct DAGLα pools in neuronal dendrites. Thus we can conclude there is a 
surface DAGLα pool on the dendrites of hippocampal neurons, and the HA-DAGLα construct can 




Figure 6-4 Live and permeabilised cell imaging reveals two pools of DAGLα in 
hippocampal neurons 
The rat hippocampal neurons in Figure 6-3 were also live labelled for surface HA epitope tag for 
20 min at room temperature. The rat anti-HA antibody was used for antibody feeding and 
unbound antibodies were washed out with buffered medium. Neurons were then briefly fixed and 
an anti-rat 488 secondary was used to detect the surface pool of DAGLα (shown in green). Cells 
were then permeablised and blocked in 5% horse serum with 0.2%Triton X-100 for 20 min. An 
anti-V5 antibody was then used to detect the total V5-DAGLα (shown in red). Surface DAGLα 
labelled by HA tag co-localizes well with total DAGLα labelled by V5 tag, and the surface DAGLα 
pool has specific punctate pattern on dendrites. The lower panel shows the zoomed in views of 
the white rectangular box. Note the presence of intracellular pools of DAGLα that only label with 





6.2.5 Time dependant internalization of the CB1 receptor in HEK293 cells 
Having established that the HA-DAGLα construct is expressed appropriately in cells and at 
synapses, we next wanted to study the membrane trafficking of DAGLα. As a prelude we first 
determined if we could follow the internalization of the CB1 receptor since constitutive 
internalization of this GPCR has been previously reported, and this could then serve as a proof-
of-principal experiment to validate our assay conditions (Hsieh et al, 1999; Osborne et al, 2009; 
Simon et al, 2013). To enable the surface labelling of the CB1 receptor, an N-terminal tagged 
CB1 construct, SEP-hCB1 was used (gift from Dr. Andrew J. Irving, University of Dundee) 
(McDonald et al, 2007b). SEP is a pH-sensitive variant of GFP that has similar fluorescence to 
wild-type GFP at physiological pH 7.4, but the fluorescent signal is reduced at acidic pH and 
completely quenched at pH 5.8 (the Golgi pH is 6.0 and endocytic vesicles pH is 5.5) (Demaurex, 
2002; McDonald et al, 2007b; Miesenbock et al, 1998). Therefore, this N-terminal tagged SEP 
construct can be used to report surface expression of the CB1 receptor. We used an antibody 
feeding assay (Arancibia-Carcamo et al, 2006) to label the surface CB1 receptor with a rabbit 
anti-GFP antibody which recognizes the SEP tag, the cells were then allowed to internalize for 
various times before been fixed and an anti-rabbit 488 conjugated secondary antibody was used 
to detect the CB1 receptor that remained on the cell surface. Cells were then permeabilized and 
an anti-rabbit 594 conjugated secondary was used to detect the internalized CB1 receptor. When 
the CB1 receptor is internalized, red fluorescence (594 channel) should be detected under 
confocal microscopy and the rate of CB1 receptor internalization can then be measured by 
comparing the intensities of 594 (red) and 488 (green) channels. In this study, HEK293 cells were 
used and transfected with SEP-hCB1, 24 h later live cells were ‘fed’ with a rabbit anti-GFP 
antibody, cells were then returned back to cell incubator to allow receptor endocytosis to take 
place. Internalized CB1 receptor can be observed after 20 min of incubation (Figure 6-5A). 
Punctate, cytoplasmic vesicles accumulated inside of the cell after prolonged incubation (Figure 
6-5A). Quantification of the intensity ratio between internalized and surface receptor revealed the 
time dependent, steady state constitutive internalization of the CB1 receptor (Figure 6-5B). These 
results were consistent with the previous studies on constitutive CB1 receptor internalization 
(McDonald et al, 2007a; McDonald et al, 2007b) and we can conclude that this antibody feeding 









Figure 6-5 Time dependant internalization of the CB1 receptor in HEK293 cells 
HEK293 cells expressing SEP-hCB1 were live labelled with a rabbit anti-GFP antibody for 20 min 
at 4°C, washed to remove unbound antibodies and then returned back to cell culture medium for 
10 to 100 minutes at 37°C in the incubator. Cells were then fixed and incubated with an anti-rabbit 
488 to label the remaining cell surface CB1 receptor. Cells were then permeabilized and 
incubated with an anti-rabbit 594 to label the internalized CB1 receptor. (A) Images show 
representative cells that were returned to the incubator for 20, 40 and 60 min at 37°C following 
the initial antibody labelling step. Constitutive internalization of the receptor (as revealed by the 
red-stain) can be seen from 20 min. All images were merged from individual images obtained in 
the green and red channels. Green channel, 488; red channel, 594. (B), Quantification of 
internalization by comparing the intensity ratio of 594 and 488 channel. Each bar represents the 
mean ± SEM (n=3 independent experiments, 10-15 fields were randomly taken from each 
coverslip, ~100 cells quantified for each group); *** P < 0.001. One-way ANOVA followed by 
Bonferroni post-tests. Scale bar: 20 µm.  
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6.2.6 Effects of CB1 agonists on the CB1 receptor internalisation 
The internalization of the CB1 receptor has been reported to be induced by several CB receptor 
agonists, for example, WIN 55,212-2, a potent aminoalkylindole CB receptor agonist, can induce 
rapid CB1 receptor internalization at low concentration (30-100 nM) (Atwood et al, 2012; Hsieh et 
al, 1999). However, CB receptor agonists vary in their ability to cause internalization. For 
example, cannabinoids like anandamide (AEA) or tetrahydrocannabinol (THC) failed to increase 
the rate of CB1 receptor internalization at relatively high concentrations (>1500 nM) (Atwood et al, 
2012; Hsieh et al, 1999). Therefore, in this study we wanted to reproduce these results to validate 
our internalization assay. WIN 55,212-2, a potent CB receptor agonist which also acts at CB2 
receptor (Atwood et al, 2012) and ACEA, a selective CB1 receptor agonist which is an analogue 
of AEA were used (Hillard et al, 1999). HEK293 cells expressing SEP-hCB1 were live labelled for 
surface receptor by antibody feeding as previously described, and the cell cultures were then 
treated with either 1µM WIN 55,212-2 or a vehicle (0.1% DMSO) control. Cells were either fixed 
or returned back to the incubator for endocytosis for up to 100 min before fixation. Quantification 
of the internalization rate was determined as previously described and is shown in Figure 6-6A. 
Treatments with WIN 55,212-2 significantly increased the level of internalised CB1 receptor at 40 
and 60 min. The treatment at 100 min was not significantly different from the control, and this is 
probably due to the degradation of the receptor after prolonged agonist activation (Hsieh et al, 
1999). We next compared the effects of WIN 55,212-2 and ACEA (1µM each) by looking at 
internalization at 30 min after antibody feeding (again using 0.1% DMSO containing media as a 
vehicle control). The results shown in Figure 6-6B confirmed that WIN 55,212-2 can stimulate 
significant internalization of the CB1 receptor while ACEA has no significant effect. Thus our 
results are consistent with the previous studies that WIN 55,212-2 increases the internalization of 










Figure 6-6 Effects of CB1 agonists on CB1 receptor internalisation 
HEK293 cells expressing SEP-hCB1 were antibody fed with a rabbit anti-GFP antibody for 20 min 
at 4°C. Cells were washed and either fixed to give the 0 min time point control or returned back to 
cell culture medium with 1µM WIN 55,212-2 or 0.1% DMSO for up to 100 min in the 37°C 
incubator for uptake before fixation. Cells were then incubated with an anti-rabbit 488 to label the 
remaining cell surface CB1 receptor. Cells were then permeabilized and incubated with an anti-
rabbit 594 to label the internalized CB1 receptor. Quantification of the internalized and surface 
intensity ratio is shown in (A), treatment with WIN 55,212-2 significantly increased the CB1 
receptor internalization rate at 40 and 60 min compared to the DMSO control. (B) HEK293 cells 
were live labelled as above before being treated with 0.1% DMSO as control, WIN 55,212-2 or 
ACEA (all at 1µM) and incubated for 30 min in the incubator. WIN 55,212-2 induced significant 
internalization of the CB1 receptor when comparing to the control, while ACEA treatment had no 
significant effect on the CB1 receptor internalization. Each bar represents the mean ± SEM (n=2, 
10-15 fields were randomly taken from each coverslip, ~100 cells quantified for each group); 
*<0.05; ** P < 0.01; *** P < 0.001. One-way or two-way ANOVA followed by Bonferroni post-tests. 
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6.2.7 DAGLα is constitutively internalized in COS-7 cells  
DAGLα is highly localised to dendritic spines in mature neurons and it plays an important role in 
synaptic plasticity by regulating DSI and DSE (Bisogno et al, 2003; Gao et al, 2010; Tanimura et 
al, 2010). Dynamic cycling of membrane receptors, e.g. NMDA and GABA(A) receptors, has been 
reported to regulate synaptic strength (Arancibia-Carcamo et al, 2006; Kittler et al, 2000). Also the 
localization of DAGLα in dendritic spines is highly correlated with the pre-synoptically expressed 
CB1 receptor, which undergoes constitutive endocytosis in mature neurons (Cecyre et al, 2014; 
Oudin et al, 2011b; Uchigashima et al, 2007; Yoshida et al, 2006; Yoshida et al, 2011). Like 
NMDA and CB1 receptors, DAGLα is a transmembrane protein largely localised to the plasma 
membrane. We therefore tested if DAGLα is also subject to dynamic cycling at the cell surface. 
Results above have shown that there is a distinct surface pool that differs from the intracellular 
pool of DAGLα in COS-7 cells as well as hippocampal neurons. Therefore we postulated that 
DAGLα may also be internalized at the synapses in a dynamic manner. We first tested our 
hypothesis in COS-7 cells as their large cell size and ease of culture makes them a good model 
system for imaging and trafficking studies (Glebov et al, 2006; Mardakheh et al, 2009; 
Vandenbulcke et al, 2000). COS-7 cells were transfected with the HA-DAGLα construct using the 
FuGene transfection kit. 24 h later, the rat anti-HA antibody was added to the live cells for 20 min 
at 4°C. After antibody feeding, cells were washed and fixed to give a zero time point, or washed 
and returned to the incubator at 37°C for various times to allow endocytosis. Cells were then fixed 
and an anti-rat 488 secondary antibody was used to detect the anti-HA antibody present on the 
cell surface. Cells were then permeabilized and an anti-rat 594 antibody was used to label the 
anti-HA antibody associated with the internalized DAGLα pool. Confocal images were then taken 
under the same setting for all the time points. Results are shown in Figure 6-7. Visual inspection 
revealed that punctate red stained vesicles accumulate with time indicating that DAGLα is 
constitutively internalized in the COS-7 cells. Internalization was obvious from 20 min and the 
internalization level of DAGLα goes up with time during this incubation period at 37°C. 
Quantification of the internalization revealed a relatively steady state internalization of DAGLα 
with time (shown in Figure 6-8). Thus we can conclude that the DAGLα can be constitutively 












Figure 6-7 DAGLα is constitutively internalized in COS-7 cells 
COS-7 cells were transfected with the HA-DAGLα construct using the FuGene transfection kit. 24 
h later, a rat anti-HA antibody was added to the live cells for 20 min at 4°C. Cells were then 
washed and fixed to give a zero time point, or washed and returned to 37°C incubator for 20 to 60 
min to allow endocytosis. After incubation, cells were briefly fixed and an anti-rat 488 secondary 
antibody was used to detect the anti-HA antibody associated with DAGLα on the cell membrane. 
Cells were then permeabilized and an anti-rat 594 antibody was used to label the anti-HA 
antibody associated with the internalized pool of DAGLα. Confocal images were taken under the 
same setting for all the time points. Note the punctate red stained vesicles accumulates inside of 
the cell after incubation. Green channel, 488 to label surface HA-DAGLα; red channel, 594 to 







Figure 6-8 Quantification of DAGLα internalized in COS-7 cells 
The 488 and 594 fluorophore intensities which were associated with surface and internalized 
DAGLα respectively were measured for the cells as shown in Figure 6-7. Intensity ratio (594 / 488) 
that indicates the rate of internalization of the cells was calculated and shown above. The results 
show DAGLα was significantly internalized after 20 min incubation at 37°C, the internalization 
level goes up with time to 60 min. Each bar represents the mean ± SEM (n=3, 10-15 fields were 
randomly taken from each coverslip, ~100 cells quantified for each group); *<0.05; ** P < 0.01; *** 
P < 0.001. One-way ANOVA followed by Bonferroni post-tests. 
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6.2.8 DAGLα is recycling in COS-7 cells 
After showing that DAGLα undergoes constitutive internalization in COS-7 cells, we next wanted 
to know if the enzyme is simply internalised for degradation, or if it is recycled back to the cell 
surface. An “acid wash” or “antibody stripping” assay has been previously used to study the 
receptor internalization in neurons with the specific aim of seeing if a receptor is returned to the 
cell surface (Carroll et al, 1999; Hanley et al, 2002; Scott et al, 2004). By washing the cells at low 
pH before fixation, the assay can selectively strip any surface-bound primary antibody and, 
importantly, leave the internalized antibody-receptor complexes intact. If the complex is degraded 
in lysosomes the antibody will not re-appear on the cell surface. In contrast if the antibody 
reappears at the cell surface, it is taken as evidence that the antigen (in this case DAGLα) is in a 
pool that be regulated by dynamic vesicular cycling from and back to the cell surface. 
The first important control in this assay is to ensure that the acid buffer can completely strip the 
surface bound antibody. COS-7 cells expressing the HA-DAGLα construct were live labelled with 
the rat anti-HA tag antibody for 30 min at RT, the cells were either washed and fixed directly or 
washed in a DMEM buffer (pH 3.0-3.5) before fixation (Figure 6-9a,b). Cells without the acid wash 
showed extensive labelling for the anti-HA antibody on the cell surface (Figure 6-9a). However, 
after acid wash, the surface staining was completely gone (Figure 6-9b), indicating the success of 
antibody stripping.  
The next step was to test if the internalized antibody-enzyme complexes can still be detected after 
the acid wash step. COS-7 cells expressing the HA-DAGLα construct were live labelled with the 
rat anti-HA tag antibody for 30 min at RT, the cells were washed and returned back to the 
incubator for uptake. After 30 min incubation, the cells were washed in acid buffer and fixed 
(Figure 6-9c). The cells in Figure 6-9c showed extensive intracellular staining of HA-DAGLα, 
indicating the internalized antibody-enzyme complexes were left intact after acid wash. However 
the surface staining was again completely absent, suggesting that the surface bound antibodies 
were completely stripped at this stage.  
The next step was to test if DAGLα can be recycled back to the cell surface. COS-7 cells 
expressing the HA-DAGLα construct were live labelled with the rat anti-HA tag antibody for 30 min 
at RT, the cells were washed and returned back to the incubator for 30 min for uptake. After 30 
min incubation, the cells were washed in acid buffer (this stage is Figure 6-9c before fixation, 
surface bound antibodies should have been completely stripped at this stage) and returned back 
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to the incubator for another 30 min. After this 30 min incubation, surface HA-DAGLα was again 
detected (Figure 6-9d). These surface antibody-protein complexes detected at step ‘d’ can only 
come from the intracellular pool of HA-DAGLα because the surface antibody was completely 
stripped before this incubation. Therefore, the presence of the surface labelling after acid wash 
and incubation indicates that DAGLα can be recycled back to the cell surface and DAGLα is 











Figure 6-9 DAGLα is recycling in COS-7 cells 
COS-7 cells expressing HA-DAGLα were live labelled with the rat anti-HA tag antibody for 30 min 
at RT. The cells were either washed and fixed directly (a) or washed in a DMEM buffer (pH 3.0-
3.5) (b) before fixation. An anti-rat 488 secondary antibody was then used to detect the anti-HA 
antibody on the cell surface. Results show the cells without the acid wash had extensive labelling 
for the anti-HA antibody on the cell surface (a). However, after acid wash, the surface staining 
was completely gone (b), indicating the success of antibody stripping. Another group of COS-7 
cells were live labelled and washed as above and returned back to the incubator for uptake for 30 
min. After incubation, the cells were washed in acid buffer and either fixed (c) or returned back to 
the incubator for another 30 min for the internalized antibody-enzyme complexes to recycle before 
fixation (d). An anti-rat 488 secondary antibody was used to detect the anti-HA antibodies 
remained on the cell surface. After permeabilization, an anti-rat 594 secondary antibody was used 
to detect the anti-HA antibodies associated with the internalized HA-DAGLα. Confocal images 
showing the surface (green stain) and internalized (red stain) HA-DAGLα. As shown by white 
arrows in (d), surface HA-DAGLα was again detected after antibody stripping and incubation, 
indicating that the DAGLα can be recycled back to the cell membrane after having been 
internalized. Scale bar: 20 µm.  
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6.2.9 DAGLα co-localizes with the early endosome marker, EEA 1 in COS-7 cells 
Endocytosis is a process involving many molecules and signalling pathways. The most well-
characterized internalization pathway is clathrin-mediated endocytosis (Arancibia-Carcamo et al, 
2006). Non-clathrin mediated pathways like caveolin or raft-dependent internalization, 
macropinocytosos, phagocytosis are less characterised, but these clathrin independent pathways 
are the key focus of many labs because of their physiological importance (Arancibia-Carcamo et 
al, 2006; Boucrot et al, 2015; Mayor et al, 2014; Renard et al, 2015; Wu et al, 2014b). Once it has 
been internalized, the receptor/protein enters the endocytic pathway and will be targeted to 
distinct endocytic organelles (Arancibia-Carcamo et al, 2006). Previous studies have suggested 
that both clathrin and caveolin-dependent endocytosis pathways are involved in the early 
endosomes (Arancibia-Carcamo et al, 2006; Pelkmans et al, 2004). The early endosome, also 
known as the sorting endosome, is a common sorting station which accepts incoming cargoes 
internalized from the plasma membrane. It has regions of thin tubular extensions and large 
vesicles that are located toward the cell periphery (Jovic et al, 2010). The early Endosome 
Antigen1 (EEA 1) is a well-characterised early endosome marker (Mu et al, 1995) and we wanted 
to test whether DAGLα co-localizes with this early endosome associated protein. COS-7 cells 
transfected with HA-DAGLα were antibody fed for 20 min at 4°C, cell were then either fixed at 0 
min for a zero time point control or returned back to 37°C incubator for 20 or 60 minutes. Cells 
were then labelled for surface HA for 0 min control or permeabilized and stained for the anti-HA 
antibodies that associate with the internalized DAGLα (green channel in (Figure 6-10). The anti-
EEA 1 antibody was then used and subsequently labelled by another secondary antibody (shown 
in red in Figure 6-10). Results of immunostaining are shown in Figure 6-10, co-localization of 
internalized DAGLα with EEA 1 can be seen at 20 min, but the co-localization is less apparent at 
60 min. This is consistent with the notion that the early endosomes accommodate the rapid 
internalized cargoes, but these cargoes will then be sorted from early endosomes to other 
organelles like lysosomes for degradation or recycling endosomes for recycling back to the 
membrane (Arancibia-Carcamo et al, 2006; Jovic et al, 2010). Thus the results suggest that the 









Figure 6-10 DAGLα co-localizes with the early endosome marker, EEA 1 in COS-7 cells 
COS-7 cells expressing HA-DAGLα were live labelled with an rat anti-HA antibody for 20 min at 
4°C then either fixed at 0 min or return back to 37°C incubator for 20 or 60 minutes. Cells were 
then labelled for HA tag associated with surface DAGLα for 0 min control or permeabilized and 
stained for the HA tag that associates with the internalized DAGLα (green channel). Cells were 
then double immunostained for the early endosome marker EEA 1 (red channel) (A). (B) (C) are 
zoomed views of the rectangular boxes indicated for 20 and 60 min uptakes respectively. The 
lower panels of (B) and (C) show the intensity profiles for the indicated dotted lines. The results 
show the internalized DAGLα co-localize with EEA 1 at 20min, but the co-localization is less 
apparent at 60 min. Scale bar: 20 µm.  
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6.2.10 DAGLα co-localizes with the early endosome marker, Rab5 in COS-7 cells 
Rab5 is a small GTPase localised to early endosomes and is commonly used as another early 
endosome marker (Bucci et al, 1992; Majzoub et al, 2015). A previous study reported that the 
expression of a Rab5 GTPase-deficient mutant resulted in membrane fusion in endocytosis and 
induced giant endosomes in cells (Stenmark et al, 1994). An anti-Rab5 antibody was used in this 
study to test if the DAGLα co-localize with this early endosome marker. COS-7 cells expressing 
HA-DAGLα were used and antibody fed with the rat anti-HA tag antibody for 20 min at 4°C. Cells 
were then washed and either fixed at 0 min to give a zero time point control or returned back to 
37°C incubator for 20 or 60 min before fixation. Cells were then permeabilized and labelled for 
anti-HA antibodies associated with the internalized DAGLα (shown in green in Figure 6-11). All 
cells were then double labelled for Rab5 (shown in red in Figure 6-11). As shown in Figure 6-11, 
similar to EEA 1 co-localization study, co-localization of internalized DAGLα and Rab5 can be 
observed at 20 min, again the co-localization was less apparent at 60 min. Therefore, we 
conclude that the internalized DAGLα first goes into the early endosomes and from here it then be 










Figure 6-11 DAGLα co-localizes with early endosome marker, Rab5 in COS-7 cells 
COS-7 cells expressing HA-DAGLα were antibody fed with the rat anti-HA tag antibody for 20 min 
at 4°C and washed. Cells were then either fixed at 0 min or returned back to the 37°C incubator 
for 20 or 60 min before fixation. Cells were then labelled for the anti-HA antibodies associated 
with surface DAGLα for 0 min control or permeabilized and stained for the anti-HA antibodies 
associated with the internalized DAGLα (green channel). All cells were then double labelled for 
Rab5 (red channel). Confocal images showing the internalized DAGLα co-localizes with Rab5 at 
20 min, but the co-localization is less apparent at 60 min (A). Zoomed views of the rectangular 
boxes indicated for 20 and 60 min uptakes are shown in (B) and (C) respectively. The lower 
panels of (B) and (C) show the intensity profiles for the dotted lines. Scale bar: 20 µm.   
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6.2.11 DAGLα does not co-localize with a lysosome marker, LAMP1 in COS-7 cells 
After the receptor/enzyme has been internalized and entered into the early endosomes, the 
protein cargo can be sorted to late endosomes or recycling endosomes (Arancibia-Carcamo et al, 
2006). Late endosomes can mature into lysosomes where the protein is degraded by lysosome 
proteases (Arancibia-Carcamo et al, 2006). We have shown above that DAGLα is recycling inside 
of the COS-7 cells. Therefore it’s unlikely that the constitutively internalized DAGLα will be sorted 
into lysosomes for degradation. A lysosome marker, LAMP1 was used to further test our 
hypothesis. LAMP1 is also called lysosome-associated membrane protein 1, its wild type form is 
exclusively localized in high density lysosomes (Akasaki et al, 2014). Antibody feeding and 
internalization assay were performed as shown above, the cells were incubated at 37°C for 40 or 
60 min instead of 20 min to allow the endosomes to mature into lysosomes. Cells were double 
stained for HA epitope tag that associate with the internalized DAGLα (green channel) as well as 
LAMP1 for lysosomes (red channel). Representative images are shown in Figure 6-12, the results 
suggest that the internalized DAGLα does not co-localize with LAMP1 at 40 or 60min. Thus we 
can conclude that DAGLα is mainly recycled back to the plasma membrane after been 









Figure 6-12 DAGLα does not co-localize with lysosome marker, LAMP1 in COS-7 cells 
COS-7 cells were transfected with HA-DAGLα construct, cell were then live labelled with the rat 
anti-HA tag antibody for 20 min at 4°C. Cells were then either fixed at 0 min or return back to 
37°C incubator for 40 or 60 min before fixation. Cells were then permeabilized and double stained 
with anti-HA antibodies that associate with DAGLα (green channel) and anti-LAMP1 for 
lysosomes (red channel). Representative confocal images are shown in (A). Zoomed views of the 
rectangular boxes indicated for 40 and 60 min uptakes were shown in (B) and (C) respectively. 
The lower panels of (B) and (C) show the intensity profiles for the dotted lines. The results 
indicate the internalized DAGLα does not co-localize with LAMP1 at 40 or 60 min. Scale bar: 20 
µm.  
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6.2.12 DAGLα does not co-localize with transferrin, a protein internalized by clathrin-
mediated endocytosis 
Transferrin is a glycoprotein which binds iron tightly and this transferrin-iron complex then binds to 
the cell surface expressed transferrin receptor which imports the iron into the cells by internalizing 
the transferrin-iron complex through receptor-mediated endocytosis (Harding et al, 1983; Testa et 
al, 1991; Tortorella & Karagiannis, 2014). Transferrin receptor-mediated endocytosis plays a 
crucial role in regulating iron uptake and transport in nearly all eukaryotic cells and since iron is an 
essential element for cell growth and metabolism, this internalization pathway is tightly regulated 
inside of the cell (Harding et al, 1983; Testa et al, 1991; Tortorella & Karagiannis, 2014). 
Transferrin is constitutively internalized in the cell and it is generally regarded that transferrin-iron 
and transferrin receptor complex enters the cell through clathrin-mediated endocytosis, a 
internalization pathway that have been extensively studied (Doherty & McMahon, 2009; Liu et al, 
2010; Mayle et al, 2012; Pearse & Robinson, 1990). After the transferrin-iron complex has been 
internalized, iron will be released while transferrin remains bound to the transferrin receptor 
throughout the endocytic cycle where they are sorted into early endosomes, and subsequently 
late and recycling endosomes to recycle back to the plasma membrane (Ciechanover et al, 1983; 
Mayle et al, 2012). We have shown that DAGLα is constitutively internalized and recycled in COS-
7 cells, after it has been internalized, DAGLα is also sorted into early endosomes. It might be 
possible that DAGLα is internalized through clathrin-mediated endocytosis in the same way as 
transferrin. To test this, a human transferrin conjugated with Alexa Fluor 555 (Tf 555) was used 
(Czibener et al, 2006). We transfected COS-7 cells with the HA-DAGLα construct, live cells were 
then used in an antibody feeding and internalization assay. Cells were antibody fed with the anti-
rat HA antibody together with Tf 555. Cells were then washed and fixed to get a 0 min control or 
allowed to internalize for 20 or 40 min before fixation. Cell were then permeabilized and DAGLα 
detected via the HA tag. Confocal images were taken and representative images are shown in 
Figure 6-13. Remarkably, the results showed that DAGLα does not co-localize with transferrin in 
20 and 40 min internalization. Thus, the results indicate that DAGLα might be associated with a 









Figure 6-13 DAGLα does not co-localize with transferrin 
COS-7 cells expressing HA-DAGLα were live labelled with the anti-HA tag antibody for 20 min at 
4°C together with Tf 555. Cells were then either fixed at 0 min or return back to 37°C incubator for 
various times. Cells were then permeabilized and labelled for HA tag antibody that associates 
with internalized DAGLα (shown in green). Confocal images were taken and representative 
images are shown above (A). The zoomed views of the rectangular boxes at 20 min and 40 min 
are shown in (B) and (C) respectively. The lower panel shows the intensity profiles of the dotted 
lines in zoomed in images. The results indicate the internalized DAGLα does not co-localize with 
transferrin at the time points tested. Scale bar: 20 µm.  
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6.2.13 DAGLα does not co-localize with Caveolin 1, Flotillin 1 and GPI, markers known to 
be internalized through clathrin independent endocytic pathways 
The results above suggest that DAGLα may not internalized by the clathrin-mediated endocytosis 
pathway. We therefore tested 3 markers that have been shown to be internalized via clathrin 
independent endocytic pathways to see if DAGLα co-localizes with any of these markers. 
Caveolae (for ‘little caves’) are clathrin independent plasma membrane buds that form flask-
shaped invaginations on the cell surface (Doherty & McMahon, 2009). This is a relatively well 
studied clathrin-independent endocytic pathway (Arancibia-Carcamo et al, 2006; Doherty & 
McMahon, 2009). Caveolin 1 is a protein enriched in caveolae which has been shown to be 
necessary for caveolar formation (Chaudhary et al, 2014; Doherty & McMahon, 2009; Pelkmans 
et al, 2004). Flotillin 1 has been shown to be one of the determinants of a second clathrin-
independent endocytic pathway in mammalian cells which is necessary for a protein of Cholera 
Toxin Subunit B (CTxB) uptake (Doherty & McMahon, 2009; Glebov et al, 2006). 
Glycosylphosphatidylinositol (GPI)-linked proteins have also been shown to be involved in 
clathrin-independent endocytic pathways (Ait-Slimane et al, 2009; Sabharanjak et al, 2002). A 
Caveolin 1-GFP (Cav 1-GFP) construct, a polyclonal Flotillin 1 antibody and a GPI-GFP construct 
were used for co-localization study (all reagents are gifts from Dr. Oleg O. Glebov, King’s College 
London) (Glebov et al, 2006; Glebov & Nichols, 2004). COS-7 cells were co-transfected with HA-
DAGLα and Cav 1-GFP or GPI-GFP or HA-DAGLα only for Flotillin 1 double staining. Cells were 
live labelled with the anti-HA tag antibody for 20 min at 4°C and washed. Cells were then either 
fixed at 0 min or return back to 37°C incubator for 20 min incubation before fixation. Cells were 
then permeabilized and labelled for HA tag that associates with the internalized DAGLα. Cells 
expressing HA-DAGLα only were then double stained for Flotillin 1. Confocal images were taken 
and representative images and intensity profiles were shown in Figure 6-14. The results suggest 
that DAGLα does not co-localize with any of these markers, indicating that DAGLα may not 









Figure 6-14 DAGLα does not co-localize with Caveolin 1, Flotillin 1 and GPI, markers 
known to be internalized through clathrin independent endocytosis pathways 
COS-7 cells were co-transfected with HA-DAGLα and Cav 1-GFP or GPI-GFP or HA-DAGLα only 
for Flotillin 1 double staining. Cells were live labelled with the anti-HA tag antibody for 20 min at 
4°C and washed. Cells were then either fixed at 0 min or return back to 37°C incubator for 20 min 
incubation before fixation. Cells were then permeabilized and labelled for HA tag that associates 
with internalized DAGLα (shown in red). Cells expressing HA-DAGLα only were then double 
immunostained for Flotillin 1. Confocal images were taken and representative images were shown 
above (A-C). The bottom panel shows the intensity profiles for the dotted lines in zoomed views. 
The results suggest that DAGLα does not co-localize with any of these three markers. Scale bar: 
20 µm.  
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6.2.14 Ionomycin has an effect on DAGLα internalization in HEK 293 cells 
Having established that DAGLα can be cycled to and from the cell surface, I next wanted to 
determine how this might be regulated. Calcium stimulated 2-AG synthesis has been reported in 
various systems like cells lines, neuron cultures and tissues (Bisogno et al, 2003; Bisogno et al, 
1999b; Hashimotodani et al, 2007; Kondo et al, 1998; Stella et al, 1997). For example, treatment 
of COS-7 cells with the calcium ionophore ionomycin significantly increased the amount of 2-AG 
that the cells produce and release in a DAGL dependent manner (Bisogno et al, 2003). Also 
calcium influx in the post-synaptic neuron was able to increase 2-AG signalling at the synapse 
(Hashimotodani et al, 2007). DAGLα can also directly interact with CamKII (Shonesy et al, 2013). 
As one of the main enzyme responsible for 2-AG synthesis, the localization of DAGLα might affect 
the production and release of 2-AG and calcium influx into the cell might in turn affect the 
distribution of DAGLα on plasma membrane or cytosol. Therefore, we tested the effects of 
ionomycin on DAGLα internalization and trafficking in COS-7 cells.  
COS-7 cells expressing HA-DAGLα were antibody fed with the rat anti-HA antibody at 4°C and 
washed, 2 µM ionomycin or equivalent DMSO vehicle control were then added into cell medium 
and cells were returned back to incubator for various times to allow internalization. The results 
pooled from four experiments showed no significant difference at 20 or 40 min, however a 
significant effect at 60 min treatment was observed (Figure 6-15) with less internalised receptor 
seen at this time point after treatment with ionomycin. One possible explanation might be the 
influx of calcium speeds up the trafficking of DAGLα inside of the cell, therefore more DAGLα 
protein is recycled back to the cell membrane after 60 min treatment. Indeed, a previous study 
has shown that ionomycin treatment increased the amount of 2-AG released into the cell medium 
(Bisogno et al, 2003). However, the rate of internalization was not significantly changed at earlier 
time points (20 and 40 min) and this does not support this hypothesis. Another explanation might 
be enzyme degradation. As shown above in Figure 6-6A, long term treatment of HEK293 cells 
with CB1 agonist reduced the CB1 receptor internalization rate back to control level at 100 min, it 
has been reported that the CB receptor degradation happens after long term exposure to the 
agonists (Hsieh et al, 1999). Therefore it might be possible the long term treatment of ionomycin 
may have caused degradation of DAGLα. However, further study will be required to confirm the 
effects of calcium on DAGLα internalization and trafficking.   
158 
 
Figure 6-15 Ionomycin has an effect on DAGLα internalization in COS-7 cells 
COS-7 cells expressing HA-DAGLα were live fed with the rat anti-HA tag antibody for 20 min at 
4°C and washed. Cells were then either fixed at 0 min or returned back to 37°C incubator for 20, 
40 or 60 min in 2 µM Ionomycin medium or 0.2% DMSO control. An anti-rat 488 conjugated 
secondary antibody was used to detect HA-DAGLα remaining on the cell surface. Cells were then 
permeabilized and stained with an anti-HA tag antibody associates with the internalized DAGLα. 
The ratio of internalized and surface DAGLα intensity was then calculated. Using Ionomycin to 
raise the intracellular level of calcium has a significant effect on DAGLα internalization at 60 min 
treatment. Each bar represents the mean ± SEM (n=4, 10-15 fields were randomly taken from 
each coverslip, ~100 cells quantified for each group)); *<0.05; ** P < 0.01; *** P < 0.001. One-way 
ANOVA followed by Bonferroni post-tests. 
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6.2.15 Peptide 1 does not have significant effect on DAGLα internalization 
AP (adaptor protein) complexes are a class of proteins that connect cargo molecules with the 
components of the vesicle coat during endocytosis, and AP-2 is one of the most important and 
most studied adaptors in clathrin-dependent endocytosis (Farsad et al, 2003; Heilker et al, 1996; 
Traub, 2003; Traub, 2009). It mediates the formation of clathrin-coated vesicles from the plasma 
membrane for endocytosis by providing a link between clathrin and the receptor complex (Traub, 
2003; Traub, 2009). AP-2 also plays an important role in cargo selection, making it a core sorting 
adaptor during endocytosis (Traub, 2009). An AP-2 binding motif (KTHLRRRSSQLK) that is 
conserved within the intracellular domains of all GABA(A) receptor beta subunit isoforms has 
been identified to be important in regulating the number of GABA(A) receptors available at the cell 
surface (Kittler et al, 2005). The phosphorylation of serine in this motif inhibits the AP-2 binding 
and therefore inhibits the GABA(A) receptor internalization (Kittler et al, 2005). Furthermore, when 
introduced into cells a dephosphorylated peptide mimetic of the AP-2 binding motif enhanced the 
amplitude of miniature inhibitory synaptic current and whole cell GABA(A) receptor current, 
indicating the inhibition of GABA(A) receptor endocytosis after peptide treatment (Kittler et al, 
2005). A bioinformatics study revealed that the N-terminal of DAGLα contains a similar motif 
(RRRWS) which is conserved across species (human, mouse and fly) but not conserved in 
DAGLβ (Gareth Williams, unpublished data). Therefore we postulated that this possible AP-2 
binding motif might play a role on DAGLα endocytosis. A peptide named “peptide 1” 
corresponding to the N-terminal of DAGLα which contains the motif was synthesised in tandem 
with a well characterised peptide that transports cargos into cells (Bechara & Sagan, 2013; 
Derossi et al, 1994; Thoren et al, 2000). We treated the HA-DAGLα expressing COS-7 cells with 
100 ng/ml peptide 1 or a control peptide for 1 h before antibody feeding. After antibody feeding, 
cells were allowed to internalize with the same concentration of peptide 1 or the control peptide in 
the incubator for various times. Cells were then fixed and a 488 conjugated secondary antibody 
was used to detect the surface DAGLα pool. Cells were then permeabilized and a 594 conjugated 
secondary antibody was used to detect the internalized DAGLα pool. The intensity ratio of the 
internalized and surface DAGLα was then calculated. The results are shown in Figure 6-16, 
although there was a trend of a reduced internalization rate after peptide 1 treatment at 20 or 40 
min internalization, these effects were not statistically significant. Therefore the AP-2 like binding 
motif in DAGLα may not be responsible for the enzyme internalization. These results together with 
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the transferrin co-localization study showed above suggest that DAGLα may not internalized by 




Figure 6-16 Peptide 1 does not have significant effect on DAGLα internalization 
COS-7 cells expressing HA-DAGLα were pre-treated with 100 ng/ml peptide 1 
(MPGIVVFRRRWSVGSDDRQIKIWFQNRRMKWKK-NH2; sequence shown in red is 
corresponding to the N-terminal of DAGLα which contains the putative AP-2 binding motif; 
sequence in green is the Antennapedia Peptide which enables a wide range of peptides to cross 
cellular membranes (Bechara & Sagan, 2013; Derossi et al, 1994; Thoren et al, 2000) or a control 
peptide for 1 h in cell culture medium. Cells were then live labelled with the rat anti-HA tag 
antibody for 20 min at 4°C and washed. Cells were then either fixed at 0 min or return back to 
37°C incubator for 20 or 40 minutes with the same concentration of peptide 1 or control peptide in 
cell medium before fixation. An anti-rat 488 secondary antibody was used to detect HA tag 
associate with surface DAGLα. Cells were then permeabilized and an anti-rat 594 secondary 
antibody was used to detect HA tag associated with the internalized DAGLα pool. The ratio of 
internalized / surface DAGLα intensity was then calculated. Peptide 1 has a trend to reduce 
DAGLα internalization, but this effect does not reach statistical significance. Each bar represents 
the mean ± SEM (n=3, 10-15 fields were randomly taken from each coverslip, ~100 cells 




6.2.16 Mutation of P975L in DAGLα does not stop DAGLα from being expressed on the 
cell surface in COS-7 cells 
We have reported above that DAGLα co-localizes with Homer in hippocampal neurons. This 
result was supported by a bioinformatics study that revealed the C-terminal tail of human (and 
rodent) DAGLα contains a consensus PPxxF Homer-binding motif (Jung et al, 2007). Co-
immunoprecipitation of Homer 2 and DAGLα protein has also been reported (Jung et al, 2007). 
Moreover, two point mutations in the Homer binding motif in DAGLα (P975L and F978R) 
abolished Homer and DAGLα co-immunoprecipitation, suggesting that these two proteins interact 
selectively through the PPxxF motif (Jung et al, 2007). Furthermore, the authors also reported 
that this P975L mutation changed the localization of DAGLα from the plasma membrane to the 
cytosol in Neuro-2a cells, suggesting that the interaction between Homer and DAGLα is required 
for the cell surface localization of DAGLα (Jung et al, 2007). It was of interest for us to test if this 
P975L mutation can stop the DAGLα from being expressed on the cell surface. COS-7 cells were 
transfected with either HA-DAGLα or a HA-DAGLα-P975L mutant construct, cells were then 
antibody fed and allowed to internalize for various time. Results, shown in Figure 6-17, clearly 
reveal green staining for the surface expressed DAGLα and red staining for the internalized 
DAGLα. The results clearly show that the P975L mutation in DAGLα did not stop DAGLα from 
being expressed on the cell surface. Also visual inspection did not indicate any obvious change in 
the rate of internalization of the mutated enzyme. Therefore, we can conclude that this Homer 
binding motif in DAGLα is not responsible for surface localization of DAGLα in COS-7 cells. 
Further study will be needed to test whether this mutant changes the localization of DAGLα in 
neuronal cell lines or neurons. 
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Figure 6-17 Mutation of P975L in DAGLα does not stop DAGLα from being expressed on 
the cell surface in COS-7 cells 
COS-7 cells expressing HA-DAGLα or HA-DAGLα-P975L mutant (P975 is a site within a potential 
homer binding motif in DAGLα) were live labelled with the rat anti-HA tag antibody for 20 min at 
4°C and washed. Cells were then either fixed at 0 min or returned back to 37°C incubator for 
various times in cell culture medium before fixation. An anti-rat 488 antibody was used to detect 
HA tag associated with surface DAGLα (shown in green). Cells were then permeabilized and an 
anti-594 antibody was used to stain the internalized DAGLα pool (shown in red). Confocal images 
showing merged images of surface DAGLα (green) and DAGLα after permeabilization (red). Both 
control and the P975L mutant expressing cells have DAGLα expressed on the cell surface at 
different time points in COS-7 cells. Scale bar: 20 µm. 
  
164 
6.2.17 DAGLα is constitutively internalized in rat hippocampal neurons 
We have shown above that DAGLα is constitutively internalized and sorted to early endosomes 
and is then recycled back to the plasma membrane in COS-7 cells. However, our ultimate goal is 
to study DAGLα in dendritic spines in neurons, where the enzyme modulates retrograde signalling 
and synaptic activity. Therefore, we tested if DAGLα can be internalized in hippocampal neurons. 
Rat hippocampal neurons were cultured from E18.5 rats. Neurons were transfected with HA-
DAGLα at 10 DIV and 3 days later, live cells were antibody fed with the rat anti-HA antibody at RT 
and washed. Cells were then returned back to the incubator for 20 min to allow endocytosis. 
Neurons were then fixed and an anti-rat 488 antibody was used to detect HA tag associate with 
surface DAGLα (shown in green in Figure 6-18). Cells were then permeabilized and an anti-594 
antibody was used to stain the internalized DAGLα pool (shown in red in Figure 6-18). As shown 
in Figure 6-18, internalized DAGLα was detected in neuronal dendrites (white arrows in Figure 
6-18). Thus we can conclude that DAGLα is constitutively internalized at the dendrites in 






Figure 6-18 DAGLα is constitutively internalized in rat hippocampal neurons 
Cultured rat hippocampal neurons were transfected by HA-DAGLα at 10 DIV. 3 days later, 
neurons were live labelled with the rat anti-HA tag antibody for 20 min at RT and washed. Cells 
were then returned back to 37°C incubator for 20 min in cell culture medium. Neurons were then 
fixed and an anti-rat 488 antibody was used to detect HA tag associate with surface DAGLα 
(shown in green). Cells were then permeabilized and an anti-594 antibody was used to stain the 
internalized DAGLα pool (shown in red). Lower panel shows the zoomed views of the rectangular 
area. White arrows indicate the internalized DAGLα at the dendrites. These results suggest 
DAGLα can be internalized at the dendrites of rat hippocampal neurons after 20 min 
internalization. Scale bar: 20 µm and 5 µm. 
  
166 
Chapter 7 Discussion 
7.1 Why study the role of eCB, FGFR and TrkB signalling on 
neuroblast migration in the RMS? 
In the introduction to this thesis I have highlighted some of the key requirements for the 
development and functioning of the brain, and commented on the role that the eCB signalling 
system plays in axonal growth and guidance, neurogenesis and synaptic plasticity. From an 
experimental perspective, the first study that I undertook was to determine the role that DAGL-
dependent eCB signalling plays in neuroblast migration in the postnatal brain. In this context the 
SVZ has recently emerged as a crucial neurogenic niche. Thousands of neural precursors are 
created in the SVZ of postnatal and adult mammalian brains and migrate in chains via the RMS to 
the OB to differentiate into interneurons (Doetsch & Alvarez-Buylla, 1996; Ming & Song, 2005; 
Ming & Song, 2011). This tangential migration of neuroblasts in the RMS is highly characteristic 
with overall movement directed towards the OB. However, directed movement is not absolute with 
other studies demonstrating that at any one time neuroblasts can be found moving back towards 
the SVZ as well as moving toward the OB (Bagley & Belluscio, 2010; Nam et al, 2007). Removal 
of the OB has no or little effect on guidance, suggesting that this is mainly determined by factors 
emanating from the SVZ and/or synthesised locally within the stream (Bagley & Belluscio, 2010). 
Studies on the migration along the RMS in the recent years have become a useful system in 
revealing the potential molecular mechanisms involved in cell migration (Ming & Song, 2005; Ming 
& Song, 2011). Many proteins and signalling pathways, including several already to be known 
involved in cancer cell migration, such as adhesion molecules (PSA-NCAM, integrin), extracellular 
cues (NRGs, Slits), GABA, Ephrins and neurotrophins have been found to contribute to 
neuroblast migration in the RMS (Anton et al, 2004; Bolteus & Bordey, 2004; Cavallaro & 
Christofori, 2004; Chazal et al, 2000; Chiaramello et al, 2007; Mobley & McCarty, 2011; Nguyen-
Ba-Charvet et al, 2004), but the whole system is far from being fully understood (Ming & Song, 
2011). Some studies have also provided evidence that the progenitor cells produced by the SVZ 
can migrate out of the RMS to the site of brain injury to contribute to brain repair (Arvidsson et al, 
2002; Christie & Turnley, 2012; Gotts & Chesselet, 2005a; Young et al, 2011). It is therefore 
fundamental to fully understand how the migration is regulated in the RMS for potential 
therapeutic applications. 
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The eCB system consists of several endogenous lipids, their target CB1 and CB2 receptors and 
enzymes responsible for their synthesis and degradation. CB1 and CB2 receptors are G-protein 
coupled receptors (GPCRs), they are found to be expressed in the developing and adult brain 
including neural stem cells and their progeny (Zhou et al, 2014). The CB1 receptor is the most 
abundant GPCR in the brain and is activated by endogenous lipids, predominantly 2-AG that can 
be synthesised on demand by the DAGLs (Ben Amar, 2006; Bisogno et al, 2003; Matsuda et al, 
1990; Mechoulam et al, 1995; Piomelli, 2003; Sugiura et al, 1995; Zhou et al, 2014). The eCB 
system regulates many physiological processes in the CNS including neurogenesis, axon 
guidance and synaptic plasticity (Harkany et al, 2008; Oudin et al, 2011b; Zhou et al, 2014). 
Recent studies have highlighted additional important roles for eCB signalling in regulating 
proliferation of neural progenitors in both the adult hippocampus and SVZ and regulating axonal 
growth and guidance, making it a key signalling system for the complex architecture and efficient 
wiring of the CNS (Gao et al, 2010; Goncalves et al, 2008; Oudin et al, 2011a; Zhou et al, 2015). 
Indeed, knock-out mice studies together with pharmacological perturbation in vivo indicate that 
the eCB signalling controls migration both pre- and post-natally, regulating interneuron positioning 
in the developing cortex and hippocampus (Berghuis et al, 2005; Berghuis et al, 2007; Mulder et 
al, 2008). A more recent study from our lab has suggested that the eCB system regulates the 
motility of stem cell-derived neuroblasts in the RMS, but this was mainly based on in vitro explant 
cultures where the polarity of the stream is lost (Oudin et al, 2011a). Therefore it was deemed to 
be of interest to look in considerable detail at the role of the eCB signalling on the neuroblast 
migration in relatively intact RMS.  
For reasons that will be discussed in more detail later, the second focus was to test the effects of 
inhibiting FGFR function on migration. The FGFR signalling system is relatively complex with 4 
receptors (FGFR1-4) and a multitude of “conventional” growth factor ligands. FGFR1-4 are highly 
conserved transmembrane tyrosine kinase receptors with each receptor containing an 
extracellular domain composed of three immunoglobulin (Ig) domains, a single transmembrane 
domain, and an intracellular tyrosine kinase domain. Alternative mRNA splicing of the 
extracellular domains has been reported in FGFRs and the resultant isoforms of these receptors 
have different ligand binding properties. Also these alternative spliced receptor variants together 
with their ligands, the FGFs, are expressed in specific spatial and temporal patterns thus allowing 
control of the specificity of FGF-FGFR interaction (Burke et al, 1998; Ornitz et al, 1996; Turner & 
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Grose, 2010). FGFs are secreted glycoproteins that are usually released by heparinises, 
proteases or specific FGF binding proteins. 18 FGFs has been found so far and most FGFs 
activate a particular subset of FGFRs (Burke et al, 1998; Reuss & von Bohlen und Halbach, 2003; 
Turner & Grose, 2010; Yang et al, 2015). This highly complex signalling system regulates a 
multitude of physiological functions and is involved in developmental and repair processes in 
almost all mammalian tissues (Turner & Grose, 2010). All four FGFRs have been found to be 
expressed in the developing and adult brain. Among these receptors, FGFR1 is expressed mainly 
on neuronal population, while FGFR2 and FGFR3 are mainly expressed by glia and other cell 
types (Zechel et al, 2010). FGF-2 has been reported to be the most abundant FGF in the CNS 
and is a high affinity ligand for the FGFR1 suggesting widespread functional coupling between 
this ligand and receptor pair (Zechel et al, 2010). Previous studies have shown that the FGFR 
signalling plays a key role in cell migration and this signalling pathway is implicated in the 
metastasis of many types of cancer (Attia et al, 2015; Bobbs et al, 2012; Cao et al, 2013b; Kadam 
et al, 2012; Nakamura et al, 2001; Turner & Grose, 2010). Molecules like selective FGFR 
inhibitors, specific FGFR blocking antibodies, FGF ligand traps or recombinant FGFs have 
therefore been developed for potential therapeutic applications by many pharmaceutical 
companies (Turner & Grose, 2010). However, further understanding of FGFR signalling on cell 
migration in the postnatal brain is still needed to better facilitate translational work. 
As alluded to earlier, our motivation for studying the role of the FGFR in neuroblast migration in 
the RMS was largely driven by previous reports of direct cross-talk between the FGFR and the 
eCB system in neurons (Williams et al, 2003). This study provided evidence for FGFR dependent 
activation of PLC, leading to the synthesis of substrate for the DAGLs and resulting in DAGL-
dependent activation of the CB1 receptor in a pathway that promotes axonal growth (Williams et 
al, 2003). This FGFR-eCB pathway can also be directly activated by cell adhesion molecules 
(CAMs), like NCAM, binding to the FGFR and NCAM has also been reported to be important for 
neuroblast migration in the RMS (Battista & Rutishauser, 2010; Cremer et al, 1994; Doherty & 
Walsh, 1996; Schmid & Maness, 2008; Williams et al, 1994a; Williams et al, 2001). Thus there is 
a clear basis for investigating whether this CAM-FGFR-eCB signalling cascade might play a role 
in the regulation of neuroblast migration in the RMS. We reasoned that a detailed comparison of 
the roles played by the FGF and eCB receptors in the regulation of neuroblast migration in the 
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RMS could serve as a critical way to test for direct cross-talk between these pathways in this 
system. 
At the outset of the study we also appreciated that we might need to consider interactions 
between other growth factors and the eCB system. In this context BDNF is one of the 
neurotrophins that helps to support the survival of existing neurons, and promotes the growth and 
differentiation of new neurons. TrkB is the main receptor for BDNF and it interacts with BDNF in a 
ligand-specific manner (Acheson et al, 1995; Huang & Reichardt, 2001; Yamada & Nabeshima, 
2003). BDNF signalling has been shown to be important for the SVZ neurogenesis of the 
mammalian brain (Bath et al, 2012). Previous studies have also shown that BDNF and TrkB are 
expressed throughout the SVZ-OB system and the TrkB receptor is expressed by the migrating 
neuroblasts. Additionally, BDNF has a motogenic effect on neuroblasts in RMS explant cultures 
(Bath et al, 2008; Chiaramello et al, 2007; Snapyan et al, 2009), indicating an important role for 
BDNF and TrkB in the RMS. However, the role of BDNF signalling in regulating neuroblast motility 
and directionality along the entire intact stream is less clear as an antibody that can block BDNF 
function has been reported to increase neuroblast motility within the RMS without disrupting 
guidance (Bagley & Belluscio, 2010), while another report showed that inhibiting BDNF signalling 
in the adult mouse brain with a TrkB-Fc impairs RMS neuroblast migration and directionality 
(Snapyan et al, 2009). Thus it was interesting to re-investigate the role of BDNF signalling on 
neuroblast motility and guidance along different regions of the stream.  
The direct cross-talk between the BDNF and eCB signalling has already been reported (Aso et al, 
2008; Berghuis et al, 2005; Blazquez et al, 2015; Lemtiri-Chlieh & Levine, 2010; Maison et al, 
2009). Interestingly, a wide range of mechanisms can account for this cross-talk. For example, 
BDNF has been shown to be able to increase the expression of CB1 receptors by increasing 
gene transcription and thereby increasing neuronal sensitivity to 2-AG in cultured cerebellar 
granule neurons (CGNs) (Maison et al, 2009). A electrophysiology study has revealed that eCB 
release at inhibitory synapses in the neocortex can be triggered by BDNF-TrkB signalling pathway 
(Lemtiri-Chlieh & Levine, 2010). Local administration of BDNF, but not other neurotrophins (NGF, 
NT-3), in the hippocampus was able to reverse the anxiety-like phenotype seen in CB1 knock-out 
mice (Aso et al, 2008) and injection of a viral vector expressing the CB1 receptor into the 
dorsolateral striatum of R6/2 mice, a well-established model of Huntington’s disease (HD), 
rescued the expression of BDNF as well as the HD-like molecular-pathology markers in these 
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animals, supporting the important role of CB1/BDNF axis in disease (Blazquez et al, 2015). There 
is also evidence that activation of the CB1 receptor can result in a ligand independent 
transactivation of the TrkB receptor in a PC12 cell line (Berghuis et al, 2005). In this study a 
Boyden chamber assay showed that a CB1 agonist stimulated interneuron migration, and that this 
could be blocked by K252a, a TrkB inhibitor, indicating that the eCBs can use TrkB receptor-
dependent signalling pathways to regulate interneuron migration (Berghuis et al, 2005). Previous 
work in our lab has shown that activation of FGFR signalling can lead to activation of PLC to 
synthesize DAG, with DAGL then using this substrate to generate 2-AG to activate the CB1 
receptor. This direct cross-talk between the FGFR and the CB1 receptor promotes axonal growth, 
a biological response that shares many features with cell migration (Williams et al, 2003). It is also 
possible that activation of TrkB signalling might lead to direct cross-talk with eCB signalling via a 
PLC dependent mechanism. Indeed, such a mechanism has recently been reported to be 
accountable for BDNF interactions with eCBs in the regulation of cocaine-induced synaptic 
plasticity in mouse dopaminergic neurons (Zhong et al, 2015). For all of the above reasons it was 
clearly of interest to compare the involvement of the eCB, FGFR and TrkB signalling pathways in 
neuroblast migration within the RMS.  
7.2 eCB signalling on neuroblast migration in the RMS 
In the present study we have used time-lapse imaging on acute brain slices to determine if and 
how eCB signalling regulates migration in the RMS within intact brain slices. To achieve this, in 
vivo postnatal electroporation and subsequent acute brain slice preparation followed by time-
lapse imaging was used. Postnatal electroporation can efficiently transfect SVZ progenitor cells, 
which in turn generate neuroblasts migrating along the RMS. Here we used a GFP-expressing 
plasmid for electroporation to label the neuroblasts migrating along the RMS. Acute brain slice 
cultures make pharmacological treatment possible and there are excellent small molecules 
available for the targeting of the eCB system. Using confocal spinning disk time-lapse microscopy 
on acute brain slice cultures, neuroblast migration can be monitored in an environment closely 
resembling the in vivo condition. Moreover, neuroblast motility can be tracked and quantitatively 
analyzed (Sonego et al, 2013b). In this part of study we have used live cell imaging of neuroblasts 
in intact brain slices to determine if eCB signalling has roles beyond their motogenic effects on 
neuroblast migration - previously documented with explant cultures (Oudin et al, 2011a). Our 
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results show that the eCB system can regulate both neuroblast motility and local guidance 
throughout the stream. 
As discussed above, many molecules can regulate neuroblast migration in the RMS, but most of 
these have been shown to primarily affect motility rather than regional guidance, and examples 
include GABA (Bolteus & Bordey, 2004) and metalloproteases (Bovetti et al, 2007). The eCB 
system has also been shown to have largely motogenic effects on cultured cells. Activation of CB 
receptors promotes neuroblast migration from explants cultures, while inhibitions of eCB 
signalling reduce this (Oudin et al, 2011a). Both CB1 and CB2 antagonists have been shown to 
have similar effect on altering neuroblast morphology within the RMS in vivo and inhibiting the 
migration of RMS neuroblasts in cultured explants in vitro (Oudin et al, 2011a). In this context, we 
first inhibited eCB signalling by using CB1 and CB2 antagonists together because both have 
previously been shown to contribute to the inhibition of eCB signalling and we wanted to fully 
inhibit the pathway. 
In this study, treating the cultured brain slices with CB1/CB2 antagonists resulted in the cells 
spending longer periods of time in an immobile state (from ~25% in control to ~45% in treated). 
These results are consistent with the in vitro explant culture studies where nucleokinesis 
(movement of the cell body and nucleus, which is key for directed neuronal migration) of the 
neuroblast was reduced approximately threefold per hour relative to the control when cells were 
treated with CB1 or CB2 antagonists (Oudin et al, 2011a). Interestingly, the average speed of 
migration was not significantly altered when treating with CB1/2 antagonists. Thus, we found the 
primary effect of the eCB on motility is on the length of time the neuroblasts are immobile, rather 
than on the speed of movement when they do migrate. One possibility is that a maintained 
momentum might help propel cells towards the OB. If the cells for some reason become immobile 
during their travel, they might lose their sense of direction and have to re-explore their immediate 
environment, thus the momentum is lost and cells spend more time exploring their local 
environment.  
The CB1/CB2 antagonist treatments not only resulted in the neuroblast migrating over shorter 
distances towards the OB compared to vehicle treated control cells, but also the net migration 
towards the OB and the total cell displacement were significantly reduced. In addition, control 
cells often display a predominant unipolar morphology usually oriented towards the OB, while 
cells treated with cannabinoid antagonists often displayed branched processes extending in all 
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directions. This is also consistent with the previous study on fixed brain slices taken from animals 
injected with a single dose of CB1 and CB2 antagonists; this caused a significant decrease in the 
length of the leading process on migratory neuroblasts in the RMS, together with an increase in 
the percentage of cells displaying secondary branching (Oudin et al, 2011a). Indeed, a single 
leading process is crucial for efficient nucleokinesis and so essential for neuroblast migration 
(Marin et al, 2010). The leading process of a migrating neuron acts as the compass which selects 
the direction of migration in response to chemotactic cues. A migrating neuron with branched 
processes often means the cell is in an ‘exploratory state’ and hasn’t decided which direction to 
follow (Cooper, 2013; Marin et al, 2010). Treatment with CB1/2 receptor antagonists caused the 
cells to be more branched which means the cells stayed longer in an ‘exploratory state’. Moreover, 
the cells with the leading process oriented other than towards the OB are more likely to migrate to 
other directions. As a result, the overall migration of the cells towards the OB was significantly 
reduced with CB1/2 receptor antagonist treatment. In summary, these results clearly support the 
hypothesis that the CB1/2 receptors regulate neuroblast migration in the intact RMS.  
The above results provide clear evidence of an important role for the eCB system in the regulation 
of neuroblast migration within the RMS. However, we know the neuroblast migration along the 
RMS is one of the longest migration processes in the mammalian brain, connecting the SVZ of 
the Lateral Ventricle and OB. However, it should be noted that key factors like developmental 
stages, architecture environments or neuronal compositions are all fundamentally different 
between SVZ and OB (Doetsch & Alvarez-Buylla, 1996; Ming & Song, 2005; Ming & Song, 2011) 
and it is possible that this could be the basis for establishing long-range gradients of 
chemoattractants or chemorepellants along the RMS. With this in mind we have tested if the eCB 
system regulates neuroblast migration in a similar manner at both the beginning (close to the SVZ) 
and end (close to the OB) of the stream and we monitored the directionality of neuroblast 
migration by calculating the “meandering” index. In the RMS close to the SVZ, treatment with CB 
receptor antagonists resulted in the increase of the number of exploratory neuroblasts and 
decrease in the number of cells migrating in a directed manner, with very similar results seen with 
neuroblasts sampled at the end of the stream. The migratory neuroblasts followed a random 
rather than directed pathway when eCB signalling was inhibited, and this effect was seen in both 
beginning and end of the RMS. Thus, we can conclude that the eCB signalling is required for 
neuroblast motility and guidance all along the RMS. 
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Having shown that the CB receptors are important for the neuroblast migration, next we wanted to 
test if other components of the eCB system also play a role in the RMS. Our previous studies 
show co-expression of the DAGLs and of the CB1 receptor in the same SVZ-derived neuroblasts 
(Oudin et al, 2011a) suggesting that 2-AG might drive the migratory response. A DAGL inhibitor, 
OMDM-188 (Ortar et al, 2008) was therefore used in cultured brain slices to block the activity of 
DAGL in the RMS to test this. The DAGL inhibitor had similar effects on migration as the CB1/2 
antagonists. When the DAGLs were inhibited, the cells spent more time immobile, the net 
migration towards the OB was significantly reduced and total cell displacement was reduced 
compared to control cells. We also looked at the effect of inhibiting DAGLs on different regions of 
the RMS, and again similar results were obtained as compared to the CB receptor antagonists. 
Treatment with the DAGL inhibitor increased the number of exploratory neuroblasts at the 
expense of the number of cells migrating in a directed manner, with similar results seen at both 
ends of the RMS. Thus, the results clearly support the hypothesis that the DAGLs regulate 
neuroblast migration in the intact RMS. We can conclude that DAGL-dependent eCB signalling is 
required for neuroblast motility and guidance within the RMS and that this pathway operates all 
along the RMS. 
We initially used drugs to inhibit eCB signalling to test the importance of the pathway for 
neuroblast migration. There are also highly selective agonists available for the CB1/2 receptors 
and it was of interest to determine what they might do within the relatively intact RMS. A 
combination of CB1/2 agonists (ACEA and JWH-133) in cultured brain slices was used to test this. 
The results showed that the CB agonists did not perturb guidance within the RMS, with the only 
obvious effect on migration being a slight increase in speed. Thus, a long-range gradient of eCB 
along the RMS is unlikely, as treatment with exogenous CB agonists would ‘flatten’ any potential 
gradient and perturb guidance. Previous work has shown co-expression of the DAGLs and CB1/2 
receptors in the same SVZ-derived neuroblasts (Oudin et al, 2011a; Sutterlin et al, 2013), 
suggesting 2-AG might act in an autocrine or paracrine way for neuroblast migration. Another 
study has shown that cell-autonomous 2-AG signalling regulates neurite outgrowth (Keimpema et 
al, 2013a). Since the neuroblasts migrate over each other in chains, it is possible that 2-AG might 
exert paracrine effects on neighbouring cells. However, it has been shown that 2-AG has a short 
half-life and does not diffuse over long distances (Rouzer et al, 2002), therefore a long-range 2-
AG gradient in the RMS is unlikely. Thus we postulate that 2-AG does not directly impart 
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positional information by forming a short or long-range gradient. A more recent study has shown 
that the eCB signalling can modulate the activity of actin-binding proteins, like fascin, which is 
important for the polarized morphology of the RMS neuroblasts (Sonego et al, 2013a). We 
therefore postulate that the eCB signalling is important for maintaining the polarized morphology 
of the neuroblast by acting on the cytoskeleton proteins. It stabilises the leading process (Oudin et 
al, 2011a) to allow the neuroblast to read and/or respond to bona fide guidance cues. However, 
the key observation from the CB receptor agonist treatment is that the agonists do not have 
significant effect on guidance within the stream, probably because the eCB signalling is already 
saturated in the RMS. These results provide substantive evidence against the notion that long 
range eCB gradients might operate along the RMS.  
In the present study we used live imaging to determine if and how eCB signalling regulates 
migration in the RMS within intact brain slices. As well as providing novel insights into how the 
eCB system regulates migration, the present study highlights some unresolved issues. One of the 
most pertinent questions is that what actually drives eCB tone in the migratory neuroblast and 
what is their relative effect in the RMS compared to the eCB system? There is ample evidence for 
direct cross-talk between FGFR, TrkB and eCB signalling (Berghuis et al, 2005; Lemtiri-Chlieh & 
Levine, 2010; Maison et al, 2009; Williams et al, 2003). Previous studies have indicated that FGF, 
BDNF and their receptors –FGFRs and TrkB are expressed in the SVZ-OB system, also FGF and 
BDNF have motogenic effect on neuroblasts in RMS explant cultures (Chiaramello et al, 2007; 
Garcia-Gonzalez et al, 2010). However, there has been no direct comparison between the roles 
of eCB and FGFR or TrkB signalling in the intact RMS and this was therefore picked on as the 
topics for the chapter 4 and 5 of this thesis and detailed comparison will be discussed below.  
In summary, by using time-lapse imaging to characterise the role of eCB system in the regulation 
of neuroblast migration, this part of the study provides detailed insights into the consequences of 
inhibiting or activating eCB function on neuroblast migration in the intact RMS. The DAGL-
dependent eCB signalling regulates neuroblast migration as well as guidance in the intact RMS, 
and this effect operates along the entire RMS. Thus we conclude the eCB system is an important 
regulator of RMS neuroblast migration in the postnatal mouse brain. 
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7.3 FGFR signalling on neuroblast migration in the RMS 
The role of FGF-2 and FGFRs on cell proliferation and neurogenesis in the SVZ has been well 
studied (Frinchi et al, 2008; Mudo et al, 2007). For example, it has been reported that FGF-2 is 
expressed in GFAP positive cells and may act on the FGFR1 which was found to be expressed in 
nestin positive neural stem cells in the SVZ (Belluardo et al, 2008; Mudo et al, 2007). By using in 
situ hybridization and double labelling together with BrdU administration, a study reported that 
both FGFR1 and FGFR2 mRNAs are expressed in proliferating precursor cells in the SVZ and 
these FGFRs may respond to FGF-2 released by non-proliferating cells in the SVZ (Frinchi et al, 
2008). The expression of FGFRs and the localisation of FGF-2 in the SVZ-RMS-OB migration 
route have also been reported on in detail in another study (Garcia-Gonzalez et al, 2010). 
Immunostaining of the dissociated neural precursors revealed that SVZ derived neuroblasts 
express the FGFR1. Treatment of explants with FGF-2 significantly increased the migration of 
neuroblasts from SVZ derived explant cultures, and this effect was inhibited by a selective FGFR1 
blocker, SU5402, suggesting an important role of FGF-2 and FGFR1 on neuroblast migration 
(Garcia-Gonzalez et al, 2010). Moreover, stronger labelling of FGF-2 in the SVZ than in the RMS 
and OB has been reported by using a FGF-2 antibody, leading the authors to suggest that a 
caudal-rostral gradient of FGF-2 exists in the neuroblast migration route in the RMS (Garcia-
Gonzalez et al, 2010). Thus high levels of FGF-2 emanating from the SVZ might form a gradient 
to drive neuroblast migration in the RMS. However, the same study also showed that the 
immunostaining for FGF-2 decreased at  P15 with only the SVZ showed a strong expression, 
suggesting that if this FGF-2 gradient does exist, it is transitory (Garcia-Gonzalez et al, 2010). 
In this study, we first treated the brain slices with two specific FGFR inhibitors to block FGFR 
activity in the RMS. These small molecules bind directly to the FGFR and block activity by 
competing for ATP binding (Gavine et al, 2012; Mohammadi et al, 1998; Tucker et al, 2014); they 
will block receptor function irrespective of the nature of the ligand. Our initial study on the 
descending arm of the RMS revealed results that very similar to those seen with eCB receptor 
antagonists. Cells stayed a longer time in an immobile state and had shorter displacement and 
the number of cells migrating towards the OB was also significantly reduced by both. However, 
when we looked at the different regions of the RMS, remarkably different effects can be seen 
between the regions. Inhibiting FGFR signalling disrupted cell migration towards the beginning of 
the RMS, more cells migrated in an exploratory rather directed manner. However, this effect was 
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not seen at the end of the RMS with the percentage of cells in the “exploratory” and “directed” 
group relatively unchanged comparing to the control. Therefore, results from inhibiting FGFR 
signalling support the role of FGFR system on neuroblast migration, but also quickly highlight 
differences with eCB receptors as the FGFR pathway appears to only operate at the beginning 
part of the RMS. 
The above results have shown the importance of the FGFR activity on neuroblast migration. To 
test which ligands are likely to be responsible for the effects we have seen above, we used a 
FGFR1-Fc in brain slice cultures as this small molecule can trap FGF ligands that bind to the 
FGFR1. FGFR1-Fc is a soluble recombinant protein that contains the extracellular domains of 
FGFR1 fused to the Fc region of human IgG1. A similar FGF ligand trap has been reported to be 
used in clinical trial to inhibit tumor growth and angiogenesis (Turner & Grose, 2010). In this study, 
use of FGFR1-Fc resulted in very similar effects as seen with the FGFR inhibitors. Disruption of 
cell migration was observed at the beginning of the RMS, while no significant effect can be seen 
at the end of the RMS. This results support the view that FGFR1 ligands are important for the 
RMS neuroblast migration.  
Next we wanted to test which FGFR1 ligand is important in the RMS. As discussed previously, 
FGF-2 is the most abundant FGF in the CNS and is able to promote neuroblast migration out of 
the RMS explant (Garcia-Gonzalez et al, 2010; Zechel et al, 2010), we therefore used a specific 
FGF-2 neutralizing antibody to block FGF-2 in brain slice cultures. bFM-1 is a very selective 
monoclonal antibody that blocks FGF-2 signalling and does not cross-react with FGF-1 
(Matsuzaki et al, 1989). After incubation of bFM-1 with the brain slice cultures, a large percentage 
of cells exhibited random migration and change their direction of migration frequently. Again, 
detailed analysis showed that disruption of the migration was only statistically significant at the 
beginning of the RMS. Thus, these results support the role of FGF-2 on neuroblast migration in 
the RMS and FGF-2 is likely to be the ligand responsible for the FGFR signalling in the RMS. 
A previous study using an anti-FGF-2 antibody for immunostaining on brain slices reported that 
FGF-2 is expressed at higher level in the SVZ than in the RMS and OB resulting in a ligand 
gradient along the RMS (Garcia-Gonzalez et al, 2010). The results of our study are clearly in 
keeping with this hypothesis. However, we have not been able to reproduce this result using 
some available anti-FGF-2 antibodies, possibly due to sensitivity issues and/or the loss of FGF-2 
proteins from the slices during immunostaining and/or as a consequence of fixation. Therefore we 
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tested the hypothesis indirectly by adding high concentration of exogenous FGF-2 into brain slice 
cultures as this would be expected to saturate and disrupt any endogenous FGF-2 gradient that 
exists in the RMS. Results here showed that adding exogenous FGF-2 to the brain slice cultures 
disrupted the migration at the beginning of the RMS and cells migrated in a more random as 
opposed to directed manner. These results together with the FGF-2 neutralizing antibody results 
suggested that a certain concentration of FGF-2 at the beginning of the RMS was required for 
directed neuroblast migration, exogenously added FGF-2 might destroy a gradient of FGFs within 
the RMS with the result being that cells lose positional information; they can still move, but lose 
their sense of direction. This is consistent with the hypothesis that there might be a caudal-rostral 
FGF-2 gradient along the SVZ and RMS that drives the migration of the neuroblasts by working 
on FGFRs and downstream pathways. Indeed, gradient of FGFs, especially FGF-2, has been 
reported to be involved in many physiological processes including embryogenesis, limb bud, 
neural development, neuronal differentiation and neurogenesis (Bokel & Brand, 2013; Dyer et al, 
2014; Keenan et al, 2012; Lahti et al, 2011; Wu et al, 2014a). Therefore our results support the 
existence of a FGF-2 gradient in the RMS and this gradient is likely to drive the neuroblast to 
leave the SVZ and migrate in the RMS. Nonetheless, an important caveat of the exogenous FGF-
2 administration experiment is that responses to this growth factor are often biphasic with higher 
concentrations acting like an inhibitor possibly due to receptor and/or pathway desensitisation 
(Williams et al, 1994b; Williams et al, 1995). Thus in our experiment the excess FGF-2 added into 
the slice cultures might have inhibited the receptor, rather than flattened a ligand gradient.  
From our results of time-lapse movies, all the treatments targeting FGFRs or FGF-2 have a 
significant effect on migration behaviour at the beginning part of RMS. The cells become more 
exploratory, change their directions frequently which resulted in a reduction in the total 
displacement. However, the actual distance the cells migrated was not significantly changed. 
There was a small but significant effect on the speed of migration by inhibiting FGF-2 with the 
neutralizing antibody. However, the average speed of neuroblast migration was not significantly 
altered by FGFR inhibitors or FGFR1-Fc. Thus we postulate that the FGFR signalling in the RMS 
(at least at the beginning part of the RMS) is important for the cells to sense the guidance cues in 
the local environment thus maintain the momentum to migrate toward the OB.  
While all the treatments targeting FGFR signalling resulted in the neuroblasts migrating more 
randomly at the beginning of the RMS, no significant effect was seen towards the end of the RMS. 
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This is consistent with the hypothesis that a FGF-2 gradient might exist in the RMS. The 
observation at the end of RMS also serve as an internal control; these indicate that the effect of 
the treatments like FGF-2 antibody and FGFR1-Fc chimera at the beginning part of RMS is not 
caused by toxic or non-specific effects on neuroblasts.  
The above results provide a very substantial body of evidence for FGF-2/FGFR function 
regulating RMS migration in a slice culture. Similar support for the importance of eCB signalling 
was obtained from a study treating animals with a range of CB1/2 antagonists for 24 h and 
showing that this resulted in changes in neuroblast morphology within the RMS, most notably a 
decrease in the length of the leading process and an increase in secondary branching (Oudin et 
al, 2011a). Here we reported a similar 24 h treatment with the FGFR inhibitor AZD4547 also 
resulted in morphological changes on the neuroblast in the RMS. Again, the leading process 
length was significantly shorter after AZD4547 treatment as compared with the control treated 
animals. A shorter process length might compromise the neuroblasts ability to sense the local 
environment for guidance cues, and therefore the direction of migration (rather than migration per 
se) might be compromised. Remarkably, when we check the process length in detail by dividing 
the RMS into 4 regions, a gradated effect was seen with cells towards the beginning of the stream 
showing a highly significant decrease in leading process length, and cells at the distal end of the 
stream showing no response. Thus our results provide evidence for FGFR signalling regulating 
neuroblast morphology in vivo, and support the conclusion made with slice cultures pointing to 
regional differences in FGFR signalling within the RMS. 
The above results all support the hypothesis that a FGF-2 gradient might exist in the RMS to 
regulate neuroblast migration, however in this study the direct antibody staining method was 
unable to demonstrate such a gradient. To further look for the evidence for the existence of FGF-
2 gradient, we turned to the RT-qPCR method to quantify the transcript expression levels of FGF-
2 and its receptor FGFR1 in different regions of RMS. Our RT-qRCR results showed that the 
FGF-2 transcripts were expressed at higher level in the SVZ tissue compared to the OB, while the 
FGFR1 transcripts level showed no significant difference. This is consistent with the previous 
study where they showed higher levels of FGF-2 in the SVZ than the OB (Garcia-Gonzalez et al, 
2010). However, transcripts encoding FGFR1 were similar at both regions. Previous studies have 
reported that the embryonic development of OB is independent of SVZ and RMS, even cortex, 
and FGFR1 is required for OB morphogenesis (Garcia-Gonzalez et al, 2010; Hebert et al, 2003; 
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Nishizumi & Sakano, 2015). Conditional knock out of FGFR1 at early stage in the telencephalon 
of mice resulted in the absence of OB, but the cells can still migrate from SVZ to an OB like 
protrusion (Hebert et al, 2003). Therefore, we postulate that the FGFR1 may have different 
functions close to the SVZ and in the OB. While the FGFR1 signalling regulates neuroblast 
migration close to the SVZ, it might act as a signal important for morphogenesis in the OB but 
unrelated to the cell migration. Thus we can conclude that the transcripts level of FGF-2 showed 
here provide basis to support the existence of putative caudal-rostral FGF-2 gradient in the RMS, 
however more accurate methods for determining the receptor and ligand levels will be needed to 
further support this evidence, especially as the difference that we found is relatively small.  
To substantiate the above results, we also studied migration in a model where in principal we 
conditionally knock-out both the FGFR1 and FGFR2 from migratory neuroblasts. Conditional 
Fgfr1/2 flox/flox mice were bred by crossing Fgfr1 and Fgfr2 conditional knock out mice (Xu et al, 
2002; Yu et al, 2003; Yu et al, 2011). Electroporating a pCAG-Cre-IRES-EGFP plasmid into the 
lateral ventricle of these mice in principle should excise the sequences flanked by LoxP 
sequences employing the Cre-LoxP system. However, conditional knock out of FGFR1/2 by 
electroporating a Cre-containing plasmid into the lateral ventricle did not result in significant 
morphological change in the RMS 5 or 10 days later. The possibility that the knock out strategy 
might have failed needs to be considered. The results showed the expression of the GFP protein 
in the neuroblasts along the RMS either 5 or 10 days after electroporation, this should mean the 
Cre recombinase was introduced into the same population of cells. However, since these mice 
were maintained on a mixed genetic background and there were multiple LoxP sequences (at 
least 4 sites were flanked by LoxP sequence on both sides) existing in the genome, there was 
chance that there might not be enough copies of Cre recombinase available in the neuroblasts to 
completely knock out both Fgfr1 and Fgfr2 alleles. Also a previous study has reported that even if 
appropriate DNA excision takes  place in two β1 intergrin transgenic LoxP mice lines, different 
outcomes have been seen with one model showed no change in β1 intergrin protein level 28 days 
later (Turlo et al, 2010). Therefore it is possible that even if the receptor genes have been deleted, 
FGFR1 and FGFR2 proteins may persist and still function in these cells at the time we checked 
the cell morphology. Unfortunately antibody staining in slice cultures is unlikely to have the 
sensitivity and resolution to be useful in determining if the strategy has worked or not. If we 
assume that the knock out strategy did work, and that we have tracked neuroblasts that lack both 
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FGFR1 and FGFR2, there are other reasons why the results obtained might have differed from 
those seen with the pharmacological and other reagents that disrupt FGF-2/FGFR signalling. For 
example, a previous study has showed that the gradient effect of FGFs on cell migration operates 
in a collective manner on large population of cells rather than at the level of an individual cell 
(Benazeraf et al, 2010). With “chain” migration in the RMS being driven by cell-cell interactions 
between the neuroblasts (Garcia-Verdugo et al, 1998; Wang et al, 2011; Wozniak & Bruska, 
1999), when adding FGFR inhibitors or FGF-2 or its’ neutralizing antibody into the brain slices, we 
clearly target FGFR signalling in the whole population of the cells in the RMS. This contrasts with 
electroporation as this generally only result in sparse labelling (5-30%) in the RMS (Boutin et al, 
2008; Sonego et al, 2013b). Therefore knock out by electroporation may not be sufficient to alter 
the graded FGFR signalling in the RMS as cells that lack the receptors might remain instructed by 
cells that continue to express the receptors. Another explanation for the divergent results might be 
the neuroblasts may adapt to the relatively chronic loss of FGFR signalling by compensatory 
mechanisms. Indeed, previous studies have reported on the ability of neural stem cells to rapidly 
adapt to the loss of FGFR signalling (Sutterlin et al, 2013). In this context, the Cor-1 neural stem 
cell line, derived from E16.5 mouse cortex, shares many properties with the NSCs and migratory 
neuroblast that we study in the slice cultures (Conti et al, 2005; Pollard et al, 2006). For example, 
the proliferation of this cell line can be inhibited by a DAGL inhibitor or CB1/2 antagonists, the 
same drugs can also inhibit the proliferation of SVZ neuroblasts (Goncalves et al, 2008). In 
addition, eCB signalling has been reported to regulate Cor-1 cell migration in a wound assay and 
the same signalling system also regulates neuroblast migration in the RMS (Oudin et al, 2011a). 
Thus, this neural stem cell line would appear to be a good model for understanding how the 
FGFR and other receptor systems cooperate to regulate neurogenesis and cell migration and also 
for determining how the cells adapt to loss of a pathway. For example, a previous study in our lab 
reported that inhibiting FGFR signalling in Cor-1 cells using PD173074 resulted in a very rapid 
reduction (~60%) of phosphorylation of ERK1/2 in these cells seen after 30 min, and importantly 
this pathway has been implicated in cell proliferation and migration (de Graauw et al, 2006; 
Turner & Grose, 2010). However, even in the continuous presence of the FGFR inhibitor, 
phosphorylation of ERK1/2 returned to control level within 3 h (Sutterlin et al, 2013). Thus this 
study showed that the Cor-1 cells were able to quickly adapt to the loss of FGFR signalling 
(Sutterlin et al, 2013). Therefore the conditional knock out of FGFR1/2 may have also resulted in 
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the neuroblasts initiating the rapid adaptation mechanism and compensated for the loss of FGFR 
signalling in vivo.  
The results above were all obtained from postnatal mice. As the neuroblast migration in the RMS 
persists into adulthood, the time point that might need more therapeutic intervention in the brain, it 
will be interesting to further test the role of FGFR signalling in mature adult mice. However, the 
study of adult animals is more challenging due to the fact that the GFP signal in the labelled 
neuroblasts is lost 2-3 weeks after the initial electroporation (Boutin et al, 2008; Sonego et al, 
2013b) and the electroporation of older mice is relatively inefficient at labelling neuroblasts in the 
RMS (Barnabe-Heider et al, 2008). Therefore in this study, I did some preliminary experiments to 
establish a model that would allow for the future study on the neuroblast migration in the RMS in 
adult animals. Conditional knockout mice employing the LoxP system caught our attention and in 
particular a ROSA26-YFP mouse line employing the Cre-LoxP system that had been reported 
previously to be able to permenantly label a subpopulation of cells (Lacar et al, 2010; Platel et al, 
2010). More specifically, the ROSA26-YFP mice genome contains a Stop sequence flanked by 
LoxP between the ubiquitous Rosa26 promoter and YFP encoding sequence. Electroporation of a 
Cre-expressing plasmids into the laterventrical of ROSA26-YFP mice will introduce the Cre 
recombinanse into a population of stem cells in the SVZ. Thus, the Cre-LoxP system will excise 
the Stop sequence and induce the permanent genomic expression of YFP in these stem cells 
which in principle will subsequently generate a continuous population of YFP-expressing 
migratory neuroblasts that will migrate from the SVZ to the OB well into adulthood. Results from 
our data using ROSA26-YFP mice showed successful labelling of the neuroblasts in the RMS up 
to 8 weeks following the initial electroporation, however, longer time point labelling is also 
possible and has been reported elsewhere (Platel et al, 2010). We also did some preliminary 
expriments on 6 weeks old (general regarded as young adult mice) ROSA26-YFP mice to test the 
role of FGFR signalling. Our preliminary data showed that a 24 h treatment with FGFR inhibitor 
AZD4547 resulted in branched cell morphology in the RMS, and there was a tendency of shorter 
process length after treatment. Thus we established in our lab a model for successful labelling of 
neuroblasts in young adult mice and by using this model our pilot study supports the role of FGFR 
signalling on neuroblast migration in the RMS in young adult mice. However, more experiments 
will be needed to confirm the role of FGFR signalling in adulthood.  
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In summary, our results suggest that FGF-2/FGFR signalling play a very important role in driving 
the migration of neuroblasts at the beginning of the RMS, but not at the end part. Our results 
suggest that FGFs within the RMS provide positional information that is “read” by FGFRs on the 
neuroblasts to direct them to the bulb. The observation that FGFR function is higher in the SVZ 
and decreases toward the OB might be explained by the existence of a FGF-2 gradient in the 
RMS which is important for the neuroblasts to leave the SVZ and migrate in the RMS. A matrix-
bound gradient of FGF-2 has been reported to provide positional information in other systems 
(Wu et al, 2014a). However, we have not been able to confirm the existence of such a gradient. 
Mechanisms other than a FGF gradient might also explain the above results, for example, there 
are feedback mechanisms within the cell that can regulate FGFR activity, including “sprouty” 
proteins (Cabrita & Christofori, 2008; Ching et al, 2014; Mason et al, 2004), and it remains 
possible that these operate in a graded manner along the RMS.  
7.4 TrkB signalling on neuroblast migration in the RMS 
The TrkB receptor is a member of a tyrosine kinase receptor family that includes TrkA and TrkC. 
TrkB is the high affinity receptor for BDNF and NT-4, and binds less efficiently with neurotrophin-3 
(NT-3) (Huang & Reichardt, 2001). The TrkA receptor binds NGF while TrkC is activated only by 
NT-3 (Huang & Reichardt, 2001; Skaper, 2012). Therefore, the TrkB receptor mediates multiple 
effects of neurotrophic factors, which include promoting neuronal differentiation and survival 
(Huang & Reichardt, 2001). As mentioned above, the effect of TrkB on neuroblast migration in the 
RMS has been reported, and this effect is likely to be attributable to BDNF serving as the ligand 
as it is present throughout the RMS (Chiaramello et al, 2007; Snapyan et al, 2009). The NGF-
TrkA pathway also regulates many physiological processes including neuronal growth and 
survival and NFG-TrkA complex endocytosis has been implicated in the signal transduction of the 
neurons (Grimes et al, 1996; Skaper, 2012). 
Although a previous study has already shown that BDNF has a motogenic effect on neuroblasts in 
RMS explant cultures (Chiaramello et al, 2007), conflicting studies have appeared on the role of 
BDNF in the RMS. A study showed that both the speed of migration and the number of 
neuroblasts migrating towards the OB were increased by using an antibody reported to block 
BDNF function (Bagley & Belluscio, 2010). However, these results are not obviously compatible 
with another study that reported BDNF promotes the migration of SVZ neuroblasts, acting both as 
inducer and attractant through TrkB activation. Also pharmacological blockade of BDNF 
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dependent pathways on SVZ explants impairs neuronal migration (Chiaramello et al, 2007). In 
agreement with the conclusion that TrkB signalling is required for migration, it has been reported 
that neuroblast migration in acute brain slices from adult mice is inhibited by incubation with TrkB-
Fc (Snapyan et al, 2009). We have revisited the role of TrkB-Fc on neuroblast motility and 
guidance along different regions of the stream in the intact brain slices to not only clarify its role, 
but also allow for a direct comparison of the results seen with agents that block eCB signalling. By 
doing so we wanted to see if there is any basis for postulating interplay between TrkB and eCB 
signalling in the regulation of migration in the RMS  
We also used TrkB- and TrkA-Fc chimeras on brain slices of intact RMS followed by time-lapse 
imaging to test the relative importance of the respective neurotrophin receptors on the neuroblast 
migration in the RMS. Again, in vivo postnatal electroporation and subsequent acute brain slice 
preparation followed by time-lapse imaging was used to visualize and analyze the migration 
dynamic of the neuroblasts after TrkB-Fc and TrkA-Fc treatment. Our results clearly support an 
important role for TrkB signalling on neuroblast migration in the RMS. The cells treated with TrkB-
Fc were less mobile and the average speed of migration was also decreased when compared to 
the control cells, supporting the role of TrkB signalling on motility of the neuroblast migration. The 
percentage of cells migrating towards the OB and the net displacement of the cells were also 
reduced, supporting the role TrkB on guidance in the RMS. Our results also suggest that TrkB 
signalling regulates migration throughout the RMS because the treatment with TrkB-Fc increased 
the percentage of exploratory cells at both beginning and end of the RMS. Our results also show 
that the effect of the TrkB-Fc on migration guidance at the end of RMS was just as substantial as 
its effect at the beginning, which is of interest given that a real-time RT-PCR study has shown 
both BDNF and TrkB receptors expressed at lower level in the SVZ compared with OB extracts 
(Chiaramello et al, 2007). Such different levels of receptor and / or ligand in the RMS might have 
been expected to lead to a graded response along the RMS, as have been suggested for slits and 
GDNF that act as chemorepellents or chemoattractant respectively in the RMS (Hu, 1999; 
Paratcha et al, 2006; Wu et al, 1999). However, a graded response for TrkB signalling was not 
observed in the present study as inhibiting the pathway showed similar effects at both ends of the 
RMS. Thus our results clearly support the notion that TrkB signalling has an important function on 
neuroblast migration in all regions of the RMS, and this is in agreement with results reported by 
others that includes a report that TrkB receptors are expressed by migrating neuroblasts in 
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different regions of the RMS (Bath et al, 2008; Chiaramello et al, 2007). Our data not only confirm 
a motogenic role for TrkB (Chiaramello et al, 2007; Snapyan et al, 2009), but also extend its 
function as a local guidance cue throughout the stream.  
Our results clearly support the role of TrkB signalling in the RMS, but it did not directly address 
the identity of the ligand. As TrkB receptor can bind to both BDNF and NT-4 in high affinity, the 
use of a TrkB-Fc can potentially inhibit both neurotrophins. Indeed, by both working through TrkB 
receptor, BDNF and NT-4 can exert very similar effects as well as differentiated effects in the 
CNS (Bosco & Linden, 1999; Heppenstall & Lewin, 2001; Hyman et al, 1994; Polleux et al, 2002). 
For example, a study using embryonic mice medial ganglionic eminence (MGE) explant co-
cultured with postnatal rat cortical slices showed that BDNF and NT4 have similar effects on 
tangential migration of the interneurons from the MGE (Polleux et al, 2002). However, another 
study on retina ganglion cells (RGCs) indicated that BDNF and NT-4 had very different effects on 
modulating neurite outgrowth, BDNF supported mainly polarized outgrowth, whereas NT-4 
induced the appearance of intensely branched symmetrical arbours (Bosco & Linden, 1999). An 
electrophysiology and knock out mice study also showed that although NT-4 was normally 
present in the mouse spinal cord, it was BDNF but not NT-4 that was required for normal flexion 
reflex plasticity and function (Heppenstall & Lewin, 2001). In this study, BDNF is more likely to be 
the key ligand for the TrkB receptor in the RMS based on the previous studies showing that BDNF 
was able to promote dendritic development of SVZ-derived neuronal precursors and was 
essential for their survival in the OB (Gascon et al, 2005; Kirschenbaum & Goldman, 1995; 
Linnarsson et al, 2000). Intraventricular administration of BDNF resulted in a substantial increase 
in the number of newly generated cells within the migratory pathway and in the OB (Pencea et al, 
2001). Moreover, both BDNF mRNA and protein were expressed throughout the RMS in young 
adult mice, and BDNF was able to promote neuroblast migration out of the explant of RMS from 
P4-10 mice and this effect was inhibited by a TrkB inhibitor, K252a (Chiaramello et al, 2007). 
Therefore in this study where P7-P9 mice were used for brain slices which was consistent with 
the time point (P4-P10) in the previous study (Chiaramello et al, 2007), it is more likely to be 
BDNF rather than NT-4 that regulates neuroblast migration in the RMS. However, the role of NT-4 
in the RMS cannot be ruled out and future study will be required to determine if it is expressed in 
the RMS and if yes, whether it regulates migration. 
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While treatment with TrkB-Fc disrupted migration in the RMS, our results showed that treatment 
with TrkA-Fc did not have a significant effect on the neuroblast migration in the RMS, suggesting 
that this receptor has little if any function in the migratory neuroblasts in the RMS. Indeed, the 
TrkA-Fc treatment in this study didn’t result in any significant effect on any of the parameters 
measured on the migration including the average speed. However, the results with the TrkA-Fc 
can be taken as a good internal control for the TrkB-Fc, as they demonstrated that Fc-chimeras 
do not have non-specific effects on any of the measured parameters. However, it is perhaps 
worth noting that there was a clear trend towards an effect for TrkA-Fc at the beginning of the 
RMS, leaving open the possibility that NGF and the Trk-A receptor might play a small role in 
migration. Further studies examining the expression of this ligand and receptor pairing would be 
required before developing this hypothesis further. Likewise, studies on the effects of NGF on 
neuroblast migration from RMS explant cultures would provide an alternative methodology for 
exploring the hypothesis. The relative lack of effect of the TrkA-Fc compared to the TrkB-Fc 
argues against a non-specific effect of the Fc chimeras on migration. Others have used the same 
tools and demonstrated differential results. For example, it has been shown that it was TrkB-Fc, 
not TrkA-Fc or TrkC-Fc, contributed to the development of kindling (Binder et al, 1999). 
Nonetheless, it would be prudent to use additional tools in future studies to further test the 
importance of TrkB signalling for neuroblast migration. This was not deemed to be a priority in this 
study as a previous study using a TrkB-Fc as well as TrkB conditional knock-out mice has shown 
the importance of TrkB signalling on neuroblast migration in adult mice (Snapyan et al, 2009).  
In summary, by using live-cell imaging on the intact brain slices, the results suggest that the TrkB 
signalling is an important regulator of RMS neuroblast migration, while NGF-TrkA does not seem 
to play a role on the neuroblast migration in the RMS. Acute disruption of TrkB signalling 
disrupted neuroblast motility and guidance at both end of the RMS, also TrkB signalling had a 
small but significant effect on the speed of neuroblast migration in the RMS. 
7.5 Comparison between eCB, FGFR and TrkB signalling on 
neuroblast migration  
Our results show that the eCB system can regulate both neuroblast motility and local guidance 
throughout the stream. By comparing these results to the FGFR system, we can see similarities 
as well as very clear differences between these two signalling systems in regulating the 
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neuroblast migration. One common effect between targeting the FGFR and eCB signalling is that 
the effect on migration is manifest as a loss of directional movement towards the OB, as opposed 
to a loss of migration per se. Treatments inhibiting the eCB system or targeting the FGFR 
signalling in brain slice cultures resulted in the cells to migrate in a more exploratory rather than 
directed manner. The cells seem to have lost their direction of migration and change their 
direction frequently, as a result, the percentage of cell migrating towards the OB and cell 
displacements were all reduced. However, when the cells do migrate the speed of migration was 
not significantly different from controls in most treatments. As discussed above, pharmacological 
inhibition of the eCB and FGFR signalling in vivo all resulted in the cells exhibiting shorter process 
lengths. Thus we postulate that both eCB and FGFR signalling might be important for maintaining 
the polarized morphology of the neuroblast in the RMS by stabilising the leading process to allow 
the neuroblast to read and/or respond to guidance cues. Apart from the similarities, the 
differences between these two signalling systems are very clear. The main difference is the 
regional effects of the FGFR signalling. Targeting FGFR signalling only affected neuroblast 
migration at the beginning of the RMS, while inhibiting the eCB system did not show regional 
differences. Also we showed that the eCB agonists did not significantly affect the directed cell 
migration in the RMS. Unlike the eCB system, results in the FGFR chapter showed that either 
inhibiting FGF-2 by a specific neutralizing antibody or adding exogenous FGF-2 to the brain slice 
cultures disrupted the migration at the beginning of the RMS and cells migrated in a more random 
as opposed to directed manner. Also the pharmacological inhibition of FGFR signalling in vivo 
showed regional specific effects on neuroblast morphology, while inhibiting the eCB signalling in 
vivo affects the neuroblast morphology throughout the RMS (Oudin et al, 2011a). Based on the 
differences above, it's very unlikely that these two pathways directly interact to regulate migration 
in the RMS, especially at the end of the RMS where the FGFR signalling is not important for 
directed cell migration.  
Targeting TrkB signalling resulted in defects in neuroblast migration that are similar to those seen 
following targeting of eCB signalling. Both treatments disrupted both motility and guidance, 
resulted in the cells to spend more time immobile, and migrating in an exploratory rather than 
directed manner. The only difference seemed to be the effects on the average speed of migration 
since the TrkB-Fc incubation slightly decreased the speed while the eCB inhibitors did not show 
significant effect, suggesting the TrkB signalling is more important for the motility. Based on the 
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above results that eCB and TrkB signalling perturbation had similar effects on neuroblast 
migration in the RMS, and evidence from the previous studies that eCB and TrkB signalling 
interact with each other in many different ways in other neuronal types (see above for details), it 
will be very interesting to investigate the direct linkage of the two systems on the intact brain 
slices. However, it might be very difficult to interpret the results from the combined treatment of 
eCB and TrkB inhibitors on brain slices, as inhibiting eCB or TrkB signalling on their own already 
resulted in substantial or maximal disruption on migration and further disruption is unlikely. For 
example, the percentage of cells migrating towards the OB decreased from ~70% to ~40% in both 
eCB antagonists and TrkB-Fc treatment and these effects were already maximal because further 
reduction in the cells towards the OB again means directed migration, but towards the opposite 
direction rather than to the OB. Using in vitro explant cultures from the RMS might be a better 
approach to test the combined effect of eCB and TrkB since the migration rate out of the explant 
can be easily measured. In this context, preliminary results showed that the maximal distance of 
the neuroblast migration from the explants can be inhibited by CB1/CB2 antagonists (Oudin et al, 
2011a) but not by a TrkB inhibitor K252a (Doherty lab, unpublished observation), suggesting that 
eCB and TrkB signalling operate independently in neuroblast migration. Nonetheless, given that 
there is extensive cross-talk between these two pathways and that inhibiting them independently 
results in very similar perturbations in migration within the RMS, it would appear likely that future 
studies might reveal some level of interaction between them. 
In summary, our results provide detailed insights into the consequences of inhibiting eCB, BDNF 
and FGFR function on neuroblast migration in the intact RMS. The DAGL-dependent eCB 
signalling is important for RMS neuroblast migration. The eCB and TrkB signalling regulate both 
neuroblast motility and local guidance throughout the stream. Acute disruption of TrkB signalling 
had similar effects as inhibiting DAGL-dependent eCB signalling on motility and guidance at both 
end of the RMS, with the only difference being that TrkB signalling had a small but significant 
effect on the speed of migration that was not seen when eCB signalling was blocked. The FGF-
2/FGFR signalling differs from the role of eCB and TrkB signalling by playing a very important role 
on driving the migration of neuroblasts at the beginning of the RMS, but not at the end part. Thus, 
in this context these results do not support direct cross-talk between the eCB and FGFR 
signalling systems on the regulation of neuroblast migration in the RMS, while further study will be 
needed to test the direct cross talk between the eCB and TrkB signalling. Although not pertinent 
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to the “cross-talk” question, it is perhaps worth noting that by comparing the effects of these three 
systems at the beginning of the RMS, we did not see any particular “rank” of these three systems 
in regulating neuroblast migration as all of them significantly disrupt the cell migration to a similar 
level.  
7.6 Why study DAGL intracellular trafficking?  
Having established the eCB signalling is important for migration, and having compared it with two 
other receptor systems, we next wanted to start to make some inroads into the mechanisms that 
might regulate DAGL function. There is no shortage of questions that might be addressed, e.g. 
the nature of the upstream ligand/receptor pairing that drives DAGL-dependent eCB signalling, 
and the molecular basis for enzyme activation. In the later context, this laboratory has postulated 
that DAGL activity will be governed by phosphorylation of a regulatory loop that limits substrate 
access to the active site within the catalytic domain (Reisenberg et al, 2012), and others are 
studying this question. However, given that location within the cell, and in particular whether the 
DAGLs are in the same membrane compartment as the upstream receptors and downstream 
effectors (the CB1/2 receptors), we decided to determine if there is dynamic cycling of the 
enzymes between an intracellular pool and a pool expressed at the cell surface. At the outset we 
viewed this as a possible mechanism for regulating the cell surface expression of DAGLα at the 
post-synaptic spine akin to the recycling mechanisms that govern the availability of 
neurotransmitter receptors in the same membrane (Arancibia-Carcamo et al, 2006; Collingridge et 
al, 2004; Kittler et al, 2005). This is important for synaptic plasticity and in brief is governed by the 
regulated endocytosis of the neurotransmitter receptors followed by the recycling of the endocytic 
vesicles back to the cell surface. 
Endocytosis is a very general cellular process used to internalize membrane proteins, lipids, 
extracellular ligands and soluble molecules (Arancibia-Carcamo et al, 2006). It is a basic cellular 
process that controls the protein and lipid compositions of the plasma membrane therefore 
regulating how the cells interact with and respond to their environment (Doherty & McMahon, 
2009). A variety of endocytic pathways have been discovered and studied so far, however, these 
pathways are generally divided into two groups: clathrin-mediated endocytosis or clathrin-
independent endocytosis. Clathrin-mediated endocytosis is by far the most extensively studied 
and best understood pathway. Clathrin is a protein that forms a triskelion shape by its heavy and 
light chain complex; this triskelion can assemble into apolygonal lattice that helps to deform the 
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plasma membrane into a clathrin-coated pit and subsequently into a clathrin coated vesicle. AP-2 
is required for the recruitment of clathrin to the plasma membrane and it provides a link between 
clathrin and the molecules that will be internalised via the clathrin coated pit (Farsad et al, 2003; 
Heilker et al, 1996; Traub, 2003; Traub, 2009). Dynamin is also essential for clathrin-coated 
vesicle formation as it is critical for the pinching and release of a completed vesicle from the 
plasma membrane (Doherty & McMahon, 2009). Once the clathrin built small vesicles detach 
from the plasma membrane, they are then transported within cells.  
Clathrin-mediated endocytosis is a ubiquitous process which is essential for all eukaryotic cells, it 
mediates the internalization of extracellular hormones or signalling factors as well as being 
involved in nutrition uptake and general signal transduction (Arancibia-Carcamo et al, 2006; 
Miaczynska & Stenmark, 2008). A recent study reported that ~95% of the earliest detectable 
endocytic vesicles arise from clathrin-coated pits (Bitsikas et al, 2014). Therefore clathrin-
mediated endocytosis is regarded as a “housekeeping” pathway by some researchers (Bitsikas et 
al, 2014; Bradford et al, 2015). Although the majority of molecules are internalized via clathrin-
mediated endocytosis, clathrin independent pathways have also been reported (Doherty & 
McMahon, 2009; Mayor et al, 2014; Miaczynska & Stenmark, 2008). Caveolin and lipid raft-
dependent pathways are relatively well characterized clathrin-independent pathways (Arancibia-
Carcamo et al, 2006). Pathways that involve Flotillin, GPI-linked proteins, Arf6 and IL2Rβ have 
also been reported (Doherty & McMahon, 2009; Glebov et al, 2006; Lamaze et al, 2001; 
Naslavsky et al, 2004). More recent studies reported Endophilin, a protein that has been assigned 
as a component of clathrin-mediated endocytosis, controls a fast-acting tubulovescicular 
endocytosis pathway that is independent of clathrin and AP-2 (Boucrot et al, 2015; Renard et al, 
2015). However, some clathrin-independent pathways are less well understood, and some 
proposed pathways remain controversial; some of these might only be functional in special 
situations like cell migration or in specific cell types like hippocampal neurons (Bitsikas et al, 2014; 
Doherty & McMahon, 2009; Howes et al, 2010; Mayor et al, 2014; Sandvig et al, 2011). For all the 
endocytosis pathways, once the molecules or cargoes have been internalized, they enter the 
endocytic pathway which consists of distinct membrane compartments like endosomes or 
lysosomes (Arancibia-Carcamo et al, 2006). The early endosome is usually the first sorting station 
for endocytic pathways; from here the molecules or cargoes will then generally be sorted for 
degradation or recycling (Jovic et al, 2010).  
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The DAGLs are key enzymes in the eCB signalling system which is a therapeutic target for many 
physiological disorders and diseases like epilepsy, pain and neurodegeneration (Ben Amar, 2006; 
Bisogno et al, 2003; Gao et al, 2010). Within neurons the DAGLs are localized to axons during 
development, but DAGLα becomes restricted to dendritic spines in the adult brain (Bisogno et al, 
2003; Yoshida et al, 2006). The underlying mechanism regulating this polarised 
compartmentalisation of DAGLα is not known, but is most probably determined by its ability to 
bind to homer proteins and/or CamKII as these molecules are also assembled into protein 
complexes that specifically localise to dendritic spines (Jung et al, 2007; Shonesy et al, 2013). 
Knock out studies have revealed that DAGLα is responsible for DSI/DSE to regulate synaptic 
plasticity in the CNS (Gao et al, 2010; Tanimura et al, 2010).  
The restricted localisation of DAGLα to the dendritic spine underpins the function of eCB 
signalling in DSI and DSE throughout the nervous system (Bisogno et al, 2003; Gao et al, 2010; 
Yoshida et al, 2006). Once localised to a post-synaptic spine, vesicular recycling of many other 
receptors like AMPA, NMDA and GABA(A) receptors can modulate synaptic strength (Arancibia-
Carcamo et al, 2006; Kittler et al, 2005). For example, GABA(A) receptors are the major sites of 
fast synaptic inhibition in the CNS, they have been shown to be constitutively internalized through 
clathrin-mediated endocytosis in hippocampal neurons (Kittler et al, 2000). Inhibition of GABA(A) 
receptor internalization can enhance the amplitude of miniature inhibitory synaptic current and 
whole cell GABA(A) receptor current, indicating the number of GABA(A) receptors expressed on 
the cell surface of the neurons regulate the efficacy of synaptic inhibition (Kittler et al, 2005; Kittler 
et al, 2000). As DAGLα also plays an important role in synaptic plasticity, we decided to develop 
and test the hypothesis that this key enzyme might also be dynamically regulated in spines, 
perhaps “shuttling” between an intracellular and cell surface location. To this end, an extracellular 
HA tagged DAGLα construct was generated to enable us to identify the enzyme at the surface of 
living cells and to follow internalisation and recycling back to the cell surface using classical 
antibody feeding experiments. Our results show that there are indeed distinct surface and 
intracellular pools of DAGLα in dendritic spines, and that DAGLα can indeed be internalized in 
several cell lines as well as in the dendrites of cultured hippocampal neurons.  
7.7 DAGLα intracellular trafficking in COS-7 cells  
Our results show that DAGLα undergoes constitutive internalization followed by recycling back to 
the plasma membrane in COS-7 cells. As endocytosis is an energy using process, it is 
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reasonable to postulate that there is a reason behind this dynamic cycling. It is possible that the 
internalization of DAGLα is used by cells to control the level of the enzyme at the cell surface and 
thereby regulate eCB signalling. Indeed, a change of localization of DAGL activity from an 
intracellular pool to plasma membrane, measured as the release of arachidonic acid (AA) from 
diacylglycerol (DAG) in human neutrophils, has been reported (Balsinde et al, 1991). In this study 
the authors simply assayed for a DAGL enzymatic activity and did not characterise a molecular 
entity. Nonetheless, this change of DAGL activity localization towards the plasma membrane in 
neutrophils was stimulated by the calcium ionophore A23187 and the translocation of DAGL may 
play an important role in regulating eCB signalling in stimulated cells (Balsinde et al, 1991). 
Further study will be required to test the role of DAGLα endocytosis in enzyme activity such as 2-
AG production.  
It was perhaps not surprising to find that internalized DAGLα co-localized with the early 
endosome markers EEA 1 and Rab5 as the early endosomes are the first sorting station for 
several endocytic pathways. (Arancibia-Carcamo et al, 2006; Jovic et al, 2010). As DAGLα can be 
recycled back to the plasma membrane, it’s likely to be sorted to recycling endosomes after the 
early endosome stage. The failure to detect co-localization of DAGLα with LAMP1 supported this 
by suggesting that DAGLα was not trafficked to the lysosomes. However, we have not been able 
to determine which endocytosis pathway is responsible for DAGLα internalisation. Our results 
failed to show DAGLα co-localization with transferrin, a protein that has been well studied and 
established to be involved in clathrin-mediated endocytosis, suggesting DAGLα might be 
internalized by a clathrin-independent pathway. In preliminary experiments with Dynasore, a 
selective dynamin inhibitor (Macia et al, 2006), or a dominant-negative dynamin-2 (K44A) mutant 
(Ringerike et al, 1998), we have not seen any obvious alteration in DAGLα internalization (data 
not shown). These data together suggest that endocytosis of DAGLα might be independent of 
clathrin and dynamin. However, further experiments will be needed to confirm this conclusion.  
Interestingly, a consensus AP-2 binding motif (RRRWS) can be found in the N-terminus of 
DAGLα, and this might suggest that AP-2 can play a role in DAGLα endocytosis (Gareth Williams, 
unpublished data). This putative AP-2 binding motif (RRRWS) is conserved across species in 
DAGLα but is absent from DAGLβ. A similar motif has been reported to be conserved in all 
GABA(A) receptor beta subunit isoforms and phosphorylation of serine in this motif inhibits the 
receptor binding to AP-2 therefore inhibiting the GABA(A) receptor internalization (Kittler et al, 
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2005). We designed a peptide named “peptide 1” corresponding to the first 17 aa of the N-
terminal of DAGLα which contains the motif in tandem with an Antennapedia peptide sequence 
which enables the peptide to penetrate cellular membranes (Bechara & Sagan, 2013; Derossi et 
al, 1994; Thoren et al, 2000). The Doherty lab has used this strategy to design numerous 
peptides that can enter cells and compete for protein-protein interactions (Hall et al, 1996b; Saffell 
et al, 1997; Vastrik et al, 1999). In principal, the cell permeant peptide mimetic of the DAGLα N-
terminus should be able to compete out the binding of any protein that might interact with this 
region of the enzyme, and this might include AP-2. Interestingly, we did see a trend of reduced 
DAGLα internalization when peptide 1 was added into the cell medium, however the results failed 
to reach statistical significance. These results suggest DAGLα internalization may be independent 
of AP-2 or other motifs/regions may be required for DAGLα endocytosis and future studies will be 
required to confirm this.  
7.8 Effects of calcium on DAGLα internalization  
Calcium has been implicated both upstream and downstream from the cannabinoid receptors in 
many studies, for example, DAGL-dependent eCB signalling can couple to CAM / FGFR 
signalling to regulate axonal growth and guidance by driving calcium influx into growth cones, and 
CB1 agonist stimulated neurite outgrowth in cerebellar neuron can be blocked by N and L-type 
calcium channel antagonists (Oudin et al, 2011b; Williams et al, 2003). The calcium ionophore 
A23187 can also stimulate DAGL and MAGL activity in neutrophils as well as increase 2-AG 
production in DRG neurons (Balsinde et al, 1991; Gammon et al, 1989). Ionomycin can also 
significantly increase 2-AG levels in a DAGL dependent manner in COS-7 cells (Bisogno et al, 
2003). Calcium influx can also increase 2-AG production in post-synaptic spines (Hashimotodani 
et al, 2007). However, the mechanism that couples calcium influx to eCB signalling is not known 
(Oudin et al, 2011b). Our results showed that increased intracellular calcium stimulated by 
Ionomycin had no effect on the initial rate of DAGL internalisation in COS-7 cells; however it did 
significantly alter the ratio of cell surface/intracellular DAGLα at 60 min in favour of relatively more 
being present at the cell surface. Importantly, this could be a consequence of more DAGL 
transport to the surface, and/or degradation of intracellular DAGL. As mentioned above, 
translocation of DAGL activity from an intracellular pool towards the plasma membrane was 
observed by treating the human neutrophils with the calcium ionophore A23187 (Balsinde et al, 
1991). However, it is also possible that the Ionomycin response that we observed reflects a 
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calcium stimulated degradation of DAGLα within the cell, and further experiments will be required 
to distinguish between these two possibilities. As calcium stimulation can increase 2-AG 
production, long-term treatment of Ionomycin may have increased 2-AG level to an extent that 
was sensed by cells, and the cells may respond by reducing the DAGLα level to control the eCB 
signalling. However, we did see considerable variation between the results obtained in this series 
of individual experiments (data not shown), and other mechanisms other than calcium influx may 
also contribute to the DAGLα endocytosis. Further detailed study will be required to confirm the 
effect of calcium on DAGLα cycling, and to determine the mechanism of any effect. 
7.9 The interaction with Homer on DAGLα cellular localization  
The Homer protein family consists of three members in mammals (Homer 1-3) (Shiraishi-
Yamaguchi & Furuichi, 2007). They are commonly known as scaffold proteins predominantly 
localized at the postsynaptic density in neurons and are thought to have a role in defining the 
cellular distribution of the proteins that interact with them (Brakeman et al, 1997; Shiraishi-
Yamaguchi & Furuichi, 2007). The interaction between DAGLα and Homer has been reported 
previously (Jung et al, 2007). This study reported DAGLα and Homer 2 can be co-
immunoprecipitated in HEK293 cells. Mutating a single site within a consensus Homer-binding 
motif PPxxF in DAGLα abolished this interaction. Moreover, one point mutation (P975) in this 
motif was able to alter the localization of DAGLα from the cell surface to intracellular structures in 
Neuro-2a cells (Jung et al, 2007). However, our study using a HA-DAGLα-P975L mutant showed 
that this DAGLα mutant can still be expressed at the cell surface, and this mutation did not 
obviously impact on the internalization rate of DAGLα, indicating that an interaction with Homer is 
not required for the transport of DAGLα to the cell surface in COS-7 cells. This conflicting result 
that we have found might due to the different experimental methods and/or different cell types 
used in the studies. For example, in Jung et al’s study, a C-terminal V5 tagged construct was 
used and the conclusion was draw from visual inspection of the fluorescent signal, making it more 
difficult to unequivocally differentiate the surface and intracellular pool of DAGLα. In contrast, in 
our study we used a surface epitope tagged DAGLα construct and antibody feeding assay, thus 
the surface expressed DAGLα can be specifically and effectively detected. It is highly possible 
that the P975L mutation cannot result in a complete change of DAGLα localization from cell 
surface to intracellular, and the remaining DAGLα on the cell surface was picked up due to the 
high sensitivity of our assay. It is also possible that the DAGLα-Homer interaction was not 
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important for DAGLα localization in COS-7 or it is very likely that the dendritic environment or 
other neuronal specific proteins are required for this interaction. Indeed, by using a Fragile X 
syndrome model, FMRP was suggested to be involved in correct localization of DAGLα to eCB 
signalling complexes which includes the scaffolding protein Homer (Jung et al, 2012). Therefore it 
will be important to further test the effects of the P975L mutation on the localisation of DAGLα to 
dendritic spines in neuronal cells.  
7.10 Conclusions  
In summary, by using a novel tagged DAGLα construct that allows us to localise surface 
expression in live cells, we found a distinct pool of DAGLα expressed on the cell surface that can 
be differentiated from an intracellular DAGLα pool. Antibody feeding and internalization assays 
were used to show that DAGLα can be constitutively internalized in several cell lines as well as 
cultured hippocampal neurons. Detailed co-localization studies showed that DAGLα co-localizes 
with Homer, a dendritic spine marker, in hippocampal neurons. Studies in COS-7 cells revealed 
that DAGLα enters the early endosomes after been internalized and can be recycled back to the 
cell surface possibly via a recycling endosome pathway. Internalized DAGLα does not co-localize 
with transferrin, also a peptide targeting a putative AP-2 binding site did not show significant effect 
on DAGLα internalization, suggesting that DAGLα endocytosis might be independent of clathrin 
and AP-2. DAGLα does not co-localize with Caveolin 1, Flotillin 1 and GPI-linked proteins, 
markers for some reported clathrin-independent endocytic pathways. These novel findings lead 
us to postulate that this energy using dynamic recycling of DAGLα is likely to be a tightly 
regulated process which directly regulates eCB signalling at the synapse as well as other cell 
types. Understanding the underlying mechanisms in DAGLα endocytosis has therapeutic potential 
for drug targets in diseases like Fragile X syndrome.  
7.11 Future directions 
A bioinformatics study scanning the DAGLα sequence might give insights to the underlying 
mechanisms governing its internalisation. Apart from the putative AP-2 and Homer binding motifs 
mentioned above, other key motifs or regions have been found that might target DAGLα to the 
proteasome. In this context, a putative destruction box (D-box) motif has been identified within the 
C-terminal tail of DAGLα (Gareth Williams, unpublished data). The D-box is the most common 
sequence recognized by the anaphase-promoting complex (APC), or cyclosome which directs the 
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ubiquitin-mediated protein degradation (Burton & Solomon, 2001). Therefore the degradation of 
DAGLα might be controlled by APC-dependent degradation. Indeed, a similar mechanism that 
regulates the degradation of MAGL, a protein responsible for the major 2-AG degradation, has 
been reported and the degradation of MAGL has been shown to be regulated by BRCA1, a 
protein which possesses ubiquitin E3 ligase activity, in cultured cholinergic neurons (Keimpema et 
al, 2013b).  
Evidence has been found to suggest that direct phosphorylation of the catalytic domain within 
DAGLα is a key regulatory mechanism for the enzyme (Reisenberg et al, 2012) (Dr Praveen K 
Singh, unpublished data). Phosphorylation may also play a role in DAGLα localization by 
modulating protein-protein interactions. Indeed, the interaction with CamKII has been reported to 
be dependent on the phosphorylation of two sites in the tail region of DAGLα (Shonesy et al, 
2013). Interestingly, this DAGLα C-terminal tail region is completely absent in DAGLβ 
(Reisenberg et al, 2012). It will be interesting to test if this tail region is important for endocytosis 
by generating a C-terminal deleted version of HA-DAGLα or by testing if a chimeric version of 
DAGLβ containing the tail region from DAGLα localises to, and can be internalised at spines. 
Constructs to test this are relatively easy to design and indeed some are now available in the 
Doherty lab. DAGLα and DAGLβ also differ in their short N-terminals which are only15-17 amino 
acids long. As mentioned above, this N-terminal sequence in DAGLα contains a putative AP-2 
binding motif (RRRWS) which is conserved across species but is absent in DAGLβ. Although the 
peptide 1 targeting this putative AP-2 binding motif didn’t show significant effect on DAGLα 
internalization, it is possible that other sites in this region also play a role. Future studies will be 
required to identify the regions of the enzyme that are required for internalisation and recycling, 
and mutagenesis as well peptide mimetic studies are planned. For example, we have designed a 
construct that swaps the first 15 amino acids of DAGLα to the N-terminal of DAGLβ to test the 
effect of this on recycling at the cell surface.  
The design of tools that specificity inhibit DAGL internalisation, or mutant constructs that cannot 
be cycled between the intracellular and cell surface compartments, will be required to test the 
function of dynamic cycling. Our hypothesis is that this will regulate the amount of enzyme on the 
surface and thereby directly impact on the levels of 2-AG synthesised in response to upstream 
signals. This in turn should impact on activation of CB1/2 receptors in the same cell (autocrine 
signalling) or activation of CB1 receptors on the terminals that synapse on DAGLα rich spines 
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(juxtacrine signalling). The studies reported in the thesis lay the groundwork for the development 
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